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Intracellular proteins are phosphorylated by kinases and dephosphorylated by
phosphatases. Protein phosphatase inhibitor-1 (1-1) inhibits protein phosphatase-1
(PP-1), thereby increasing the phosphorylated state of proteins in the cell. The initial
aim of the work reported here was to determine whether 1-1 is a kidney 'stem' cell
marker (Svennilson et al., 1995); if so, it would be the first unique marker for these
cells. The project involved characterizing the protein coding region of the mouse 1-1
gene, determining the 1-1 protein expression pattern in the developing mouse embryo
and analysing potential promoter elements of the 1-1 gene.
A mouse genomic library was screened using a mouse cDNA clone homologous to the
published rat 1-1 mRNA and two types of clones with positive sequence homology to
the rat mRNA sequence were isolated. These overlapping clones were sequenced, and
analysis showed that the predicted mRNA and protein sequences contain 513
nucleotides and 171 amino acids, respectively, with both sharing over 95% homology
with the known rat sequences. Further comparison of the predicted mouse protein 1-1
sequence to those of rabbit, rat and human showed that there is strong homology
across species, and that all share motifs which are important for inhibiting PP-1 (a
KIQF sequence at amino acid positions 9-12 and a threonine at position 35). The
mouse 1-1 gene contains seven protein-coding exons which lie in a 7 kb region of
DNA on chromosome 15, band F.
Svennilson et al. (1995) detected 1-1 expression in peripheral metanephric
mesenchyme (nephron progenitor) cells in rat sections using RNA in situ
hybridization. With this in mind, the mouse protein expression pattern was
determined using whole-mount tissue, a commercially available anti-I-1 antibody and
fluorescent confocal microscopy. The results showed that 1-1 is not a 'stem' cell
marker in the developing kidney, but is restricted to the peripheral epithelial layer of
cells of the kidney i.e. the mesothelium. The epithelial phenotype was confirmed by
x
the use of laminin and pan cytokeratin antibodies, while a Pax-2 antibody showed that
the 1-1-positive cells were not metanephric mesenchyme. Further analysis of tissue
from the coelomic cavity (lung, liver, heart, intestine and gonad) showed 1-1
specificity to the mesothelium in embryonic and adult tissue. There was internal 1-1
expression in the developing sex cords of ~E13 testis, but expression was down-
regulated as the testis developed. Inhibitor-1 was also expressed in the surface layer
of ectoderm. Human lung tissue was analysed for 1-1 expression but, since it had high
levels of autofluorescence, it was unsuitable for fluorescent microscopy.
A construct containing ~9 kb of 5' upstream sequence from one of the isolated
genomic clones was inserted into the promoterless vector pEGFP-1, which will only
produce an enhanced green fluorescent protein (EGFP) if the inserted DNA contains a
functional promoter. A second construct was built using ~3 kb of upstream genomic
DNA. The two constructs were used to transiently transfect the cell lines HEK293
(human embryonic kidney) and 4/4 RM-4 (rat mesothelial) using FuGENE 6 (Roche).
The transfection protocol was optimized for each of the cell lines but neither of the
two constructs resulted in EGFP-positive cells. However, the results do indicate the
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The research reported here was undertaken to characterize the mouse protein
phosphatase inhibitor-1 gene, and to determine whether it is a candidate stem cell
marker of the developing kidney, as suggested by Svennilson et al. (1995). This
chapter consists of: an anatomical section describing the kidney and its
development; a description of kidney stem cells; a brief account of genes
expressed during kidney development; and an overview of protein phosphatase
inhibitor-1.
1.2. Mammalian renal formation: an overview
The mouse embryo is a widely used model for mammalian development. The
main reasons for this include ease of handling and a short gestation period that
allows embryological development to be determined within a narrow time-scale.
Mouse development can be compared to other higher vertebrates, including
humans, although one main difference is the process axial rotation (also referred to
as turning) of the murine embryo, resulting in the inversion of the germ layers (see
review by Kaufman & Bard 1999).
Kaufman & Bard (1999) reviewed the development of the post-implantation
mouse embryo, analysing each organ system in isolation and with reference to
gross embryonic development. The murine embryo has a gestation period of
approximately 19 days. At around E7-5 (E = embryonic day; EO-5 is defined as
midday on the day of plug detection), the embryo undergoes gastrulation where
the epiblast cells migrate into the primitive streak and separate the epiblast from
the underlying hypoblast. This process results in the formation of the three germ
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Figure 1.1. Diagram of the developing mouse embryo at ~E8 showing the
formation of the mesoderm. The paraxial plate mesoderm forms the somites,
the intermediate mesoderm forms the nephrogenic cord, and the lateral plate
mesoderm forms the somatopleure and the splanchnopleure (indicated by the
blue arrows). Adapted from Kaufman & Bard (1999).
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The mesoderm itself partitions into three components:
(1) the paraxial mesoderm which gives rise to the somites at ~E8;
(2) the intermediate plate mesoderm (~E8) which forms the urogenital ridge at E9,
and further develops into the gonads, urogenital mesentery, paramesonephric
duct and the nephric duct; and
(3) the lateral plate mesoderm which is the last of the mesodermal tissues to form
at E8-5, splitting to form the somatopleure (which will form body wall
musculature) and the splanchnopleure (which will form gut musculature). The
mesothelium is the cellular layer lining the inner coelomic cavities and is
derived from this lateral plate mesoderm.
Renal formation in mammals and birds involves inductive interactions between
two types of tissue derived from the intermediate mesoderm which form the
transient but functionally distinct pronephros and mesonephros before formation
of the permanent excretory organ of higher vertebrates, the metanephros. The
nephron is the basic functional unit of the metanephric kidney.
The pronephros is derived from the intermediate mesoderm, but both the
mesonephros and the metanephros form by condensation of the nephrogenic cord
(also referred to as the mesenchymal blastema) that lies in the urogenital ridge.
The urogenital ridge itself gives rise to the metanephric mesenchyme (MM) and
the epithelial ureteric bud (UB), an outgrowth of the mesonephric or Wolffian
duct, and these two tissue types form the metanephric kidney. Although the MM
and UB are both derived from the intermediate plate mesoderm, they are otherwise
unrelated, neither being descended from the other. In the mouse, the transient
pronephros and mesonephros form at E9 and E9-5, respectively, followed by








Figure 1.2. Schematic representation of the developing mouse embryo showing
the position of the developing pronephros, mesonephros and metanephros.
Adapted from Kaufman & Bard (1999).
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1.2.1. The pronephros
The pronephros is the functional excretory organ in larval fish and amphibians, but
the mesonephros is the permanent organ in the adult organisms. There are
differences between the types of nephron found in the pronephros and the more
complex excretory organs: the pronephros contains nephrons which are not
integrated into the renal tubule (Fig. 1.3). The pronephros of amphibians is a
functional structure, but is considered to be one large unintegrated nephron that
filters wastes into the coelomic (or body) cavity. In comparison to non-teleost fish
and amphibians, teleost fish have a more advanced pronephric structure that
consists of a glomerulus, and when two of these structures fuse, a glomus is
formed. The pronephros of reptiles, birds and mammals do not form glomera or
glomeruli, and may have a limited functional role (for reviews, see Vize 1997; and
Kaufman & Bard 1999).
1.2.2. The mesonephros
During the renal development of mammals, the pronephric duct degenerates, but
the caudal region forms the Wolffian duct, forming part of the excretory system.
The mesonephros is also known as the Wolffian body and is a less complex
structure than the metanephros, although both structures have a similar vascular
system. Pigs have a functional mesonephros, but the mouse and human structures
are obsolete. The mesonephros contains two types of nephron: an integrated
glomerulus; and a ciliated nephrostomal connection to the coelom (the latter is
often not present in mammals and birds since the placenta is well developed in
these organisms; for review, see Kuure et al. 2000). As the nephrogenic cord
extends caudally, there is regression at the rostral end, and thus, the organ is never
fully complete. The paramesonephric (Miillerian) ducts form from the urogenital
ridge and eventually become part of the female reproductive system whereas the
Wolffian duct forms part of the male reproductive system as the mesonephros













Figure 1.3. The (a) integrated and (b) unintegrated nephron. In the integrated
nephron, the blood supply (shown in red and blue to represent entry into and exit
from the kidney, respectively) is associated with the proximal and distal tubules of
the nephron. In the unintegrated nephron, there is no close contact between the





Figure 1.4. Development of the vertebrate excretory system (not drawn to scale),
(a) An unintegrated nephron of the pronephros, (b) The pronephros degenerates
(dotted lines) as the mesonephros develops, and glomeruli form (10-50 nephrons
may be present), (c) The ureteric bud grows from the nephric duct and will
eventually form the metanephros, consisting of hundreds of thousands of nephrons.
The broken line represents the degenerating mesonephric duct. Adapted from
Vize et al. (1997).
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1.2.3. The metanephros
The metanephric kidney controls osmoregulation of the blood system of higher
vertebrates and removes the collected vascular waste; there are approximately one
million nephrons in the adult human organ. The maturing metanephros has a
gradient of nephron maturation with the fully formed structures situated near the
medulla and the early aggregates located at the cortex (Fig. 1.4; for reviews, see
Herzlinger 1994; Bard et al. 1994; Davies 1996; Vize 1997; Davies & Bard 1998;
Kaufman & Bard 1999).
The kidney has been a favoured organ for studying development since its
successful culture in vitro by Grobstein (1956). This allows the maturation of the
organ to be studied and thus, the phenotypic changes which occur in vivo can be
mimicked in vitro. This has obvious benefits to the investigator since it would be
difficult to visualize and manipulate such processes in vivo. The requirements for
normal development of the kidney were also established by Grobstein (1956): the
ureteric bud (UB) must be in contact with the metanephric mesenchyme (MM) for
elongation and branching, but the MM can be induced by other inducing tissues
such as spinal cord. Tack of contact of the MM cells with the inducing UB results
in apoptosis of the mesenchyme (Saxen et al. 1983), although the survival factors
present that prevent apoptosis are unknown (for review, see Davies 1996).
However, recent studies have shown that isolated MM and UB can be cultured in
the absence of the reciprocal tissue (Karavanova et al. 1996; Qiao et al. 1999a)
although the medium must be conditioned or contain specific molecules (see
section 1.5 for details).
Signals from the mesenchyme initiate growth of the UB, which itself induces
mesenchyme-to-epithelial transition of the MM to form the nephron (see section
1.5 for details). The altered phenotype associated with mesenchyme-to-epithelial
transition is peculiar to the kidney since it is not a feature of other glandular
organs, such as the lung and salivary gland (Hay 1995). However, modern
techniques, such as gene targeting, have allowed developmental processes to be
analysed in terms of genetic controls in vivo since genes can be switched off and
their role during embryogenesis determined (see section 1.5 for further details).
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In the metanephric kidney, the peripheral stem or blast cells of the MM have the
potential to form both stromal and epithelial cells. These stem cells are termed
pluripotent since they are have one of several fates, as opposed to precursor cells
which have a single predetermined fate. During epithelialization, the stem cells
condense and form pretubular aggregates, comma- and S-shaped structures, and
finally, the nephron. Vascularization of the nephron occurs during the S-shaped
phase of development to form the glomerulus and is an important process after the
inductive interactions have been initiated (Sorokin & Ekblom 1992). The
integrated metanephric nephron consists of the glomerulus and the Bowman's
capsule, which are closely associated with each other, as well as the proximal and
distal convoluted tubules, and the loop of Henle. The nephron is derived from the
MM and the urinary collecting ducts from the UB (Fig. 1.5; for reviews, see
Davies 1996; Vize 1997; Kaufman & Bard 1999).
1.3. Stem cells in the developing kidney
At the end of the nineteenth and in the early twentieth centuries, the renal blast or
stem cells were thought to derive from the epithelial UB, suggesting that such cells
would have to be included in the MM before nephron development. It is now
widely acknowledged that the metanephric blastema is the origin of the range of
epithelial cells of the kidney, as highlighted by the work by Grobstein (1956).
However, in a review article, Herzlinger (1994) supported the former stem cell
theory by postulating that cells of the ureteric bud (UB) can give rise to nephron
progenitors within the metanephric blastema. Herzlinger (1994) based this theory
on work using a lineage marker system and transfection studies using lacZ tagged
cells. These studies showed that the uriniferous tubule is derived exclusively from
the UB, but also, controversially, that the UB is a source of stem cells for the
metanephric blastema. This is at odds with more recent work, particularly with
reference to glial cell-line derived neurotrophic factor (GDNF) and its tyrosine
kinase receptor, c-ret, which belongs to a family of proto-oncogenes. GDNF is
10
Collecting duct Nephron
Figure 1.5. Development of the vertebrate integrated nephron: (a) the loose
mesenchyme (M) and ureteric bud (UB) undergo reciprocal interactions which
lead to (b) condensation of the mesenchyme around the bifurcated ureteric
bud; the condensed mesenchyme leads to (c) comma- then (d) S-shaped
structures; and (e & f) the final stages of development of the nephron. The
nephron is derived from the metanephric mesenchyme and the collecting duct
from the UB. Vascularization of the nephron occurs during the S-shaped
stage, but the final glomerulus (G) is indicated in (f). Adapted from Sorokin &
Ekblom (1992).
expressed by kidney mesenchyme and is required for early induction and
subsequent growth of the UB (Pichel et al. 1996; Pepicelli et al. 1997; Sainio et al.
1997). The c-ret receptor is expressed by the UB and disruption of its expression
results in abnormal kidney development. The phenotypes of c-ret and GDNF
knock-out mice are identical (see section 1.5.2 for further details). However,
mesenchyme from c-ret ~ ~ mice can be induced to form nephrons in culture
(Durbec et al. 1996; Schuchardt et al. 1994, 1996), an observation that would not
be expected if Herzlinger's (1994) theory is correct. It may be possible that there
is integration of epithelial cells from both the UB and epithelialized MM during
nephron formation, and this could explain Herzlinger's (1994) hypothesis.
The term 'stem cell' is contentious since researchers have conflicting views as to
its exact definition. However, it is agreed that stem cells are not precursor cells,
since the former are multipotent whereas the latter are committed to differentiate
to a specific cell type. Bard et al. (1996) referred to stem cells as already induced
MM, and similarly, Davies & Brandli (1997) suggested that stem cells are early
condensates or at least are not uninduced MM, having undergone the initial
inductive step. Dressier & Douglass (1992) characterized the transcription factor,
Pax-2, which is expressed by the condensed mesenchyme and its epithelial
derivatives, but the term 'stem cells' was not used by these authors, although these
Pax-2-positive cells could be classified as stem cells since they are early
condensates. In this thesis, stem cell will refer to the early-induced mesenchyme.
In the developing kidney, the stem cells are located at the periphery of the organ
during development since the cells undergo nephrogenesis after induction by the
UB, thus giving the characteristic gradient of nephron formation found in the
developing kidney. As described earlier, if the MM is not invaded by the UB, then
the uninduced cells die by apoptosis (Koseki et al. 1992), but the stem cells must
have survival factors to prevent this from occurring. Therefore, the stem cells
cannot be uninduced MM since they do not die. The lack of data for stem cell
phenotype and exact location during kidney development highlights the need for a
suitable stem cell marker. Although Pax-2 (Dressier & Douglass 1992) and
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hepatocyte growth factor (HGF; Sonnenberg et al. 1993) do label uninduced MM
cells, there is no unique marker for the kidney stem cells (Davies & Brandli 1997).
1.4. Other cell types in the kidney
The metanephric mesenchyme, epithelial ureteric bud and the stem cells are not
the only cell populations found in the kidney. Proper renal function is only
possible if the organ has undergone the correct developmental processes to
produce a range of different cell types.
Kidney stromal cells are derived from the mesenchyme and are an important
source of growth factors for the developing organ to ensure mesenchyme-to-
epithelial transformation, and for UB and collecting duct growth. These key roles
were highlighted by analysis of brain factor 2 (BF-2; also termed Foxdl) a
forkhead/winged helix transcription factor that is expressed in the mesenchyme-
derived stromal cells of the kidney. BF-2' knock-out mice survived for 24 h after
birth; the kidneys were small, fused longitudinally and had a small number of large
condensates, although the presence of the stromal cells was unaffected in the
knock-out mice. The mutant mice had limited branching of the ducts and there
was a failure of epithelial differentiation (Hatini et al. 1996).
The glomerular basement membrane is produced by the podocytes and endothelial
cells (Ekblorn 1981; Sariola et al. 1984) and maintains the structure of the
glomerulus since it is the framework upon which other cells grow. Laminins are
major components of this glomerular basement membrane. The laminin a5
mutant mouse had abnormal basement membrane structure resulting in altered
glomerular growth and development: the glomerular epithelial cells were not
properly arranged, and some of the mutant mice lacked one or both kidneys (Miner
& Li 2000).
Endothelial cells present in the kidney are believed to arise from the blood vessels
as the organ develops, as suggested by in vitro culture of MM that showed a lack
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of both endothelial and mesangial cells (Ekblom 1981). Risau & Ekblom (1986)
showed that developing endothelial cells secrete angiogenic factors and suggested
that these factors increase blood vessel development in the kidney. Breier et al.
(1992) analysed the expression pattern of vascular endothelial growth factor
(VEGF), an angiogenic mitogen that targets vascular endothelial cells. The
protein was observed in epithelial cells of the glomerulus, suggesting a role for
VEGF during endothelial growth and development. Kitamoto et al. (1997)
showed that VEGF is an important molecule for glomerulogenesis since newborn
mice injected with an anti-VEGF antibody had fewer nephrons than control
animals. Endothelial cells also give rise to neurons but the process of innervation
of the kidney has not been fully characterized. Renal nerves do effect kidney
development and sympathetic innervation function alters during maturation (for
review, see Robillard et al. 1993). Afferent renal innervation of rat kidneys is
more complete by birth since the nerves are already in their target regions, but the
efferent nerves mainly develop postnatally (Liu & Barajas 1993). GDNF~'~ mice
have defective enteric innervation, and lack ureteric bud induction and kidney
formation (Moore et al. 1996; Pichel et al. 1996; Sanchez et al. 1996) although
whether this neuronal growth factor directly affects kidney innervation has not
been determined.
Mesangial cells are mesenchymal, smooth muscle-like cells and maintain the
structure of the glomerular capillaries in association with the endothelial cells.
Mesangial cell development is dependent upon platelet derived growth factor
(PDGF-B; Leveen et al. 1994) and its receptor (PDGF-R(3; Soriano 1994; Lindahl
et al. 1998). GDNF is expressed in the human kidney; it is a growth factor for the
mesangial cells and may have a role in the pathogenesis of glomerulosclerosis
(Orth et al. 2000).
Dendritic cells are involved in the primary immune reaction, and in the kidney
they are located in the glomerular mesangium, cortical cells and the endothelia
surrounding the convoluted tubules. Gieseler et al. (1997) enriched and
characterized the dendritic cells from rat kidneys, and found that there is a shared
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phenotype with those from the spleen. Therefore, it is likely that these dendritic
cells mount an immunological attack during allograft rejection.
1.5. Genetic control of kidney development
Metanephric kidney development involves the time-specific expression of a range
of genes to form the final organ and hundreds of genes are already known to
express during kidney development. The Kidney Development Database'
developed by Davies & Brandli (1997), lists the current genes expressed by the
developing kidney and can be accessed on the world-wide web at
http://golgi.ana.ed.ac.uk/kidhome.html. However, it is important to isolate the genes
which have a direct developmental role from the housekeeping genes that are
present for normal cellular function.
Genes contain regions of DNA which code for proteins and regulatory functional
elements, the latter of which can be used as a tool for studying kidney
development and disease. The technology that allows gene transfer in vitro has the
potential to be applied in vivo (for review, see Fine 1996). For example, vectors
which have reporter molecules, such as lacZ, can be fused with a stretch of
genomic DNA containing regulatory elements. Transgenic mice can then be
produced and analysed for expression of the fusion protein. Mutation analysis in
mice and molecular techniques, such as differential display, have identified new
and previously uncharacterized genes switched on during renal development.
Rosenblum & Yager (1997) modified the differential display technique by pooling
expressed cDNAs from mouse metanephroi and using this as a multiplex probe to
screen a total mouse embryo cDNA library. This allowed identification of
previously undetermined genes expressed in the induced mouse metanephros.
The genes expressed in the UB or MM which are responsible for normal kidney
development can be broadly divided into the groups of transcription factors,
signalling molecules, and the receptors and components of the extra-cellular
matrix (ECM).
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Figure 1.6 shows the complex relationship between genes, transcription factors
and external signalling molecules which regulate gene function leading to
developmental changes (reproduced by kind permission of Dr Jonathan Bard).
Disruption of function by gene targeting can confirm the contribution of an
individual gene to kidney development and allows the role of the gene in
embryonic and adult development to be analysed. However, there are genes which
must be expressed during two or more stages of kidney development for normal
embryonic development. For example, Pax-2 is required for outgrowth of the UB
during early induction of the kidney, but is also important for the spatial
orientation of the ureter (Sanyanusin et al 1995). Therefore, it would be
misleading to assume that the Pax-2 gene only has a role during kidney formation
since early death of the embryo would not highlight any later function of the gene.
Conversely, if a gene has an essential role in embryonic development before
kidney formation and results in embryo lethality before renal development, then its
function or expression during nephrogenesis will not be fully realized. Therefore,
alternative methods would have to be used, such as lacZ tagging of the protein and
analysis of the resulting transgenic mice, to determine whether the gene was
expressed in the kidney.
It is possible that alternative pathways in the mouse physiology compensate for
lack of a gene's function. Transforming growth factor-(3l (TGF-pl) knock-out
mice are normal at birth (Shull et al 1992), but this does not signify the lack of a
role for the gene during kidney development. The TGF-(3l protein is expressed in
the mesenchyme underlying epithelial structures in the kidney (Heine et al 1987),
reflecting mRNA expression (Tehnert & Akhurst 1988). In vitro studies have also
shown that there is enhanced nephrogenesis when TGF-(3l antibodies are applied
in culture, suggesting that branching morphogenesis is inhibited by the growth
factor (Sakurai & Nigam 1997).
16
Externalsig l e.g.induction
Motorsf r:differentiation; growth/apoptosis;and morphogenesis. Changeicompetence (newTFs).
Figure1.6.Typicalgeneticn tworkfodevelopm nt.C esyfDJ ath nBard.
Thus, compensatory pathways may allow for normal development after knock-out
of the gene, which could lead to misinterpretation of the results since the initial
conclusion would be that the gene had no function at that particular stage of
development.
1.5.1. Transcription factors
Transcription factors are nuclear proteins which regulate gene expression. One of
the earliest genes expressed during kidney development is the Wilm's tumour
suppressor gene (WT-1) present in the mesenchyme before UB formation, and in
the comma- and S-shaped structures after induction (Pritchard-Jones et al. 1990).
Mutations in the WT-1 gene can result in childhood renal tumours. Pax-2 is a
nuclear transcription factor of the paired-box family and, as mentioned earlier, is
expressed by the nuclei of condensing mesenchyme and the epithelial derivatives,
hut the gene is down-regulated as the kidney matures (Dressier et al. 1990;
Dressier & Douglass 1992). Pax-2 ^ mice lack kidneys and even Pax-2+/~mice
have kidney hypoplasia (Torres et al. 1995). WT-1 mice do not express Pax-2 in
the mesenchyme, suggesting that WT-1 is expressed upstream of Pax-2 during
kidney development (Kreidberg et al. 1993).
The Liml homeodomain gene encodes a transcription factor that controls early
inductive events during renal development (Barnes et al. 1994). The protein is
expressed in the UB. induced MM aggregates and the developing nephron (Fujii et
al. 1994; Karavanov et al. 1998; for review, see Piscione & Rosenblum 1999).
Liml~~ mice have a lethal phenotype as well as renal and gonad agenesis, and they
lack anterior head development (Shawlot & Behringer 1995).
As described earlier, the BF-2 (Foxdl) gene codes for a nuclear binding protein
that is expressed in the stroma of the developing kidney. The stroma is an
important source of growth factors for the developing kidney, and transgenic mice
lacking BF-2 expression do not have a duct system and have few nephrons (Hatini
et al. 1996). This transcription factor has an important role in three separate
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processes: differentiation of the condensed mesenchyme, growth and branching of
the UB, and elongation of the ureter.
Analysis of heterozygous and homozygous mice for other genes of the
forkhead/winged helix family, Foxcl and Foxc2 (formerly known as Mfl and
Mfhl, respectively), has suggested a role for these overlapping genes in kidney and
cardiovascular development (Kume et al. 2000). Compound heterozygous mice
have hypoplastic kidneys and a single hydroureter, whereas the heterozygotes are
normal.
1.5.2. Signalling molecules, receptors and signal transduction
pathways
External factors, such as growth factors and hormones, can have a direct effect on
gene transcription through the activation of cell surface receptors which then
excite the intracellular signal cascade pathways. This results in transmission of the
signal through the cytoplasm of the cell to the nucleus, altering gene transcription
and leading to effects on morphogenesis and development (Fig. 1.6).
Growth factors are bioactive peptides which have a range of functions. These
peptides act upon the cell by binding to specific cell surface receptors, causing a
cascade reaction within the cell. The two main classes of growth factor receptors
are the protein tyrosine kinases and the guanine nucleotide-binding (G) proteins.
Growth factors may control development by autocrine (affecting the same tissue
type) or paracrine (affecting a different tissue type) control pathways (for review,
see Mumby & Walter 1993). Adding to the complexity of the regulatory systems
involved, the factors may be regulated by more than one signalling pathway in the
cell, depending upon receptor expression.
The phosphorylation and dephosphorylation of regulating proteins controls cellular
processes, such as the cell cycle and protein synthesis. Protein kinases are
enzymes which phosphorylate proteins (i.e. add a phosphate group to a protein) in
the cell and protein phosphatases dephosphorylate proteins (i.e. remove a
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phosphate group from a protein). This balance between the phosphorylated state
of the target proteins is important for normal growth and development.
Protein kinases comprise of serine/threonine kinases and tyrosine kinases. The
mitogen-activated protein kinases (MAPKs) are a major serine/threonine kinase
group involved in signal transduction, and there are at least three MAPK signalling
pathways: extra-cellular signal-regulated kinase (ERK); c-jun N-terminal kinases
(JNKs); and p38-MAPK. Since regulation of the phosphorylated state of a protein
affects the cell cycle, growth (and consequently development), then abnormal
receptor expression, altered cytokine/hormone levels or disruption of the signal
transduction pathway can have a direct effect on morphogenesis. Protein
phosphatases are discussed in further detail in section 1.7.
There are many signalling molecules expressed in the developing kidney and one
of the main groups is the TGF-(3 superfamily. TGF-f5l can inhibit nephrogenesis,
although the growth factor has no effect on uninduced tissue (Rogers et al. 1993).
Experiments using conditioned media and cell lines cultured in collagen gels have
shown that TGF-(3l influences the nephrogenic epithelia by: inhibition of
branching morphogenesis only; inhibition of branching morphogenesis and
tubulogenesis; and inhibition of growth factors influencing morphogenesis and
tubulogenesis (Sakurai & Nigarn 1997). However, as discussed previously in
section 1.5, TGF-(3r mice have no obvious renal abnormalities (Shull et al.
1992) a finding that conflicts with in vitro analyses, suggesting that there are
compensatory signalling pathways allowing for normal development in the
absence of this growth factor. Kallapur et al. (1999) showed that lethality caused
by TGF-/31 gene deletion was mouse strain-dependent and that a genetic
component influences susceptibility to the mutation.
GDNF is also a member of the TGF-(3 superfamily and is a survival factor for
dopaminergic neurons (Fin et al. 1993). As described earlier in sections, GDNF is
expressed by MM, and is required for early induction and subsequent growth of
the UB. GDNFmice have kidney agenesis or dysgenesis, and lack enteric
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innervation (Pichel et al. 1996; Pepicelli et al. 1997; Sainio et al. 1997). The
GDNF tyrosine kinase receptor, c-ret, is expressed by the UB. Disruption of c-ret
expression results in similar development abnormalities to the GDNF knock-out
mice (Durbec et al. 1996; Schuchardt et al. 1994, 1996). In GDNF mutants, the
MM continues to express Pax-2 at E12-5, indicating that GDNF may be expressed
downstream of Pax-2 (Pichel et al. 1996).
As mentioned earlier in section 1.4, VEGF is an angiogenic cytokine important for
blood vessel development within the kidney. Carmeliet et al. (1996) showed that
formation of blood vessels was abnormal (but not absent) in heterozygous
VEGF embryos, but is more impaired in VEGF homozygotes, resulting in
death at mid-gestation. This suggests dose-dependent regulation of embryonic
vessel development by VEGF. Similarly, Ferrara et al. (1996) disrupted the
VEGF gene in embryonic stem cells and showed that the loss of a single VEGF
allele is lethal in the mouse embryo between Ell and E12. Angiogenesis and
blood-island formation are impaired, resulting in several developmental
abnormalities.
There are several known ligands for epidermal growth factor receptor (EGFR),
including EGF, TGF-a and heparin-binding EGF. Sakurai et al. (1997)
demonstrated incomplete branching morphogenesis by inhibition of EGFR and
HGF in vitro, suggesting that there are other tubulogenic pathways present in the
developing kidney. The interaction between TGF-a, EGF and EGFR has been
implicated in polycystic kidney disease (Fouser & Avner 1993). Richards et al.
(1998) mutated EFGR and then introduced the gene into mice affected by
autosomal recessive polycystic kidney disease (ARPKD). The kidney function
improved, suggesting that EGFR has a role in the formation of kidney cysts. FIGF
is expressed by the MM, and transcripts of c-met (its receptor) have been localized
to the ureter, proximal and distal tubule (Sonnenberg et al. 1993). Kjelsberg et al.
(1997) showed that the HGF and c-met pathway is not vital for the mesenchyme-
to-epithelial transformation in the kidney since cultured mef cells respond to
EGF and TGF-a, and undergo conversion. However, the cells form tubules in the
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presence of TGF-a, but not HGF. Increased levels of interleukin-6 (IL-6) and
TNF-cc are both associated with glomerulonephritis and tubulointerstitial nephritis.
Leonard et al. (1999) showed that TNF-a induced IL-6 by activation of the p38-
MAPK and ERK pathways in human cultured primary mesangial and proximal
tubular cells.
There is growing evidence that fibroblast growth factors (FGFs) and their
pathways have a role during kidney development since mice lacking the broad-
range FGF receptor (FGFR) have either small kidneys or lack renal development.
There are also lung, cutaneous, glandular and limb disorders associated with this
FGFR disruption (Celli et al. 1998). A dominant-negative mutant FGFR disrupted
early inductive signalling in the affected tissues, indicating that FGF is required
for growth and patterning. Karavanova et al. (1996) successfully cultured
metanephric mesenchyme in vitro in the absence of inductive tissue using cultured
medium from a UB cell line supplemented with basic FGF (bFGF or FGF-2) and
TGF-a. This showed that the physical contact between the MM and UB is not
necessary for induction, but does depend on a range of soluble factors present in
the medium. Qiao et al. (1999b) analysed FGF-7~~ mice, and found that the
kidneys from these mice were smaller, the number of nephrons was significantly
lower and the collecting system was reduced in size in comparison to the wild-type
mice. The presence of FGF-7 was found to be vital for UB growth and survival,
and high levels of FGF-7 delayed differentiation. Short term exposure of
exogenously applied FGF-7 to kidney cultures resulted in an increase in nephron
number and collecting system size.
The family of Wnt genes encode for secreted glycoproteins, some of which are
expressed in the developing kidney. Kispert et al. (1996) showed that Wnt-4 is
expressed in the condensing mesenchyme, and comma- and S-shaped bodies (first
shown by Stark et al. 1994), Wnt-7b is present in collecting duct epithelia, and Wnt
7 7 is restricted to the branching ureteric tips. Wnt-4 is required for tubule
formation and can induce tubulogenesis in isolated mesenchyme culture, but Wnt-
11 cannot (Kispert et al. 1998).
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It is apparent that a range of growth factors is required for normal kidney
development, as highlighted by the in vitro experiments carried out by Karavanova
et al. (1996) but more recently by Plisov et al. (2001). Plisov et al. (2001) has
shown that cultured rat UB cells secrete TGF-(32 and leukaemia inhibitory factor
(LIF), factors which resulted in enhanced tubulogenesis in isolated, uninduced rat
MM cultures, although TGF-(32 can induce MM epithelialization in the absence of
LIF. Furthermore, the experiments suggested that a common Wnt-dependent
pathway is shared by TGF-(32, LIF and FGF-2, since exogenous Frizzled-related
protein 1 (which neutralize Wnt ligands) negated the stimulatory effect of the
factors.
1.5.3. Components of the extra-cellular matrix
The extra-cellular matrix (ECM) provides the necessary framework to support the
branching ureteric bud and has a role in controlling the differentiation and
morphogenesis of the developing kidney (Fouser & Avner 1993). The cell-cell or
cell-matrix contact dictates differentiation of a cell because of the presence of cell
adhesion receptors and the growth factors in the environment, resulting in
excitation of one of the signal transduction pathways (for review, see Sastry &
Horwitz 1996).
The basal lamina is composed of cell adhesion molecules, proteins, proteoglycans
and a range of receptors, and the collagen and laminin components form sheets
which are bound by nidogen (also referred to as entactin; Ekblom 1996). The
basal lamina changes in composition as the kidney develops (Fouser & Avner
1993), a process that is important since the membrane must support the change in
the physiology of the mesenchymal cells and regulate the cell polarity of the
epithelial cells (Hay 1995). Before kidney induction, the basal lamina consists of
fibronectin, and collagen types I and III, but after induction, collagen type IV and
laminin predominate. Polycystic kidney disease is a result of disruption of the
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basal lamina, although other elements, such as altered growth factor levels, are
also involved.
Laminins are heterotrimeric glycoproteins and are one of the main components of
basement membranes. In vitro experiments using a blocking antibody specific to
the laminin E8 cell-binding site resulted in inhibition of epithelial structures
(Sorokin et al. 1990). As described earlier, the glomerular basement membrane is
an important structure of the glomerular filtration unit, but is also essential for
vascular organization during development since homozygous mice lacking the
gene for laminin a5 lack properly vascularized glomeruli. Furthermore, some of
these mice have only one or no kidney, suggesting a role for a5 in kidney
development (Miner & Li 2000).
Integrins are heterodimers consisting of a and (3 peptides, and are the main cell
surface receptors of the basal lamina (for review, see Ekblorn 1996). As the
kidney develops, there is an alteration in the expression pattern of the a and (3
chains (Korhonen et al. 1990). The a3(3l integrin receptor, expressed by the UB
and derived ducts, has a role during branching morphogenesis (Ekblom et al.
1991; Rahilly & Fleming 1992). The a3fir'~ mice have abnormal kidneys,
exhibiting irregularities including lack of organization of the basement membrane
and reduced branching of the glomerular capillary loops. The lungs also show
signs of decreased branching and the mice die on the first day after birth
(Kreidberg et al. 1996).
The a8(3l integrin is expressed in the MM before and after condensation but not in
later structures. Heterozygous mice which carry one mutated a8 locus are
phenotypically normal. Most of the homozygous mice lacking this a8 subunit die
soon after birth as a result of kidney agenesis or dysgenesis, although a small
number of animals survive because of the presence of one kidney. These findings
show the importance of integrins for kidney morphogenesis (Muller et al. 1997).
24
1.5.4. Other factors involved in kidney development
Sulphated glycosaminoglycans (GAGs) are proteins expressed by both the ureteric
bud and nephrons. Syndecan-1, the first identified GAG to be expressed during
kidney development, increases in expression during mesenchymal condensation.
Davies et al. (1995) used an in vivo culture system to show that GAGs regulate
growth and morphogenesis of the UB, and inhibition of the UB (but not nephron
formation) occurs if sodium chlorate, an inhibitor ofGAG sulphation, is present in
the culture medium. Expression of the secreted glycoprotein Wnt-11 is lost when
metanephric kidneys are cultured in the presence of chlorate, suggesting that
sulphated proteoglycans are important for sustained Wnt-11 expression (Kispert et
al. 1996). Kispert et al. (1998) also showed that Wnt-4 signalling requires GAGs
and cell contact for tubulogenesis. Heparin sulphate proteoglycans (HSPGs)
interact with a range of signalling molecules, including members of the Wnt
family. Homozygous mice lacking the gene encoding heparin sulphate 2-
sulphotransferase (HS2ST) do not develop kidneys, have increased bone
mineralization of the skeleton and show signs of reduced eye development
(Bullock et al. 1998).
Lithium ions can induce epithelial morphogenesis of metanephric mesenchyme
without the presence of an inducing tissue in vivo (Davies & Garrod 1995). In
vitro experiments by Klein & Melton (1996) have shown that lithium inhibits the
enzyme glycogen synthase kinase-3(3 (GSK-3(3), thereby mimicking the Wnt
signalling pathway. Whatever the precise mechanisms involved, these
experiments showed that a chemical inducer of mesenchymal differentiation can
replace the inducing tissue for in vitro experiments.
1.5.5. Summary
The complex interaction of the transcription factors, signalling molecules and
ECM receptors all have a role in the control of embryonic growth and
development. In terms of metanephric formation, WT-1 is one of the first factors
expressed, but normal kidney development involves sequential and parallel
expression of a range of genes after initiation.
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1.6. Protein phosphatase inhibitor-1 may be a stem cell
marker in the developing kidney
As described above, kidney-specific markers have been identified for certain cell
populations (e.g. BF-2/Foxdl for the stromal cells; Pax-2 is expressed by early
mesenchyme-to-epithelial cells), but there is currently no unique cellular marker
for the stem cells of the kidney. This sub-population of cells has an important role
in forming the stromal and epithelial cells of the kidney, and it is thought that adult
kidneys can partially regenerate after surgery, presumably because of the presence
of these cells.
Svennilson et al. (1995) analysed frozen cryostat sections of El5 rat kidneys for
protein phosphatase types 1 and 2A (PP-1 and PP-2A, respectively) using RNA in
situ hybridization. Protein phosphatases are required for regulation of growth and
differentiation, and Svennilson et al. (1995) showed that both types of
phosphatases are ubiquitously expressed in most cellular compartments of the rat
kidney. However, sections incubated with radio-labelled oligonucleotides for PP-
1 inhibitor-1 (inhibitor-1 or I-1, an endogenous inhibitor to PP-1) show specific
expression in mesenchymal cells at the periphery of the tissue. On the basis of
these results, Svennilson et al. (1995) suggested that 1-1 is the first marker specific
to the cortical mesenchymal stem cells of the kidney and classified these stem cells
as phenotypically unaltered by the ureteric bud. Bard et al. (1996) and Davies &
Brandli (1997) both referred to stem cells as already induced metanephric
mesenchyme (hence these cells would be expected to express Pax-2). The
confusion surrounding the definition of a stem cell highlights the need for a
suitable marker for defining such cells in the kidney. However, for the 1-1 protein
to be a candidate stem cell marker, it would have to fulfil certain criteria. The
protein should only be expressed in a sub-population of MM kidney cells in the
periphery of the organ and should co-express with other stem cell markers (e.g.
Pax-2 and I IGF, although both proteins are not exclusively expressed by the stem
cells). Stem cells should exhibit reduced apoptosis since these cells must survive
to ensure continued nephron formation during development.
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1.7. Protein phosphatases and inhibitor-1
Inhibitor-1 is a small heat- and acid-stable protein, and an endogenous inhibitor to
PP-1. Protein phosphatase-1 and PP-2 are the two main classes of protein
phosphatases and their function is to remove phosphate groups from a protein. PP-
1 is comprised of four isoforms derived from three genes. PP-2 has three
subgroups: 2A, 2B and 2C. PP-2B (or calcineurin) is more substrate-specific than
PP-1 or PP-2A. There are other phosphatases (e.g. PP-6), but less is known about
their tissue specificity and functions in the cell. Protein phosphatase-1 and -2A
comprise over 90% of the protein/serine phosphatase activity in mammalian cells,
and dephosphorylate proteins in a range of processes and pathways, including the
cell cycle and protein synthesis. These phosphatases are the main antagonists to
the protein kinases which phosphorylate proteins in the cell. It is this balance of
phosphorylation and dephosphorylation that regulates cellular functions and
processes such as protein synthesis, the cell cycle and carbohydrate metabolism
(for reviews, see Mumby & Walter 1993; Oliver & Shenolikar 1998).
Phosphorylation of 1-1 by cAMP-dependent protein kinase results in the
suppression of PP-1 activity, leading to a large increase in intracellular
phosphorylation reactions (for reviews, see Mumby & Walter 1993; Oliver &
Shenolikar 1998). The unique conformational change of 1-1 upon phosphorylation
appears to be selectively recognized by PP-1 and 1-1 is likely to have no other role
in the cell than to inhibit PP-1 (Endo et al. 1996). Since the phosphorylation of 1-1
can be altered in response to hormones and neurotransmitters, 1-1 has a role in
signal transduction.
The rabbit 1-1 protein sequence was first derived from skeletal muscle protein by
Aitken et al. (1982) and has strong homology with the 1-1 sequences derived from:
rabbit liver protein (MacDougall et al. 1989); the predicted protein sequence from
rat muscle cDNA by Elbrecht et al. (1990); and the predicted human sequence
from a cDNA brain library (Endo et al. 1996). Allen et al. (2000) created I-l
mice which underwent normal physical development. Thus, loss of the I-l protein
is not lethal to the developing embryo, but long-term potentiation (LTP) was
27
down-regulated at perforant path-dentate granule cell synapses, although the mice
performed as well as wild types during water maze tests. LTP is important for
maintaining long-term synaptic strength.
Aitken et al. (1982) determined that rabbit 1-1 protein had a molecular weight (Mr)
of 18 640 but a Mr of 26 000 was estimated after polyacrylamide gel
electrophoresis in the presence of sodium dodecyl sulphate (SDS-PAGE). The
latter figure is in agreement with the Mr of 26 500 detected by Hemmings et al.
(1992) from rabbit brain tissue and the Mrof 26 000 found by MacDougall et al.
(1989) from a range of rabbit tissue. In mouse, the 1-1 protein has an apparent
molecular mass of 30-5 kDa (extracted from brain by Hemmings et al. 1992), and
it is 30 kDa for rat (MacDougall et al. 1989; Hemmings et al. 1992; Fryckstedt et
al. 1993; Lowenstein et al. 1995; all determined by SDS-PAGE). The apparently
higher than expected values obtained by SDS-PAGE were a result of the
abnormally low binding of the detergent (Aitken et al. 1982).
The expression pattern of 1-1 has mainly been demonstrated by immunoblotting
and Northern analysis. MacDougall et al. (1989) detected 1-1 by immunoblotting
in rabbit and rat skeletal muscle, brain, heart, kidney, uterus and adipose tissue.
Inhibitor-1 was not detected in rat or mouse liver, but was present in the tissue
from rabbit, pig, sheep and guinea pig. MacDougall et al. (1989) also detected 1-1
in the skeletal muscle of a range of species, including mouse, pig, rabbit, rat and
guinea pig. Hemmings et al. (1992) detected 1-1 by immunoblotting in various
compartments of the brain of frog, turtle, canary, pigeon, mouse, rabbit, cow and
monkey, but not goldfish. Peripheral tissues such as heart, kidney and pancreas
from a range of species (including rabbit, rat and cow) also expressed 1-1 at
various levels. There was no 1-1 detected in rat and cow liver, a similar finding to
the results obtained by MacDougall et al. (1989). Fryckstedt et al. (1993) detected
1-1 in rat kidneys by immunoblotting and immunocytochemistry. Sakagami et al.
(1994) used in situ hybridization and immunoblotting to detect 1-1 in rat brains and
showed high levels in certain cortical compartments, including the hippocampal
formation and the piriform cortex. Lowenstein et al. (1995) showed the presence
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of 1-1 by immunoblotting and immunocytochemistry in the neocortex of adult rat,
cat and ferret.
1.8. Functions of inhibitor-1
The role of 1-1 appears to be solely to inhibit PP-1, and thus, it would be
reasonable to assume that any function of 1-1 will ultimately involve PP-1. The
four identified areas of 1-1 function are: synaptic plasticity; glycogen metabolism;
cell growth; and muscle contraction (Oliver & Shenolikar 1998).
The 1-1 knock-out mice developed by Allen et al. (2000) showed no obvious
physical abnormalities. However, this does not necessarily imply lack of
physiological roles in the cell for 1-1 since it is feasible that alternative
compensatory pathways could be involved. For example, the presence of another
PP-1 inhibitor could increase the phosphorylation reactions in the cell. As
mentioned earlier, the 1-1 knock-out mice lacked long-term potentiation, although
the animals performed equally as well as wild types during memory tests.
Adrenalin activates protein kinases in the cell and inactivates the enzyme glycogen
synthase via phosphorylation. This is thought to be because of the kinase
phosphorylation of 1-1 leading to PP-1 inactivation (for review, see Oliver &
Shenolikar 1998). Scrimgeour et al. (1999) compared wild type and 1-1 knock-out
mice to test the hypothesis that activation of glycogen synthase by insulin is
caused by the lowering of PP-1 inhibition by 1-1. However, there was no
difference between mouse types since insulin increased glycogen synthase activity,
and subsequently, glycogen synthesis in both cases. This finding suggests that 1-1
is not essential in the stimulation of glycogen synthesis and the current model for
glycogen synthase in cultured cells involving a PP-1 targetting subunit may not be
valid. However, the work of Scrimgeour et al. (1999) does not exclude the
possibility that there may be subsidiary pathways involved in glycogen synthesis.
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Protein phosphatase-1 is necessary for the growth of cultured pituitary tumour
cells. The addition of cAMP and cyclosporin A (both are antiproliferative)
increased the levels of 1-1 phosphorylation, and thus, 1-1 may be a growth
regulator (for review, see Oliver & Shenolikar 1998). However, PP-1 levels do
not fluctuate during the cell cycle.
Gupta et al. (1996) showed that 1-1 is present in guinea pig ventricular
cardiomyocytes and that levels are hormonally regulated since treatment of I-1 -
enriched extract with isoproterenol (a (3-adrenergic agonist) resulted in
phosphorylation. This may be important for cardiac contractility through
inhibition of PP-1.
Smooth muscle PP-1 is bound to myosin and dephosphorylation of the myosin
light chain protein results in relaxation of the muscle, but an increase in
intracellular levels of cAMP also leads to the relaxation of smooth muscle. This
conflicting observation is a result of hormonal activation of 1-1 (e.g. by
epinephrine), inhibiting the PP-1 that interacts with smooth muscle myosin light
chain kinase (MLCK) phosphorylation. Thus, the balance of phosphorylation and
dephosphorylation is required for normal muscle control (for review, see Oliver &
Shenolikar 1998).
1.9. Other inhibitors of protein phosphatase-1
Inhibitor-1 is not the only inhibitor to PP-1. Other inhibitors have different tissue
distribution and different modes of PP-1 inhibition.
1.9.1. DARPP-32
Dopamine- and AMP-regulated phosphoprotein with an apparent Mr of 32 000
(DARPP-32) is structurally related to 1-1, is also a cAMP-regulated inhibitor of
PP-l. but is the product of a separate gene and has different tissue distribution
(Hemmings et al. 1992; Fryckstsedt et al. 1993; Towenstein et al. 1995).
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Furthermore, the two proteins may interact differently with the PP-1 catalytic sub-
unit (Connor et al. 1998). DARPP-32 inhibits PP1 activity only after
phosphorylation on threonine 34 by protein kinase A (Walaas et al. 1983).
DARPP-32 levels are reduced in the striatum of transgenic mice presymptomatic
for Huntington's disease (Bibb et al. 2000).
DARPP-32 is found predominantly in the brain (particularly in the basal ganglia)
and neuronal tissue in a range of species (Hemmings et al. 1992), and was initially
extracted from bovine adipose tissue (Stralfors et al. 1989). However, adipose
tissue from rabbit and rat mainly contains 1-1 (Hemmings 1992) and. although the
significance of this difference is unclear, it suggests there may be a role for both
inhibitors in adipogenesis.
DARPP-32 is present in the kidney (Aperia et al. 1987) and the protein is
concentrated more in the renal medulla than the cortex, and is present in the UB
(Fryckstedt et al. 1993). In renal tubules, DARPP-32 inhibits sodium resorption
by blocking the activity of Na , K+-ATPase (Aperia et al. 1987; Meister et al.
1989).
Double knock-out DARPP-32 and 1-1 mice (i.e. mice with both DARPP-32 and I-
1 genes disrupted) have been generated and the regulation of glycogen synthase
was found to be similar to the wild type mice (Scrimgeour et al. 1999).
1.9.2. lnhibitor-2
Inhibitor-2 (1-2) is an acid- and heat-stable protein (for review, see Oliver &
Shenolikar 1998). In human fibroblasts, 1-2 reaches its highest expression during
S phase and mitosis during the cell cycle, as determined by Kakinoki et al. (1997)
using green fluorescent protein fused to 1-2. Unlike 1-1,1-2 can inhibit PP-1 when
unphosphorylated, and Connor et al. (2000) characterized a novel interaction
between the N terminus of the 1-2 protein and the PP-1 domain, consisting of
amino acids Glu-53, Glu-55, Asp-165, Glu-166 and Lys-167. However, 1-2 and
DARPP-32 have separate unrelated motifs required for binding PP-1 (Huang et al.
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1999). Osawa et al. (1996) isolated three separate isotypes of 1-2 from a rat testis
cDNA library: I-2al, I-2a2 and 1-2(3. Inhibitor-2al and I-2a2 are derived from
the same gene, but 1-2(3 is coded from a different gene, is only expressed in the
testis, and may have a role in sperm motility (Osawa et al. 1996).
1.9.3. NIPP-1
Nuclear inhibitor of PP1 (NIPP-l) was originally isolated from bovine thymus
nuclei (Beullens et al. 1992) and the protein is expressed in a range of mammalian
tissues (Van Eynde et al. 1995). NIPP-1 is similar to 1-2 in that it is a potent
phosphatase inhibitor in the dephosphorylated state and forms a stable, inactive
complex with PP1. Wera et al. (1997) showed that NIPP-1 expression in
reticulocyte lysates and COS-1 cells is controlled at the translation level, and thus,
over-expression of this PP-1 inhibitor in the COS-1 cells was unsuccessful (NIPP-
1 is one thousand times more potent as an inhibitor of PP-1 than 1-1 or 1-2).
1.9.4. RIPP-1
Buellens et al.( 1996) isolated a ribosomal 23 kDa basic polypeptide inhibitor
(RIPP-1) from rat liver that was more efficient in inhibiting ribosome-associated
PP-1 (PP-1 R) than other protein phosphatases.
1.9.5. CPI17
C-kinase activated phosphatase inhibitor (CPI17) is a novel inhibitor of PP-l. ft
was isolated from porcine smooth muscle (Eto at al. 1995) and is the same protein
encoded by a cDNA clone isolated from a porcine aorta cDNA library (Eto et al.
1997). The CPU 7 protein is 16-7 kDa and is only expressed in smooth muscle: the
mRNA for CPI17 is expressed exclusively in smooth muscle such as aorta and
bladder, but not in skeletal muscle or non-muscle tissues (determined by Northern
analysis). CPU 7 inhibits the myosin-bound PP1 complex as well as the free PP1
catalytic sub-unit, suggesting that it is functionally different to 1-1 and DARPP-32.
CPU 7 has a role in the control of smooth muscle, and myofibril-bound PP-1 has
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been identified as a target of CPI17 in vascular smooth muscle by Senba et al.
(1999), who analysed the myofibrillar extract from porcine aorta.
1.9.6. lnhibitor-4
Shirato et al. (2000) isolated I-4 from a human cDNA library of germ cell
tumours, and the protein shares 44% homology to 1-2. Inhibitor-4 strongly
interacts with PP-1C.
1.9.7. Summary
The inhibitors DARRP-32, 1-2 and NIPP-1 may be present in the developing
kidney but RIPP-1 and CPI17 are not likely to be found outwith their own
specified tissue. However, the full array of inhibitors to protein phosphatases is
not complete since the use ofmore sensitive molecular techniques is revealing the
presence of other inhibitors. Thus, the presence of other inhibitors in the cell
cannot be discounted.
1.10. The aim of the project
The initial aim of this research project was to test the hypothesis of Svennilson et
al. (1995) that the 1-1 protein is a kidney stem cell marker. Kidney stem cells
differentiate to give both nephrogenic and stromal cells following induction, as
described earlier, and signal transduction will be important in this process.
Therefore, 1-1 may have an important role in modulation of differentiation of these
cells. Determining a unique cellular marker for the stem cells would have benefits
in confirming the location and physiological role of these cells during kidney
development. Initially, genomic clones were isolated after a mouse library
screening and were analysed to ensure homology to the known rat 1-1 mRNA
sequence. From these clones, the genomic structure of the mouse 1-1 gene was
determined, the mRNA and protein sequences were predicted, and the
chromosomal localization of the gene was identified (Chapter 3). The protein
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expression of 1-1 in the developing mouse embryo was determined using whole-
mount tissue, a commercially available antibody and confocal microscopy
(Chapter 4). Finally, the presence of regulatory elements in the 5' flanking







Before any practical work was initiated, safety procedures were followed according
to the Department of Biomedical Sciences safety manual
(http://www.bms.ed.ac.uk/healthsafe/home.htm) and the University of Edinburgh Health and
Safety Policy (http://www.safety.ed.ac.uk/h&spof). Gloves and a lab coat were worn at all
times in the laboratory. If particularly hazardous substances were handled (e.g. radio¬
isotopes) then double gloves were worn. This provided not only personal safety but
also a safe working environment for others in the laboratory.
Laboratory waste (i.e. hazardous, biological or general refuse) was disposed of in
accordance with departmental and university rules. Risk assessments and forms for
the control of substances hazardous to health (COSHH) were completed for
chemicals, equipment and protocols used in the laboratory. The codes of practice for
genetic modification and the handling of radioisotopes were followed, including the
attendance of courses associated with the relevant topics. Manual instructions for
equipment were read before use and all electrical equipment had been safety-tested
by the university.
2.2. General materials and solutions
The general solutions used in the laboratory were used according to protocols from
the laboratory manuals by Sambrook et al. (1989) and Ausubel et al. (2000), or from
datasheets provided by the manufacturers. Sigma water (Sigma, St Louis, MO, USA)
was used for the elution of plasmid DNA and for some of the solutions, since it is
ultra-pure.
Antibiotics Ampicillin (disodium salt) and kanamycin were dissolved in
Sigma water to a final concentration of 50mgmL~' and
25 mg mL"1, respectively, and stored at -20 °C.
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L-Broth Miller's modification medium (Luria broth base; Sigma) was
used at 15-5 g L~ . The solution was autoclaved and stored at
room temperature.
LB agar plates L-Broth was prepared as above and Select agar (Sigma) was
added at 15 g L autoclaved then cooled to 55 °C in a
waterbath. The plates were poured in the laminar flow hood,
allowed to dry and stored at 4 °C until required. For antibiotic
plates, L-B agar was prepared and after cooling to 50 °C,
antibiotic was then added before pouring the plates: ampicillin
and kanamycin were used at final concentrations of 50 pg mL"1
and 25 pg mL"1, respectively. The plates were stored at 4 °C
until required.
PBS A PBS tablet (Sigma) was dissolved in 200 mL distilled water,
then autoclaved. This gave a final concentration of 10 mM
phosphate buffer, 2-7 mM potassium chloride, 137 mM sodium
chloride.
4% PFA Four grams of paraformaldehyde (PFA; Sigma) per 100 mL
PBS was heated to 90 °C to dissolve, then stored at -20 °C.
TBE 5 x TBE was prepared by dissolving one sachet (Sigma) in one
litre of deionized water.
TBS 100 mM Tris-HCl pH 7-5
400 mM sodium chloride
The solution was autoclaved before use.
TE Buffer 10 inM Tris
1 mM EDTA
The solution was pH'd to 7-5 then autoclaved.
SM 0 • 1 M Sodium chloride
10 mM magnesium sulphate MgSCfi.7FLO
50 mM Tris.HCl, pH 7-5
The solution was autoclaved then gelatin was added, to give a
final concentration of 0-01%.
SOB 2% w/v Bacto-tryptone (Sigma)
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0-5% w/v Bacto-yeast extract (Sigma)
10 mM sodium chloride
2-5 mM potassium chloride
The solution was autoclaved and sterile 1 M magnesium
chloride was added to give a final concentration of 20 mM.
SOC A 1 M glucose solution was added to SOB (made up as above)
to give a final concentration of 20 mM.
SSC (20 x) 3 m sodium chloride
0-3 M Tri-sodium citrate
The solution was diluted to give a 1 x stock as required.
Xgal/IPTG Plates A 10% w/v solution of Xgal in Dimethyl Formamide (DMF)
was prepared. IPTG was dissolved to a concentration of 0-2 M
in Sigma water. 20 pL each of Xgal and IPTG were spread
over a dried L-agar plate. The plates were allowed to dry in
the fume hood for 30 min before plating the cells.
2.3. General methods
2.3.1. Growth conditions for bacterial cultures
A liquid culture of bacterial cells was grown overnight in a 37 °C shaking incubator at
225 rotations per minute (rpm). Streaked-out cultures were grown inverted on L-agar
plates in a 37 °C incubator. The plates or liquid cultures were not allowed to grow for
over 17 h, to ensure optimal growth conditions for the bacterial cells and to maintain
maximum plasmid integrity. The genetic manipulation room in the Anatomy Section
(Department of Biomedical Sciences) was level containment 1 and was sufficient for
all genetic modification work carried out for the project.
2.3.1.1. Plates: A streaked-out plate was obtained by initially sealing the end of a
glass Pasteur pipette. Bacteria (e.g. from a frozen glycerol stock or a scraping from
an older streaked-out plate) were transferred using the closed end of the pipette and
then streaked onto a fresh plate, according to the method in the laboratory manual by
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Sambrook et al. (1989). For plating a liquid culture (e.g. transformation of competent
cells), 100 pL-200 pL of culture was spread onto a fresh plate using a sterile glass
spreader. After overnight growth, the plates were sealed with Parafilm and stored
inverted at 4 °C until required.
2.3.1.2. Liquid: A sterile Gilson yellow tip was used to inoculate 5 mL of L-broth
(in a 30-mL sterile plastic Universal tube) using a single, well isolated colony from a
streaked-out plate. The cap was loosely taped to allow adequate aeration of the
culture. A sterile 50-mL plastic Falcon tube was used if the volume of culture was
between 5-15 mL. Larger volumes of culture (i.e. more than 15 mL) were grown in
autoclaved, sterile conical flasks.
After overnight growth of the liquid culture, a 15% glycerol stock was prepared as
follows: 150 pL glycerol (sterilized by autoclaving) was added to 850 pL liquid
culture in a sterile 1-5-mL Eppendorf tube. The contents were vortexed to mix and
stored at -70 °C. This glycerol stock was used to re-streak the culture to avoid re-
transformation of the plasmid DNA. Thus, only one clone was used for analysis.
2.3.2. Preparation of competent Escherichia coli strain DH5a cells
Competent cells Escherichia coli (E. coli) strain DH5oc were prepared using the
calcium chloride protocol described in the laboratory manual by Ausubel et al.
(2000).
2.3.3. Transformation of competent Escherichia coli strain DH5a cells
(1) An aliquot of competent cells was removed from the -70 °C freezer and thawed
on ice. Fifty-mL or 30-mL sterile plastic tubes were cooled on ice.
(2) A 20 pL aliquot of the competent cells was placed into each cooled tube and 1 pL
of plasmid DNA was added. The contents were swirled gently to mix, and the
tubes incubated on ice for 30 min.
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(3) The cells were heat-shocked for 40 s in a 42 °C waterbath and returned to ice for
2 min. Eighty microlitres of SOC was added to the cells and the tubes were
incubated at 37 °C, 225 rpm, for 1 h.
(4) The cells were plated onto L-agar plates with ampicillin or kanamycin (used at
50 and 25 pg mL respectively), as described above in section 2.3.1. The plates
were grown inverted overnight at 37 °C.
(5) After growth of the colonies, a sterile yellow tip was used to inoculate 5 mL L-
Broth plus antibiotic. The cultures were grown overnight in the 37 °C shaking
incubator at 225 rpm.
When scaling up the transformation reagents, 100 pL competent cells and 5 pL
plasmid DNA were used but the cells were heat shocked for 50 s then added to
100 pL ofwarmed SOC medium.
2.3.4. Transformation ofXL10-Gold ultra-competent cells
This procedure was carried out according to the instructions supplied by Stratagene
(La Jolla, CA, USA).
2.3.5. Plasmid DNA preparation
Figure Ala-g, Appendix l (pp. 166-172) lists the maps of the vectors used in this
research project. QIAprep Spin miniprep kit (QIAGEN GmbH, Hilden, Germany),
PERFECT prep miniprep kit (5 Prime —> 3 Prime, Inc., Boulder. CO, USA), GFX™
Micro plasmid prep kit (Amersham Pharmacia Biotech, Little Chalfont, UK),
Wizard" Plus MiniPrep and Wizard" Plus MaxiPrep DNA Purification System
(Proinega Corporation, Madison, WI, USA) were all used according to the
manufacturer's instructions. All plasmid miniprep DNA was eluted in a final volume
of 100 pL. However, if the insert size was larger than 10 kb, the Sigma water was
heated to 70 °C to before elution, as recommended by the QIAGEN handbook. This
step was included for each miniprep kit where appropriate. The maxiprep DNA was
eluted in 1 mL of Sigma water.
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2.3.6. Restriction digestion of DNA
Reaction volumes for digestion of DNA depended upon the concentration of DNA
used. The values given in Table 2.1 were a guide for setting up single, double and
triple digests, assuming that the DNA concentration was between 500 and
1000 ng pL~'. Ifmore DNA was required for digestion (e.g. for excising a band from
a low melting point agarose gel), then the reaction volumes were increased, but the
volume of reaction buffer was maintained at 10% of the final volume. Routinely, the
volume of enzyme used was 1 pL of stock. Most enzymes had a concentration of
10 units pL_I, and since 1 unit of enzyme is defined as digesting 1 pg of DNA in one
hour at 37 °C, then adding excess enzyme should allow for complete digestion.
Table 2.1. The volume of reagents (pL) for restriction digestion of DNA. The volume of water used
per digest was dependent on the concentration ofDNA, and thus, values 'x' and 'y' were variable.
Reagent Single digest Double digest Triple digest
DNA X X X
10 x Buffer 1 1 1
Enzyme 1 1 1 1
Enzyme 2 - 1 1
Enzyme 3 - - 1
Sigma water y y y
Final volume 10 10 10
2.3.7. Agarose gel electrophoresis
Ethidium bromide was handled carefully, and contaminated solid waste was disposed
of according to local health and safety rules. When viewing a gel using the ultra
violet (UV) transilluminator, gloves and a full-face mask were worn. Any liquid
waste containing ethidium bromide was passed through an ethidium bromide
adsorption column (BDH, Poole UK) to remove the chemical. The pass-through
liquid was rendered safe by the column.
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The electrophoresis buffer, TAE, was prepared according to the method described in
the laboratory manual by Sambrook et al. (1989) and TBE was prepared as described
in section 2.2. Agarose from Sigma (type EEO) was prepared in 1 x TBE for
standard gel electrophoresis. SeaKem agarose (BioWhittaker Molecular Applications,
Rockland, ME, USA) and low-melting-point agarose (Sigma) were prepared in
1 x TAE for optimal recovery of DNA from the gel. Markers were included in the
gels to allow for both prediction of the size of bands and also to estimate the
concentration of DNA. The 1-kb ladder from Life Technologies Inc. (GIBCO BRL,
Rockville, MD, USA) was used routinely.
(1) Powdered agarose was added to 1 x TBE or 1 x TAE in a conical flask, and
loosely covered with cling film. The solution was weighed and the mass
recorded. The agarose solution was carefully heated in the microwave until the
agarose was dissolved, but care was taken to ensure that the solution did not over¬
boil. The weight of the flask was noted and distilled water was added if there was
a loss of mass (otherwise a more concentrated agarose concentration would
result). The agarose solution was placed in a 55 °C waterbath to cool before
pouring into the mould.
(2) The gel apparatus was set up according to the manufacturers instructions. The gel
moulds were cleaned in 70% ethanol and the ends taped using insulating tape.
(3) Ethidium bromide (Sigma) was added to a final concentration of 125 ng mL~' to
the cooled agarose before casting. The gel was allowed to set at room
temperature.
(4) Once the agarose had solidified, the tape and comb were removed from the gel
mould and the assembly placed into the tank of 1 x TBE or 1 x TAE.
(5) DNA loading buffer (Sigma) was added to samples of digests at a dilution of
approximately 1:5 with sample. An appropriate DNA ladder was also prepared
with gel loading buffer. The samples were then loaded into the wells of the gel.
(6) The gel tank was then connected to a power supply (e.g. midi sized gels, were set
at 25 V overnight).
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(7) Once the gel front had migrated a suitable distance along the gel, the gel was
removed and photographed using a Polaroid land camera and UV
transilluminator.
Midi-sized gels were often used, but ethidium bromide cannot be added directly to
the melted agarose gel before casting. After electrophoresis overnight, the gel was
stained in a solution of 250 ng mL"1 ethidium bromide (diluted from a stock of
500 pg mL'1).
2.3.8. GENECLEAN protocol
The GENECLEAN kits were used to purify DNA according to the manufacturer's
instructions (BIO 101, Vista, CA, USA). The GENECLEAN and GENECLEAN
Spin kits were used.
2.3.9. Ligation reactions
Ligation of DNA into Promega pGEM1'-T Easy vector (Fig. Ala, Appendix 1,
p. 166) was carried out according to manufacturers instructions (see Table 2.2 for
volumes used). The vector, 10 x buffer and T4 DNA ligase were provided in the kit.
The tubes were either incubated at 22°C for several hours or overnight at 4°C.
Table 2.2. The volume of reagents (pL) used for ligation of PCR product into vector pGEM®-T Easy
(Promega).
Reagent Normal Control
336-bp PCR DNA 1 -
10 x Ligase Buffer 1 1
pGEM* -T Easy Vector 1 1
T4 DNA Ligase 1 1
Sigma water 6 7
Final volume 10 10
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Ligation of insert DNA into vector will only be successful if the insert and vector
DNA strands have compatible ends. Complementary overhanging ends are more
efficient at ligation than blunt-ended DNA. However, if the vector has identical ends
(i.e. if the DNA was digested using one enzyme only), then there is the potential of
self-ligation, resulting in no ligation of the insert DNA. Treating the vector with calf
intestinal alkaline phosphatase (CIAP) reduces this risk (Doyle 1996). Therefore,
after digestion with the appropriate enzyme, one unit of CIAP (Roche Diagnostics
Ltd, Lewes, UK.) was added to the digest, incubated for 15 min at 37 °C and then
heated to 65 °C to remove any CIAP activity. The reaction mixture was then
GENECLEANed. If the vector had been digested with two different enzymes which
had incompatible ends, the DNA was GENECLEANed without CIAP treatment since
self-ligation was not likely to occur.
The concentration of insert used per ligation reaction was calculated using the
following equation from Doyle (1996):
ng of vector x kb insert size x molar ratio of insert = ng insert
kb size of vector vector
The ligation reactions were set up with the desired molar ratio of insert:vector at 3:1
(Table 2.3). Therefore:
ng of vector x kb insert size x 3 = ng insert
kb size of vector 1
Table 2.3. The volume of reagents (gL) used for ligation of insert into vector. Values 'w', 'x' and 'y'
were variable.
Reagent Control Ligation
Insert DNA w w
Vector DNA X -
10 x Ligase buffer (Roche) 1 1
T4 DNA Ligase (Roche) 1 1
Sigma water y z
Final volume 10 10
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A control ligation reaction was included (i.e. no insert DNA present) to determine if
self-ligation had occurred. The final reaction volume was usually 10 pL or 20 pL but
the quantity of 10 x buffer was increased to 2 pL if using the larger volume. The
quantity of total quantity of DNA per ligation reaction was usually 50 ng.
2.3.10. Polymerase chain reaction (PCR)
Ready-To-Go PCR beads (Amersham Pharmacia Biotech) were used according to the
manufacturer's instructions. The Hybaid PCR machine (ThermoHybaid, Ashford,
UK) was programmed for 40 cycles, each cycle consisting of denaturation for 30 s at
95 °C, annealing of primers to template at 55 °C for 1 min, and finally, extension of
the primer to give amplification of template at 72 °C for 1 min. Routinely, one-fifth
of the reaction mixture was analysed by agarose gel electrophoresis.
2.3.11. Southern blot
The protocol described in the laboratory manual by Ausubel et al. (2000) was
followed.
2.3.12. Radioactive labelling of DNA and hybridization of filters
All radioactive work was carried out in a designated room to contain the
radioisotopes. The work area was monitored for contamination before and after use.
The High Prime kit (Roche) was used to label the DNA, according to manufacturer's
instructions.
Church Hybridization Mix 0-5 M PO4 pH 7-2 (made from 1m NaPCfi stock)
7% SDS
l mM EDTA
1% BSA (bovine serum albumin)
Church Wash 1%SDS
1 mM EDTA
40 mM NaP04 pH 7-2
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The Southern blot filters were wetted with 2 x SSC and placed in Hybaid
hybridization tubes. If several filters were being hybridized, a sheet of nylon
membrane was sandwiched between the filters to allow adequate flow of the radio-
labelled probe. Approximately 40 mL of prehybridization solution was used per
bottle. Just before use, denatured salmon sperm DNA was added to a final
concentration of 100 pg mL-1. The tubes were prehybridized at 65 °C in the Hybaid
oven for 60 min to equilibrate the membrane. The prehybridization solution was
discarded and replaced with 20 mL of fresh hybridization mix and salmon sperm.
The ,2P-radio-labelled DNA was added and the filters were hybridized overnight at
65 °C.
The hybridization mix was carefully discarded into the drainage system using plenty
of running water. The waste was monitored to prevent both splashes and the
formation of an aerosol. The filters were washed at 65 °C in the hybridization oven
for 3 x 20 min. The filters were then carefully wrapped in cling film and taped into
X-ray cassettes and exposed onto photographic film (Fuji or Kodak). After exposure
at -70 °C or room temperature (depending upon the strength of signal), the film was
developed.




Miller's modification medium (Sigma) and sodium chloride
were added at 15-5 and 4-5 g Lof water, respectively. The
solution was autoclaved and stored at room temperature.
LB Broth was prepared as described above and Select agar
(Sigma) was added at 15 g L-1. The solution was autoclaved
then cooled in a 50 °C waterbath. The plates were poured in
the laminar flow hood, allowed to dry and then stored at 4 °C.
LB agar was prepared as described above but antibiotics were
added before pouring the plates.
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LB/MgS04 LB agar was prepared as described above, but sterile 1 M
MgS04 was added to a final concentration of 10 niM before
pouring the plates.
LB++ LB broth was prepared as above then autoclaved. One molar
MgSO-t was added to a final concentration of 10 mM, and
maltose to a final concentration of 0-2% (from a stock of 20%).
The solution was stored at room temperature.
20% Maltose Twenty grams of maltose was dissolved in lOOmL sterile
water and then filter sterilized using a Nalgene 0-22 (im filter
unit.
LB/Top agarose LB broth was prepared as above and added MgSCfi to give a
final concentration of 10 mm (from a stock of 1 m), then added
agarose to 7-2 g L~'. The solution was autoclaved and stored at
room temperature until required. Before use, the LB/top
agarose was liquified in the microwave or in a boiling
waterbath and cooled to 50 °C.
2.5. Specialized methods used in Chapter 3
2.5.1. I.M.A.G.E. clone analysis
In order to obtain cDNA clones corresponding to the mouse l-l mRNA sequence, the
dbEST database was screened using a keyword search. The clones were ordered
through the HGMP-RC (UK Human Genome Mapping Project Resource Centre,
Hinxton, Cambridge, UK), an authorized distributor for the I.M.A.G.E. consortium.
Only the first few hundred base pairs of the clones had been sequenced by
I.M.A.G.E., and therefore, there was only partial homology to the deduced rat 1-1
mRNA.
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2.5.2. Isolation of the 5' PCR product and 3' restriction fragment of 1912-
d05 into vectors
The primers used for isolation of the PCR product were synthesized by MWG-
Biotech UK Ltd (Milton Keynes, UK). The PCR product was amplified using clone
1912-d05 as template and Ready-To-Go beads from Amersham Pharmacia Biotech
(as described in section 2.3.10). The PCR product was excised from a low-melting-
point agarose TAE gel, GENECLEANed and then inserted into pGEM^-T Easy
vector. Plasmid DNA was isolated after transformation of DH5a competent cells.
A 3' restriction fragment of clone 1912-d05 was excised from a low-melting-point
agarose gel (Sigma) then ligated into pBluescriptUKS- Plasmid DNA was isolated
after transformation of DH5a competent cells.
2.5.3. Library plating
The MoBiTec APS library (male, 129 SV D3; Fig. Alb. Appendix 1, p. 167) and the
plating cells (C600 and BNN132) were handled according to the information booklet
provided by the manufacturer (NBL Gene Sciences Limited, Cramlington. UK).
Likewise, all media and solutions were prepared according to the MoBiTec protocol.
The titre of the library was initially established to allow representation of all of the
mouse genome before the screening could commence.
2.5.4. Screening of the library
2.5.4.1. Primary screening: Reinforced cellulose nitrate membrane (Optitran
BA-S 83, 0-2 |tm, 200 mm x 200 mm) was used according to the manufacturers
instructions (Schleicher and Schuel, Dassel, Germany). The first lifts (labelled LI to
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10.1) and the second lifts (1.2 to 10.2) of the library were hybridized with the P-
labelled 336-bp PCR product and the full length 1912-d05 I.M.A.G.E. DNA clone,
respectively.
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After exposure of the hybridized filters onto photographic film, coincident plaques
were selected by alignment of the autoradiographs. For example, the exposed films
for lifts 1.1 and 1.2 were aligned and only coincident positive plaques were selected
from plate 1.
2.5.4.2. Secondary screening: After the primary phage was titred (from 10 2 to
10 6), lifts from selected plates using Flybond N+ filters (Roche) were hybridized
with radio-labelled 336-bp PCR product to screen for positive plaques.
2.5.5. Characterization of clones isolated from the library
Cre-expressing BNN132 cells were transformed with the isolated phage (from the
secondary library screening) which resulted in automatic subcloning and isolation of
the genomic insert contained within the pBluescript vector (Fig. Ale, Appendix 1,
p. 168). Therefore, the successfully excised clones grew as normal bacterial colonies
without the need for phage growth protocols. DF15a competent cells were also
transformed using the resulting plasmid DNA.
Restriction digests of the isolated genomic DNA were prepared using a range of
enzymes, loaded onto midi agarose gels and then Southern blotted. The fdters were
hybridized with radio-labelled 336-bp PCR product to confirm 1-1 sequence
homology of the clones. The gels and resulting autoradiographs were analysed by the
Gel-ProIM Analyzer for the Macintosh, Version 2.0 (Media Cybernetics, USA)
computer program to give accurate estimates of the DNA fragment sizes.
2.5.6. Orientation of the inhibitor-1 gene and the restriction maps of the
clones isolated after the library screening
The orientation of the 1-1 gene was determined by the preparation of duplicate gels
followed by hybridization using radio-labelled the 5' and 3' subclones from clone
1912-d05.
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The restriction maps of clone types were determined using the restriction digest data
and analysis of the gels by the Gel-Pro1X1 computer program.
2.5.7. Subcloning of the inhibitor-1 gene
The isolated clones from the library screening were digested with restriction
enzymes, loaded onto agarose gels and Southern blotted. The resulting positive
bands (i.e. after hybridization with the 1912-d05 full-length clone or the 336-bp PCR
product) were subcloned into pBluescriptllKS- vector (Fig. Aid, Appendix 1,
p. 169). Using the restriction map from each clone as a guide, non-hybridizing
fragments were also subcloned.
2.5.8. The sequence of the mouse inhibitor-1 gene
The subcloned genomic restriction fragments prepared in section 2.5.7 were
commercially sequenced. Each subclone was sequenced using universal and reverse
primers, but the sequence derived from the 3'-5' direction was rewritten to give the
reverse-complement sequence. The commercial companies DNASHEF (Edinburgh,
UK), MWG-Biotech (Germany) and Molecular Biology Services (King's College,
London, UK) were used.
The mouse genomic sequences were analysed using the bioinformatic program NIX
at the UK HGMP Resource Centre, Flinxton, Cambridge, UK
(http://wvvw.hgmp.mrc.ac.uk/).
2.5.9. Chromosomal localization of the inhibitor-1 gene
Chromosomal localization was carried out by Shelagh Boyle, MRC, Edinburgh, UK.
The protocol for FISH was used as described by Fantes el al. (1992).
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2.6. Specialized materials used in Chapter 4
3-aminopropyltriethoxysilane (TESPA) was used to coat microscope slides to prevent
loss of tissue after sectioning. TESPA was handled according to the safety
procedures provided from the supplier (Sigma).
PBSTX. i.e. PBS with 1% Triton X-100 (Sigma), was used as a wash and diluent for
immunocytochemistry. A stock 1% solution of the preservative sodium azide was
prepared and used at a final concentration of 0-01% for blocker solutions to prevent
growth of bacteria.
2.7. Specialized methods used in Chapter 4
2.7.1. Preparation of TESPA slides
The microscope glass slides (BDH) were loaded into racks, and cleaned in the
dishwasher, air dried, washed in absolute alcohol with l% hydrochloric acid (or
glacial acetic acid) and then air dried again.
The slides were prepared as follows:
(1) placed in 2% TESPA in acetone for 5 s;
(2) transferred to acetone for 2 x 15 s; and
(3) washed in water for 15 s then air dried.
2.7.2. Wax embedding of tissue
Tissue was fixed in 4% PFA for 1-3 h (depending upon size) at room temperature on
an orbital shaker. For larger tissue (e.g. whole-mount embryos), samples were stored
overnight at 4 °C in fixative to allow for adequate penetration. The tissue was
washed in PBS, placed into 30% ethanol for one hour and then into 70% ethanol
overnight. The sample was passed through 85%, 95% then 2 x 100% ethanol (15 min
per solution). The tissue was transferred to a glass Bijoux and placed in 50%
absolute alcohol:50% xylene for -15 min. This was replaced with xylene until the
tissue 'cleared'. The tissue was placed into three separate liquid wax baths (if the
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sample was large, a vacuum was applied) for 10 rnin per bath. The tissue was then
embedded in wax and stored at 4 °C for at least 24 h. The wax-embedded tissue was
then transferred onto a 'chuck' or wooden block for sectioning.
2.7.3. Sectioning of tissue onto TESPA slides
Seven micrometre sections of wax embedded tissue were prepared using a microtome
and placed onto the TESPA slides. The racks of slides were wrapped in foil and
placed in a 37 °C oven to dry the sections. The slides were then stored at room
temperature until required.
2.7.4. lnhibitor-1 expression in whole-mount tissue
The mouse embryos were supplied by John Verth. Jean Flockhart and Margaret
Keighren (Department of Biomedical Sciences, University of Edinburgh). Therefore,
whole-mount tissue from a range of mouse strains was analysed. The tissue was
fixed in 4% paraformaldehyde (PFA) in PBS for several hours or overnight,
depending upon size. Samples were then stored at 4 °C in PBSTX or PBS, and then
processed as follows:
(1) The tissue was incubated in the primary anti-I-1 antibody at room temperature
using an orbital shaker to ensure exposure of all of the tissue to antibody. The
anti-I-1 antibodies from Serotec Ltd (Kidlington, UK) and Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA, USA) were diluted 1:200 and 1:50 in
PBSTX, respectively.
(2) The tissue was washed in PBSTX over several hours. The PBSTX was replaced
several times.
(3) The tissue was blocked in 5% normal serum or 1% BSA in PBSTX/azide. The
tissue was incubated for several hours at room temperature on the orbital shaker.
(4) The tissue was placed into the FITC-labelled secondary antibody (Sigma), diluted
1:100 in PBSTX. The diluted antibody was vortexed then spun at full speed in a
microcentrifuge for 5 rnin to remove conjugates before applying to the tissue. The
samples were incubated overnight in secondary antibody on the orbital shaker.
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(5) The tissue was washed in PBSTX over several hours.
(6) The tissue was washed in 2 x SSC then incubated in 10 pg mLRNase (from a
stock of 10 mg mL"1) for approximately 1 h at 37 °C. During the final 20 min
incubation, propidium iodide was added to a final concentration of 0-75 pg pL"1.
For larger tissues, the samples were incubated in RNase and propidium iodide
overnight.
(7) The tissue was washed in PBS, mounted in Vectashield and analysed using the
Leica TCS NT confocal microscope.
Methanol-fixed kidneys were also processed as described but the tissue was stored at
-20 °C in fixative and no Triton X-100 was added to any of the solutions.
Gluteraldehyde (Sigma) was added to the PFA for some of the PFA-fixed kidneys.
2.7.5. Pax-2 expression in whole-mount tissue
The tissue was fixed as described in section 2.7.4, above. Flowever, the tissue was
incubated overnight at 37 °C in anti-Pax-2 antibody (made in rabbit, diluted 1:200 in
PBSTX; a kind gift from Dr Dressier). The tissue was processed as described in
section 2.7.4, steps 3-5. The tissue was then incubated in secondary antibody (FITC,
anti-rabbit, Sigma) diluted 1:100 and processed as described above.
2.7.6. Laminin expression in whole-mount tissue
The tissue was processed as described for the 1-1 antibody (see section 2.7.4, above)
but an anti-laminin primary antibody (Sigma) and an anti-rabbit FITC secondary
antibody (Sigma) were used.
2.7.7. Pan cytokeratin expression in whole-mount kidney
Kidneys were fixed and stored in methanol at -20 °C until required. Kidneys were
processed as described for the 1-1 antibody (see section 2.7.4, above) but used anti-
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pan cytokeratin (Sigma) and anti-rabbit FITC secondary (Sigma) antibodies. No
Triton X-100 was added to any of the solutions.
2.7.8. lnhibitor-1 expression in kidney sections
(1) All incubations were carried out at room temperature. The sections were de-
waxed for 10 min each in xylene; xylene and absolute alcohol (50/50); and then
ethanol dilutions of 95%, 85%, 70%, 50% and 30%. The slides were then
incubated in PBS for 5 min. The sections were blocked in serum or 1% BSA
(diluted in PBSTX) for ~1 h.
(2) The blocker was tapped off the slide and any remaining solution was carefully
dried around the section.
(3) The 1-1 antibody (Serotec) was diluted 1:500 in PBSTX and applied under a
coverslip and incubated overnight in a moisture chamber.
(4) The slides were washed for 2 x 15 min in PBSTX.
(5) The sections were blocked for ~1 h.
(6) The blocker was tapped off the slide and carefully dried around the section.
(7) The anti-sheep FITC secondary antibody was diluted 1:50 in PBSTX and was
applied under a coverslip. and incubated for over 1 h at room temperature.
(8) The slides were washed for 2x15 min in PBSTX.
(9) The FITC-labelled sections were mounted in Vectashield.
2.8. Specialized materials used in Chapter 5
The medium used for tissue culture contained L-glutamine and was ordered from
Sigma. The foetal calf serum (FCS), sterile disposable 3-mL plastic pastettes, Iwaki
tissue culture plasticware and the individual 3-cm2 sterile plastic dishes were all
ordered from Labtech International (Ringmer, UK). The cell lines were cultured
according to ECCAC method sheets. The FuGENEIM 6 transfection reagent (Roche)
was used according to manufacturer's instructions.
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2.9. Specialized methods used in Chapter 5
2.9.1. Modification of genomic type 2 clone and pBluescriptll
The insertion of oligonucleotides (to introduce unique restriction sites) into clone
type 2 was carried out according to the protocol described by Doyle (1996). The
oligonucleotides were modified by the addition of a 5' phosphate group and were
synthesized commercially (MWG-Biotech). The complementary oligonucleotides
were heated together in a boiling waterbath for 5 min, cooled to room temperature to
anneal and were then ligated to the genomic DNA. If the oligonucleotides were to be
inserted into a site that was not unique, then the DNA was partially digested. The
resulting modified DNA was used to transform competent DH5a cells.
The vector pBluescriptllKS-/+ was digested with Sail and then the site was removed
using the enzyme Pfu polymerase (Stratagene). This enzyme fills in the 5' overhangs
in the presence of excess dNTPs. After treatment, the pBluescriptllKS vector was re-
ligated and used to transform competent DH5a cells. The plasmid vector was then
digested to ensure that the restriction site had been deleted. Genomic DNA was then
inserted into this modified pBluescriptll vector.
2.9.2. The pGTT8IRES|3geo construct
The pGTl-8IRESPgeo vector (Fig. Ale, Appendix 1, p. 170) was digested, isolated
by agarose gel electrophoresis and GENECLEANed. The genomic DNA (inserted
into the Sail knock-out pBluescriptll vector) was digested then treated with CIAP.
Tigation reactions were set up to insert the GTl-8IRES(3geo DNA into the genomic
plasmid.
2.9.3. The pEGFP-1 construct
The modified type 2 clone (from section 2.9.1, above) was digested then separated by
agarose gel electrophoresis to isolate the desired fragment. The DNA was ligated
into the multiple cloning site (MCS) of the pEGFP-1 vector (Clontech, Palo Alto
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USA; GenBank accession number U55761; Fig. Alf, Appendix 1, page 171). A
shorter genomic restriction fragment was also ligated into the MCS of pEGFP-1
2.9.4. Preparation of DNA for use in transfection experiments
Maxipreps of the pEGFP-1 vector only, pEGFP-Nl (Clontech; accession number
U55762; Fig. Alg, Appendix 1, page 172) and the genomic constructs were prepared
using the Pronrega Wizard" Plus MaxiPrep DNA Purification System.
2.9.5. Cell culture
HEK293 cells (a kind gift from Dr Rory Duncan, Department of Biomedical
Sciences, University of Edinburgh) were grown in Eagle's minimum essential
medium with 10% foetal calf serum. 4/4 RM-4 cells were grown in Ham's F12
medium with 10% foetal calf serum, according to the information sheet supplied by
ECACC. All cells were grown at 37 °C in a humidified CCL incubator.
For the transfection studies, a confluent 25-cm2 tissue culture flask was trypsinized
and the cells were spun for 5 min at 1000 rpm, then resuspended in 10 mL of the
appropriate medium. A sterile, autoclaved 22 x 22 mm glass coverslip was placed at
the bottom of a 30-mm Petri dish before the addition of 1 mL of the cell suspension.
A further 1 mL of medium was added to each plate and this gave an approximate
seeding of 1 x 10" cells per plate.
2.9.6. lnhibitor-1 protein expression of the cell lines
The cell lines were cultured in individual 30-mm plates, as described in section 2.9.5.
The cells were grown overnight or until confluent, fixed in 4% PFA for 20 min at
room temperature and incubated with the anti-I-1 antibody (Santa Cruz
Biotechnology, Inc.; diluted 1:50 with PBSTX) for several hours. After washing in
PBSTX, the cells were blocked with serum then incubated in anti-goat FITC
secondary antibody (diluted 1:200) for several hours. The cells were washed then the
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coverslip was mounted in Vectashield (containing propidium iodide at a
concentration of 0-75 pg pL~') onto a microscope slide, sealed with nail varnish and
then viewed using the confocal microscope. Control cells were not incubated with
the 1-1 antibody.
2.9.7. Transfection of the cell lines
The transfection protocol outlined in the Roche handbook was followed. Fixed cells
were washed in PBS and treated with 4% PFA for 20 min at room temperature,
whereas unfixed cells were washed in PBS only before mounting. The coverslips
were mounted as described in section 2.9.6.
The number of transfected cells was determined by counting the positive cells per
500 x 500-pm area using the confocal microscope computer screen. The average
number of positive cells was taken from six random 500 pm2 areas across the slide.









A range of mouse cDNA clones which contained sequence homology to rat I-l
mRNA were selected from a database after a keyword search. One of these clones
(1912-d05) was shortened to give a 5' PCR product and a 3' restriction fragment.
A mouse genomic library was screened using the 5' PCR product of 1912-d05 and
two types of clones were isolated from the library that contained homology to rat
1-1 mRNA. Sequencing and analysis of these two clone types showed that the
protein coding region of the mouse I-l gene spans ~7 kb of genomic DNA and is
encoded by seven exons. The predicted mouse mRNA and protein sequences are
95% homologous to the published rat sequences, and the I-l gene is located on
chromosome 15, band F.
3.1.2. Aim of the chapter
The aim of this chapter was to isolate and characterize the mouse protein
phosphatase I-l gene. Analysis of the known I-l sequences of rabbit, rat and
human shows strong homology, and therefore, it was thought likely that the mouse
I-l sequence was similar to those published. The plan of work for this research
chapter was to screen a mouse genomic library to isolate clones which shared
sequence homology to rat I-l mRNA. The recombinants isolated after the
screening could then be characterized by restriction digestion, and these clones
would then be used to produce transgenic mice (Chapter 5). After the
recombinants had been subcloned and sequenced to confirm I-l homology to the
rat 1-1 mRNA, then the predicted I-l mRNA and protein sequences could be
derived. The chromosomal localization of the I-l gene could also be determined
by fluorescent in situ hybridization (FISH) and compared to other genes found in
this chromosome region.
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3.1.3. Strategy for isolating the mouse inhibitor-1 gene
The UK Medical Research Council (MRC) formed the Human Genome Mapping
Project Resource Centre (HG-MPRC) in 1990. The centre provides facilities for
genome mapping and gene isolation for the research community, as well as access
to various databases and biological materials (e.g. human YAC and mouse cosmid
libraries). Access to the facility was obtained through the Internet
(http://www.hgmp.mrc.ac.uk/). online help and advice was available if required. One
of the databases was screened using a keyword search and a list of mouse cDNA
clones homologous to the rat 1-1 mRNA sequence was obtained, allowing rapid
and reliable isolation of clones relevant to the project. One of these mouse cDNA
clones was selected for the library screening, but was shortened to give 5' and 3'
fragments.
A cDNA library is formed from messenger RNA (mRNA) isolated from tissue at a
particular developmental age and only contains the transcripts of expressed genes,
unlike a genomic library, which represents the entire genome. The commercial
library used in this project was a APS vector that contained 16-20-kb inserts of
mouse genomic DNA. There were two loxP sites flanking the insert that was
targetted for recombination, and in the presence of the enzyme Cre recombinase,
there was excision of the insert from the phage backbone (Fig. Alb, Appendix 1,
p. 167). The presence of pBluescript in the insert allowed easier handling of the
final isolated clones. The Cre-loxP system allows tissue- and time-specific DNA
recombination and has been used in vivo (for review, see Stricklett et al. 1999).
Screening of the library using the 5' fragment of a selected cDNA clone reduced
the potential for the selection of false positive clones from the library since the
homopolymeric 3' sequence was eliminated. The orientation of the 1-1 gene was
also determined by hybridization of identical Southern blots using the "P-radio-
labelled 5' and 3' DNA fragments.
Restriction digestion allowed the restriction map for each isolated clone to be
determined. Southern blotting also confirmed the presence of 1-1 gene homology
of the clones isolated after library screening and allowed the DNA to be subcloned
then sequenced. The sequences of these positive clones were determined,
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followed by comparative analysis using the computer program NIX, which is a
tool to aid the identification of nucleic acid sequences
fhttp://menu.hgmp.mrc.ac.uk/menu-bin/Nix/Nix.pfi. NIX encompasses a variety of
different nucleic acid analysis computer programs, but has the advantage that the
sequence of interest is submitted only once. As a final characterization of the
gene, the chromosomal localization of 1-1 was visualized by FISH.
3.2. Results
3.2.1. I.M.A.G.E. clone analysis
The first step towards cloning of the mouse 1-1 gene was to obtain mouse cDNA
clones with homology to the rat 1-1 mRNA sequence, one of which would then be
used to screen the mouse genomic library. Integrated Molecular Analysis of
Genomes and their Expression (I.M.A.G.E.; Lennon et al. 1996) had a variety of
high quality, partially sequenced clones, and the sequencing data had been
deposited in the public databases (e.g. EMBL and GenBank). Only the first few
hundred base pairs of the clones had been sequenced by I.M.A.G.E., and therefore,
there was only partial homology to the deduced rat 1-1 mRNA. Ten candidate
Expressed Sequence Tags (ESTs) were identified after a keyword search of the
dbEST database using the Entrez computer program. This facility was available
from the MRC HGMP-RC website at http://www.hgmp.mrc.ac.uk/. The partial
sequences were submitted to the sequence database FASTA (FastA@ebi.ac.uk) to
determine the extent of homology to rat 1-1 mRNA (Table 3.1) and the 10 selected
clones were ordered through HGMP-RC.
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Table 3.1. The l.M.A.G.E. clones selected from the dbEST database. The dbEST identification
(ID) number, clone name and I.M.A.G.E. ID number and percentage homology to rat 1-1 mRNA
are listed.
DbEST ID Clone Name l.M.A.G.E. ID number Percentage homology to rat 1-1
mRNA (FASTA)
1562249 3174-cl5 1260998 94-9
1156220 2313-c 12 0930371 94-3
745267 1244-p24 0520199 950
1481105 3141-O09 1248608 92-9
517532 706-j 19 0313458 950
926702 1912-d05 0776404 94-1
673408 804-hl2 0351035 94-7
644539 1099-j07 0464358 60-2
674484 940-i01 0403272 950
761351 1396-a05 0578188 93-9
The I.M.A.G.E. clones were received and the plasmid DNA isolated according to
section 2.3.6 in Chapter 2. Preliminary digestion of the clones determined insert
size (Table 3.2).
Table 3.2. The I.M.A.G.E. clones obtained from HGMP-RC and the insert size determined by
restriction digest and agarose gel electrophoresis: NA-the insert size was not stated by I.M.A.G.E.
Clone name Vector Enzymes used to Insert size Insert size
isolate insert stated by predicted by
from vector I.M.A.G.E. gel (kb)
3174-cl 5 pBluescript EcoRl, Xho 0-6 1
2313-c 12 pBluescript EcoRl, Xho 1-5 1-5
1244-p24 pBluescript EcoRl, Xho 1 1
3141-o09 pT7T3D-Pac EcoRl, Notl NA 1
706-j 19 pT7T3D-Pac EcoRl, Notl NA 0-8
1912-d05 pT7T3D-Pac EcoRl, Notl 0-7 0-8
804-hl2 pT7T3D-Pac EcoRl, Notl NA 1
1099-j07 pT7T3D-Pac EcoRl, Notl NA 1
940-i01 pT7T3D-Pac EcoRl, Notl NA 0-8
1396-a05 pT7T3D-Pac EcoRl, Notl NA 1-2
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Digestion of the I.M.A.G.E. DNA using the appropriate enzymes listed in Table
3.2 showed the presence of insert. However, clones 3174-cl5, 2313-c 12 and
1244-p24 gave unpredicted fragments when digested with EcoRl and Xhol, and
thus, further analysis of these was abandoned. Some of the I.M.A.G.E. clone
inserts had a higher molecular weight than stated in the data sheet from I.M.A.G.E.
Clones 1912-d05 and 3141-o09 were randomly selected for further study and were
sequenced to confirm identity (Figs A2-A4, Appendix 1, pp. 173-178). For
further analysis, the shorter clone 1912-d05 was selected since this clone would
have a reduced 3' homopolymeric sequence in comparison to clone 3141-o09.
Clone 1912-d05 was derived from a mouse BALB/c kidney library (developmental
age 6 weeks) constructed by Dr Robert Barstead as part of the Marra M/Mouse
EST project (unpublished results 1996).
3.2.2. Subcloning of the 5' PCR product and 3' restriction fragment of
1912-d05 into vectors
A 5' PCR product and a 3' restriction fragment were generated from clone 1912-
d05. The main reason for this was that the full-length and 5' product of clone
1912-d05 would be used for screening the genomic library and only coincident
plaques would be selected: the presence of the 3' homopolymeric region may give
rise to false positive clone selection. Also, orientation of the 1-1 gene could be
determined using the 5' and 3' fragments hybridized to duplicate gels (see section
3.2.6, below).
The Webcutter computer program (http://www.medkem.gu.sel) confirmed that there
was a lack of suitable restriction sites within the 1912-d05 sequence. Therefore,
PCR was used to generate a 5' product since the size of the fragment could be
accurately predicted. The primers were designed to allow a substantial 5'
fragment to be produced and the final 336-bp PCR product sequence was
homologous to the sequences of rat 1-1 mRNA, and the I.M.A.G.E. 1912-d05 and
3141-o09 sequences (Fig. 3.1).
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Figure 3.1. The first 400-nucleotide IMAGE, sequence of clone 1912-d05. The positions of the
forward and reverse primers are indicated by the highlighted green and pink nucleotides,
respectively. Thus, a 336-bp product was generated.
1 gttcagaggc caagaattcg gatccatggc cgctgcctga ccgggaoss
51 — HHIccca cggaagatcc agtttacggt cccgctgctg
101 gagcctcacc tggacccgga ggcggcggag cagattcgga ggcgccgccc
151 cacccctgcc acacttgtgc tgaccagtga tcagtcctcc ccagaaatag
201 atgaagaccg gatccccaac tcacttctca agtccacctt gtcaatgtct
251 ccacggcaac ggaagaagat gacaaggacc acacccacca tgaaagagct
301 ccagacgatg gttgaacatc acctagggca acagaagcaa ggggaaagaa
351 cctgagggag ccac-TGAGAG CACAGGGAAC BMgagtcct gcccacctgg
Forward primer Nucleotides 48-66 5'-ccatggagcccgacaacag-3'
Reverse primer: Nucleotides 365-383 5 -ctggttccctgtgctctca-3'
The primers were analysed using the computer program from Williamstone
Enterprises at http://www.williamstone.com ('Primers! for the web'). This program
predicted any potential self-annealing. The PGR product was generated using
Promega 'Ready-To-Go' PCR beads, and the product was excised from an agarose
gel, GENECLEANed and inserted into pGEM®-T Easy vector (Fig. Ala,
Appendix 1, p. 166).
A triple digest of 1912-d05 DNA with Notl, BamWl and ZscoRI isolated a
BamHl/Notl 3' fragment (-280 bp) that was excised from a low melting point gel
then ligated into pBluescriptllKS- Figure 3.2 shows the sizes of the 5' PCR
product and the 3' restriction fragment in relation to each other. The 3' fragment
was -280 bp in length, but the precise size was difficult to determine because of
degeneration of sequencing towards the 3' end.
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Figure 3.2. The sequence of 1912-d05 (from MWG-Biotech) showing the relative sizes of the 5'
PCR product and the 3' fragment highlighted in blue and pink, respectively.
GCTGCCTAGA CCGGGAGCC(| HHHHI HHHH HBHfll
mmmmH bbbhh ■HHH ———b
1 mrnHH nnm RRHHHH ■■■■■ ■■
151 HHHH b§gaccgga am HHHH
■mm■■■mmmm HHHH hbhhhh
251 mm amHmHHI HHHHI H^HH
301 HHHIHHBi HBBBHI HHHHH HHHHH
351 |GAGTCCTGC CCACCTGjm CCCAGACACA GGCTCGGCGT
4 01 f'TACCCCCGG
451 GAGCAGTGTG
GACAGCACAAA AGTCTGCAGA ATCCAACCCC AAGACTCAG
GTGTGGAGCCC AGAACAGAGG ATTCTTCAGG CCACATGCT
501 ACCACTGGAT TCCCAGGGAGC CAGCTTGGTC TGACAGAAGt TGGTATCCG
551 GGGATCACCA GTGCAGTGTGG AAATTCATGG AC ACTGGATG TTTCTTAAT
601 CTCTTGTTTT TAAAAAGTGAT AAATTTGGTG H AGGTCAAA AAAAAAAAA
Gel electrophoresis and sequencing confirmed that the 5' 336 bp-PCR product and
the 3' restriction fragment derived from clone 1912-d05 were successfully ligated
into the vectors (Figs Ala & d, Appendix 1, pp. 166 & 169, respectively).
3.2.3. Library preparation
The genomic ?lPS library (male 129 SV D3, MoBiTec) was screened in order to
isolate genomic clones which contained homology to rat 1-1 mRNA sequence.
Initially, the titre of the library was determined by diluting the library stock from
10~2 to KT6 Since each colony or plaque was derived from a single infected
bacterial cell, the average number of plaque forming units (PFUs) per microlitre of
library stock was calculated (Table 3.3, below). As a control, water replaced the X
DNA.
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Table 3.3. The number of colonies per dilution of the XPS library: (PFUs) plaque forming units.




10 5 12 106
KT4 116 106
10 3 980 106
I0"2 Confluent -
In accordance with the protocol from MoBiTec, 2 x 106 phage allowed complete
representation of the mouse genome. Therefore, 2 pL of the stock library was
plated and die resulting filters were processed as described in Chapter 2.
3.2.4. Screening of the library
The first and the second lifts of the library were hybridized with the 32P-labelled
336-bp PCR product and the full-length 1912-d05 I.M.A.G.E. DNA clone,
respectively. After primary screening, a total of 36 plaques were picked (Table
3.4). Identification of the plugs refers to the plate number followed by the plug
picked from the plate e.g. 1A referred to plate number 1, plug A. Only coincident
plaques were selected to reduce the potential for negative clone selection.
Table 3.4. The plugs selected after the primary screening of the 7.PS library; for example, 1A
refers to plate 1, plug B; and 7B refers to plate 7, plug B.







8A; 8B; 8C; 8D; 8E
9A; 9B; 9C; 9D
10A;10B
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After the primary phage plug was titred (using the range 1CT2 to 10~6), lifts were
taken from selected plates using Hybond N+ filters (Roche). These filters were
hybridized with the radio-labelled 336-bp PCR product to screen for positive
plaques. After this secondary screening, 60 positive clones were isolated (see
Table 3.5 for the full list). A tertiary screening was not necessary since the
positive plugs selected were well isolated, which reduced the chances of
contamination from neighbouring plaques.
Table 3.5. The plugs selected after the secondary screening of the APS library; for example, 1A1
refers to plug 1 selected from plate 1 A; and 8D6 is plug number 6 selected from plate 8D.
1A1; 1A2; 1A3; 1A4; 1A5
1 CI; IC2; 1C3; 1CM; IC5
1 D1; 1D2; 1D3; 1D4; 1D5; 1D6; 1D7; 1D8; 1D9; 1D10; 1D11
3A1; 3A2; 3A3; 3A4; 3A5; 3A6; 3A7; 3A8; 3A9
4A1; 4A2; 4A3; 4A4
4C1; 4C2; 4C3; 4C4; 4C5; 4C6
8D1; 8D2; 8D3; 8D4; 8D5; 8D6; 8D7; 8D8; 8D9; 8D10
9A1; 9A2
9D1; 9D2; 9D3; 9D4; 9D5; 9D6; 9D7; 9D8
3.2.5. Characterization of clone types isolated from the library
The isolated clones had DNA inserts (from 16 to 20-kb) packaged in a phage
vector. The APS vector contained an automatic plasmid subcloning facility that
allowed isolation of large fragment sizes of genomic DNA with the benefits of
plasmid handling. Within the phage, there were two loxP sites flanking the
pBluescript sequence and insert. Initially, the phage were transferred into E. coli
C600 plating cells (these cells do not express Cre recombinase). When phage
were introduced into the Cre-recombinasc expressing cells E. coli BNN132,
automatic subcloning resulted in a loss of phage material to reveal pBluescript
plasmid containing the genomic insert (Fig. Alb, Appendix 1, p. 167). This
allowed ease of handling and manipulation of the resulting genomic DNA clones,
and was more convenient than working with standard phage libraries.
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The following recombinants isolated from the library were selected and BNN132-
competent cells were transformed to isolate the insert DNA contained within
pBluescript (Fig. Ale, Appendix 1, p. 168):
1A1A 1A1B 1C1A 1C1B 1D1A 1D1B 3A1A 3A1B 4A1A4A1B
4C1A 4C1B 8D1A 8D1B 9A1A 9A1B 9D1A 9D1B
The yield of DNA after transformation of BNN132 cells was very low. Flowever,
DFI5a competent cells were transformed with the plasmid DNA, and the resulting
DNA was more concentrated and there was no loss of genomic DNA, as
confirmed by restriction digest and agarose gel electrophoresis.
The plasmid DNA isolated from the clones was double digested with Kpnl and
Shrcl to release the insert DNA from pBluescript vector, and four different types of
clones were determined by the restriction digest pattern, termed types 1-4. In
order to further characterize the clones, PCR analysis was carried out using
Promega Ready-To-Go beads (following the instruction manual to optimize the
reaction conditions) using the forward and reverse primers designed in section
3.2.2. However, analysis of the PCR products by agarose gel electrophoresis
showed the presence of only three different types of clones (Table 3.6).
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Table 3.6. The different types of clones (1-4) isolated after screening of the kPS library, as
determined by double restriction digest with Kpnl and Sad, and PCR.



















The pooled restriction digestion and PCR results suggested that there were four
different types of clone isolated from the library. Clones 4C1A, 9A1A and 9A1B
all had the same PCR pattern (type 3), but when double digested with Kpnl and
Sacl, clone 4C1A generated a different restriction pattern to 9A1A and 9A1B.
DNA from clones 1C1A, 4A1A, 4C1A and 9A1A (selected to represent clone
types 1-4, respectively) was digested with a range of double digests, and the midi
gels were blotted and hybridized with radio-labelled 336-bp PCR product. This
further characterization showed that clone types 4C1A and 9A1A (types 3 and 4,
respectively) did not have any sequence homology to 1-1 since the resulting
autoradiographs were blank. However, DNA from clones 1C1A and 4A1A (types
1 and 2, respectively) had 1-1 homology (Figs 3.3 & 3.4).
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Figure 3.3. Analysis of type 1 clone DNA: (a) 1 x TBE, 0-7% agarose gel of
type 1 clone DNA (1C1A) digested with a range of enzymes; and then (b)
Southern blotted and hybridized with the 5' 336-bp PCR product. The gel and
autoradiograph was analysed by the Gel-Pro computer program, and the 1-kb
ladder from the agarose gel was superimposed onto the autoradiograph.
Lanes:
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Figure 3.4. Analysis of type 2 clone DNA: (a) 1 x TBE, 0-7% agarose gel of type
2 clone DNA (4A1A) digested with a range of enzymes; and then (b) Southern
blotted and hybridized with the 5' 336-bp PGR product. The agarose gel and the
autoradiograph were analysed by the Gel-Pro computer program and the 1-kb
ladder superimposed onto the autoradiograph. Lanes:

















Lane 18: 50-bp ladder, 500 ng
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Analysis of the autoradiograph of the remaining 14 clones double-digested with
Kpnl and Sad (Fig. 3.5) showed that there was no DNA present on the gel for
clone 1A1B (reason unknown). The restriction pattern for 9D1B was odd,
although there was I-1 homology since the autoradiograph showed positive signal
(Fig. 3.5) and this result may have been as a result of partial digestion of the clone.
The previous Kpnl/Sad digestion pattern showed that both clones 1A1B and
9D1B were of type 1 clone (Table 3.6, above).
Analysis of the Kpnl/Sad digest of type 1 clone (Figs 3.3-3.5) gave seven
restriction fragments (Table 3.7). In Fig. 3.5, the 3-kb and 2-7-kb bands were not
well resolved after agarose electrophoresis, but Fig. 3.3 showed that three out of
the six genomic restriction fragments had I-1 sequence homology, as shown by the
presence of positive bands on the Southern blot.
Table 3.7. The restriction fragments from clone 1C1A (type 1) after digestion with Kpnl and Sacl:
(+ and —) whether the fragment contained 1-1 sequence homology (from Southern blot analysis);
and (*) pBluescript vector.
Fragment size (kb) Positive band on
Southern blot









This section of work showed that the type 1 clone was the dominant recombinant
isolated from the library: out of 18 clones isolated from the library and analysed by
restriction digest, 13 were of type 1 and two recombinants were of type 2. The
insert sizes of type 1 and type 2 clone were ~14 and ~12 kb, respectively.
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Figure 3.5. Analysis of the remaining clones isolated from the library screening:
(a) l x TBE, 0-7% agarose gel, with the remaining clones isolated from the library
screening after digestion with Kpnl and Sacl; and then (b) Southern blotted and
hybridized with the 5' 336-bp PCR product. The agarose gel and autoradiograph
were analysed by the Gel-Pro computer program. Lanes:
















3.2.6. Orientation of the inhibitor-1 gene and the restriction maps of
the two clone types
The orientation of the I-l gene was determined after hybridization of two duplicate
Southern blots with the 5' and 3' fragments of I.M.A.G.E. clone 1912-d05 (Fig.
3.6). Analysis of the Kpnl/Sacl and Kpnl/Sacl/Xbal digests gave the following
sized bands, as shown in Table 3.8, below.
Table 3.8. The size of the Kpn\!Sac\ restriction fragments (bp) from the A5 and B3
autoradiographs for type 1 (1C1A) DNA, derived from the Gel-Pro,M computer analysis system.
Filters A and B were hybridized with the 336-bp PCR product and the 3' restriction fragment,
respectively. The bands which are bracketed represent weak or faint bands; (-) an absent band;
and bold font represents the strongest radio-labelled fragment.
Kpnl/Sacl Kpnl/Sacl/Xbal
A5 B3 A5 B3
3015 2903
2759 (2799) 2742 (2779)
(1982) 1901 (1950) 1901
Analysis of filter 'A' (probed with the 5' sequence) showed that the strongest
hybridizing Kpnl/Sacl fragment was the 3015-bp band, followed by the 2759-bp
band. The 1982-bp fragment labelled the weakest (Table 3.8 and Fig. 3.6). This
suggested that the subclone at the 5' position of the gene was the 3-kb fragment,
and the 3' end of the gene contained the 1-9-kb band. Therefore, the 2-7-kb band
must lie between these two fragments.
Analysis of filter 'B' (probed with the 3' fragment) showed that the 1901-bp band
hybridized most strongly and the 2799-bp band most weakly. The 3000-bp band
did not hybridize at all (Table 3.8 and Fig. 3.6). This suggested that the fragment
at the 3' end of the gene is the 1901-bp band, with the 2799-bp fragment between
the other two since it weakly hybridized. Since the 3-kb fragment did not
hybridize at all to the radio-labelled 3' restriction fragment, then this subclone did
not contain any 3' sequence, and thus, must contain only 5' sequence. This model




Lanes 1, 20: 1-kb ladder Lane 11: KpnlPvullXbal
Lanes 2-16: 1C1A DNA Lane 12: KpnlSacl
Lane 2: BcimHIHindlU Lane 13: Kpn\Sac\Xba\
Lane 3: BamHIKpnl Lane 14: Pst\Pvu\\
Lane 4: Bam\\\Pvu\\ Lane 15: Pst\PviA\Xha\
Lane 5: HindlllPstl Lane 16: PvullXbcA
Lane 6: HindlllPvuU Lanes 17-19: 4A1A DNA
Lane 7: HindlUPvullXbal Lane 17: BamU\Hind\U
Lane 8: HindWIEcoRl Lane 18: HindlllEcoRl
Lane 9: HindWIXbal Lane 19 HinMlXbal
Lane 10: KpnlPvull
Figure 3.6. The orientation of the 1-1 gene determined by restriction digest
followed by agarose gel electrophoresis and Southern blot, (a) Two identical
1 x TBE, 1-2% agarose gels with DNA digests of clone types 1 and 2. The
Southern blots were then hybridized with the (b) 5' and (c) 3' products of clone
1912-d05. The 1-kb marker from the original gel was superimposed onto the
autoradiograph using the Gel-Pro computer program.
.. ■
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Therefore, the results suggested that the orientation of the 1-1 gene is: the 3-kb
fragment at the 5' end; the 2-7-kb band in the middle; and the 2-kb band at the 3'
end (Fig. 3.7).
Figure 3.7. The preliminary orientation of the 1-1 gene and restriction fragments predicted by
hybridization of 1C1A DNA (type 1 clone) with radio-labelled 5' and 3' fragments of 1912-d05.
The scale bar is shown.
< ►
Restriction fragment: 3000-bp 2700-bp 1900-bp
1 kb
The restriction maps were determined for clone types 1 and 2 (clones 1C1A and
4A1A, respectively) from the various restriction digests (Figs A5 & A6, Appendix
1, pp. 179 & 180, respectively). The predicted orientation of the 1-1 gene was
confirmed from the restriction map of 1C1A.
3.2.7. Subcloning of the inhibitor-1 gene
In order to facilitate sequencing of clone type l, it was decided to subclone the
positive restriction fragments determined by Southern blotting (i.e. hybridization
with the 336-bp PCR fragment; Fig. 3.3) into a suitable vector. Therefore, the
Kpnl/Sacl restriction fragments from clone type 1 (1CI A) of sizes 3, 2-7 and 2 kb
were ligated into pBluescriptllKS- (Fig. Aid, Appendix 1, p. 169). To complete
the subcloning of clone type 1, the non-hybridizing 900-bp and 600-bp restriction
fragments (determined by the restriction map of 1C1A as shown in Table 3.7)
were also subcloned into pBluescriptllKS-. To confirm overlap of the two clone
types, the 2-kb Hindlll fragment from each clone was subcloned into
pBluescriptllKS-.
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3.2.8. The sequence of the mouse inhibitor-1 gene
The subcloned fragments from the genomic clones 1C1A and 4A1A were
commercially sequenced by DNASHEF (Edinburgh) and MWG-Biotech
(Germany) for reasons of cost and convenience since no cost was incurred if no
sequence was obtained. In some instances, the same plasmid DNA was sent to
different companies for sequencing (Fig. A4, Appendix 1, p. 176, for comparative
analysis). A total of 9 kb of genomic DNA was sequenced (Fig. A7, Appendix 1,
p. 181). Nucleotide 1 does not refer to the position of the transcription start site
since the promoter regions are not known, but does refer to the 5' flanking region
ofDNA that was sequenced.
Figure 3.8. I he final arrangement of subclones which contain the 1-1 gene spanning ~9 kb of
genomic DNA. The Sac\ and Kpn\ restriction sites and the scale bar are shown.
5' 3'
Sacl Kpn\ Sacl Sacl Sacl KpnI
< ><><->< X >
3-kb 0-6-kb 0-9-kb 2-7-kb 2-kb
Comparison of the 2-kb Hindlll fragments from the clone types 1 and 2 showed
strong sequence homology (Fig. A8, Appendix 1. p. 186). Therefore, the two
clones overlapped as predicted from the restriction maps and Southern blot
analysis. From the restriction map, the order of the subclones from type 1 clone
was then determined. Analysis of ~ 500 bp of 5' sequence (i.e. the first 300 bp
immediately before the first exon, the first exon and 80 bp immediately after the
first exon) has a CpG score of 0-74. This was derived from an algorithm based on
work by Gardiner-Garden & Frommer (1987) to identify CpG islands (i.e. GC-rich
regions) in the vertebrate genome. The algorithm has a scale between 0 and 1,
with the values closer to 1 indicating the presence of a CpG island. These islands
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are often present in the 5' region of housekeeping and tissue-specific genes
(although some genes have 3' CpG islands). The 5' CpG island may extend into
the translation start site in protein-coding genes, which is the case for the 1-1
sequence (Fig. 3.9).
Figure 3.9. Diagram showing the overlap of clones type 1 and 2 isolated from the library
(represented by the red and green arrows, respectively). The seven coding exons for the predicted
mouse 1-1 protein span 7 kb of genomic DNA. The position of the CpG island, selected restriction
sites and the scale bar are shown.
CpG island
<—>
5' Exon: 1 2 3 4 5 6 7 3'
1 II II 111111 1
in 1 KpM S&cl Sic! i 1 I 1 1 1 I Kpt\
►
Type 2 clone (12 kb)
•4 *■
Type 1 clone (14 kb)
2 kb
NIX analysis of the subcloned 1-1 fragments showed that the encoding region for
the predicted protein sequence spans a 7 kb region of genomic DNA and is
encoded by seven exons. Furthermore, the mouse mRNA and protein sequences
were predicted (Fig. 3.10) by comparison of the genomic sequences, the various
1912-d05 and 3141-o09 I.M.A.G.E. sequences, plus the remaining partially
sequenced I.M.A.G.E. clones available from I.M.A.G.E. The computer program
Translate (http://expasv.ch/tools/dna.html) was used to determine the protein sequence
from the submitted mRNA sequence using the three possible alignments analysed
for both sequence directions (i.e. 5' to 3' and 3' to 5'; p. xvi for the list of amino
acids and their one letter code).
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Figure 3.10. The coding sequence of mouse 1-1 mRNA showing the position of the exons 1-7:
Exon 1. pxQiflf, exon 3, exon 4 |xon. 5 exon 6 and fxon | (including the stop codon, underlined).














133 AQKSAESNPKTQEQCGVEPR T E
463 gattcttcagcccacatgctaccactggattcccagggagccagcttggtctga
155 DSSAHMLPLDSQGASLV STOP
The predicted mouse 1-1 sequence was compared to that of rat and there were a
total of 25 nucleotide difference between the two sequences. From the deduced
mRNA sequence, the predicted mouse protein sequence was determined and
compared to the known 1-1 sequences (Fig. 3.11). Thus, the mRNA sequence is
513 bp in length, and as predicted, is similar to the rat inhibitor-1 mRNA
sequence, sharing 95-1% homology (Fig. 3.11).
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Figure 3.11. Comparison ofmouse, rat (Elbrecht et at. 1990), human (Endo el al. 1996) and rabbit
(Aitken et al. 1982) protein sequences by Clustal analysis: (-) a space in the sequence to give best
alignment; (*) 100% homology for all sequences. The stop codon is not included. The shared
KIQF motif at amino acid sites 9-12, and the threonine at amino acid 35, are highlighted in blue
and are important for PP-1 inhibition. The differences between the mouse and rat sequences are
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Comparison of the mouse protein inhibitor-1 sequence with rat, human and rabbit
showed strongest homology in the amino region of the protein. The main
differences in the amino acid sequence were toward the carboxyl end, a finding
which is consistent with previous comparisons of the sequences (Endo et al. 1996).
The predicted mouse 1-1 sequence has a KIQF motif at amino acid sites 9-12 and
a threonine at residue 35, both of which have been shown to be important for
inhibition of PP-1 (Endo et al. 1996).
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3.2.9. Chromosomal localization of the inhibitor-1 gene
As a final characterization of the mouse 1-1 gene, the location of the 1-1 gene was
determined. The 14-kb clone type 1 isolated from the library was an adequate size
to use for FISH analysis. Ms Shelagh Boyle detennined the chromosomal
localization of the gene since she has the expertise and facilities for the procedure.
The 1-1 gene was located at the end of the long arm of chromosome 15, band F.
Figure 3.12 shows that the 1-1 FITC signal is apparent on each chromatid of
chromosome 15 and there is a positive signal in an adjacent interphase cell. A
more detailed localization of the gene was not relevant to this project.
According to the Chromosome 22 Mapping Group at the Sanger Centre
(http://www.sanger.ac.uk/HGP/Chr22/), there is synteny for human chromosome 22 and
mouse chromosome 15. Other genes located in this area ofmouse chromosome 15
include Wnt-1 and the Hox C cluster. A transgene-induced deletion that causes
perinatal lethality (pie) has also been mapped to 15F (Beier et al. 1989). A
number of known mouse mutants map to this region. These include shaven (Sha),
crimpy (cpy), Naked (N) and caracul (Ca), which affect skin and hair texture, and
probably involve mutations of the Keratin type II complex [Compton et al., 1991;
data from Blake et al. (2001) at the Mouse Genome Database (MGD), Mouse
Genome Informatics, The Jackson Laboratory, Bar Harbor, Maine USA; April
2001; http://www.informatics.jax.org/].
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Figure 3.12. Chromosomal localization of the 1-1 gene on normal mouse
metaphase spreads using fluorescent in situ hybridization, (a) The white
arrows show the positive signal on the metaphase spread and in a nearby
interphase cell, (b) The Giemsa-banded chromosomes show that the gene is
located on chromosome 15F, as indicated by the red arrows.
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3.3. Discussion
The aim of this research chapter was to screen a mouse genomic library and isolate
clones which contained homology to the rat 1-1 mRNA sequence, which could
then be used to produce transgenic mice. The screening of the library resulted in
two types of clone being isolated which contained such homology. This allowed
the mouse 1-1 gene to be successfully characterized by restriction digestion,
sequence analysis and FISH.
3.3.1. I.M.A.G.E. clone analysis and library screening
The initial section of this research chapter confirmed that the correct I.M.A.G.E.
cDNA clones were sent from HGMP-RC, which was important to establish since
one of the clones was selected to screen the mouse genomic library. The 5' 336-
bp product obtained by PCR from the 1912-d05 clone was used in preference to a
restriction digest fragment. This was because the size of the 5' fragment could be
accurately predicted and there was no guarantee that a suitably sized fragment
could be obtained by restriction digest: this was confirmed by sequence analysis
with the Webcutter computer program. Fortunately, there was a BamHl site within
the 1912-d05 sequence that produced a 3' fragment of suitable length (-280 bp).
Screening of the X129 mouse genomic library isolated clones containing homology
to the rat 1-1 mRNA sequence. The automatic subcloning facility of the library
allowed easier handling and manipulation of the resulting isolated clones.
Restriction digestion was used to analyse 18 clones isolated from the library and
this showed the presence of four different types of clone. PCR analysis of these
clones was less accurate for characterization since only three types of clones were
identified: the presence of introns in the genomic sequence is the likely cause of
this.
Southern blot analysis confirmed that there were two different types of clones
containing 1-1 sequence homology (termed type 1 and type 2 with inserts of-14
and -12 kb, respectively). Fifteen out of the 18 clones were positive for 1-1
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sequence homology: the type 1 clone was the predominant recombinant isolated
from the library (13 out of these 15 I-1-positive clones were of type 1). The low
number of negatives was probably a result of the use of the 5' PCR product for
screening since presence of the 3' homopolymeric region would have had
homology with other mRNAs, and negative clones would have then been selected.
Furthermore, only well-isolated plaques were picked after the secondary screening
which reduced the selection of negative clones.
3.3.2. Characterization of the protein-coding region of the inhibitor-1
gene
The restriction maps of clone types 1 and 2 were determined by single, double and
triple digests of the DNA with a range of enzymes. Subcloning of the positive
fragments (identified by Southern blotting) from the two clones was successful.
The two remaining non-hybridizing fragments to rat 1-1 mRNA from the type 1
clone (600 and 900 bp in size) were also subcloned, which allowed ~9 kb of
genomic DNA to be sequenced (Fig. 3.6 and Fig. A7, Appendix 1, p. 181).
Analysis of these subcloned sequences by the NIX computer program showed that
clone type 2 contained the first exon and ~9 kb of flanking upstream 5' sequence,
most of which remains unsequenced. The clone type 1 contained the seven 1-1
protein-coding exons. Therefore, there was overlap between types 1 and 2 clones
since both contained the first protein coding exon.
The predicted mRNA sequence for the mouse 1-1 protein was obtained by
comparison of: the 10 partially sequenced I.M.A.G.E. clones; genomic sequences;
and the various commercial sequences of clone 1912-d05. This resulted in a
reliable final mRNA sequence. The mRNA coding sequence was 513 bp in length
and was strongly homologous to rat 1-1, sharing 95-1% identity; and the deduced I-
1 protein sequence contains 171 amino acids, sharing 95-3% homology to rat.
There were a total of 25 nucleotide differences between the mouse and rat mRNA
sequences, resulting in eight amino acid differences. Only one of the amino acid
changes was conservative (amino acid 50; isoleucine and valine in the mouse and
rat sequences, respectively): the remaining seven differences were non-
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conservative. Comparisons of the mouse protein 1-1 sequence with rat, human and
rabbit showed strongest homology in the amino region of the protein. The main
differences in the amino acid sequence were toward the carboxyl end, which is
consistent with previous comparisons of the sequences (Endo et al. 1996; McLaren
et al. 2000, Appendix 2, p. 188).
Two elements in the 1-1 protein structure which are required for efficient PP-1
inhibition are a KIQF motif at the amino end of the sequence and a threonine at
position 35 (Endo et al. 1996). Both features are present in the mouse, rat, rabbit
and human inhibitor-1 sequences. Aitken et al. (1982) concluded that
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phosphorylation of the serine at amino acid site 67 (Ser ) does not regulate 1-1
function. However, Huang & Paudel (2000) used recombinant human 1-1 to show
that phosphorylation of Ser67 does activate 1-1, possibly in a similar mechanism to
Thr33 phosphorylation.
CpG islands contain non-methylated CpG dinucleotides and are usually associated
with coding regions of genes. The CpG score for the mouse 1-1 gene is 0-74, using
a scale between 0 and 1 based on work by Gardiner-Garden & Frommer (1987):
the values closer to 1 indicate the presence of a CpG island. These islands are
often present in the 5' region of housekeeping and tissue-specific genes, and may
extend into the translation start site, which is the case for the mouse 1-1 gene: the
5' CpG island lies within a region extending 250 bp before to 70 bp past the first
exon. As a final characterization of the mouse 1-1 gene, FISH was used to localize
the gene to chromosome 15F and there may be synteny with human chromosome
22. No mutant phenotypes map to the region for which 1-1 may be a candidate
gene. As it is now known that 1-1 mice have no overt phenotype (Allen et al.
2000), this is not surprising.
The work carried out in this research chapter confirmed the strong homology of
the 1-1 gene across a range of species. A total of 9 kb of genomic DNA was
sequenced, within which lay the seven protein-coding exons (Fig. A7, Appendix 1,
p. 181). The type 2 clone isolated from the library had ~9 kb of 5' upstream
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sequence that could be used to build expression constructs with a view to









The mouse 1-1 protein expression pattern in the developing kidney was analysed
using whole-mount tissue, a commercially available antibody for 1-1 and confocal
microscopy. The initial results showed that 1-1 was only expressed in the
peripheral layer of cells in mouse kidneys from El 2-5 through to adult. No other
cells in the kidney expressed 1-1. Analysis of early kidneys showed I-l expression
in the coelomic epithelium of embryos at stage ~E11. The phenotype of the I-l
positive cells suggested that they were epithelial, and this was confirmed using
antibodies against laminin and pan cytokeratin. The expression pattern suggested
that the I-l antibody labelled the mesothelium, a cellular layer that bounds the
internal coelomic cavity. This was confirmed by I-l labelling of tissue from the
coelom (i.e. liver, lung, heart, gonad and intestine). Inhibitor-1 was also present in
the surface layer of ectoderm in the developing embryo and adult mouse.
4.1.2. Aim of the chapter
Chapter 3 determined the genomic sequence of the I-l gene, and from this, the
predicted mRNA and protein sequences. In order to further characterize the
mouse I-l gene, its protein expression pattern in the developing mouse kidney was
analysed. This would determine whether I-l is a kidney stem cell marker, as
suggested by Svennilson et al. (1995). Although cell type-specific markers have
been described for other cellular compartments of the developing kidney (e.g. BF-
2 for stromal cells and Pax-2 for the stem cells, the condensed tubules and the
ureteric bud epithelium), there is no unique marker for the kidney stem cells.
Therefore, whole-mount tissue, a commercially available antibody and confocal
microscopy were used to identify the I-l protein expression pattern in the
developing mouse kidney.
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4.1.3. Background and experimental approach
The use of whole-mount tissue for the analysis of protein expression eliminates the
need for processes such as wax embedding, which can introduce factors, such as
non-specific fluorescence as a result of contaminated solutions. Also, there is less
handling of the specimen. Analysis of whole-mount tissue by confocal
microscopy has the advantage that the optically sectioned tissue can be observed in
terms of the tissue or embryo as a whole. This is not possible in sectioned
material, unless images of the tissue are layered using computer graphics to
produce a three-dimensional image. Therefore, whole-mount kidney tissue, a
commercially available I-l antibody, and confocal microscopy were used to
analyse the I-l expression pattern in the developing kidney. The expression
pattern was compared to the I-l expression pattern in kidney sections.
If I-l is a kidney stem cell marker, as predicted by Svennilson et al. (1995), then it
would be expressed in the uncondensed, unepithelialized cells at and near the
periphery of the kidney. These cells would express Pax-2, a marker of all stages
of nephrogenic mesenchyme (Dressier et al. 1990), but they would not yet have
epithelialized and so have no basal lamina and, thus, would not express laminin.
Therefore, antibodies against I-l, Pax-2 and laminin proteins could be used to
characterize the stem cells of the kidney.
The only published data of I-l protein detection on kidney sections was by
Fryckstedt et al. (1993) who analysed the I-l and DARPP-32 protein expression
patterns using sectioned rat kidneys. There is no published analysis of I-l protein
expression using whole-mount tissue and confocal microscopy. The commercially
available polyclonal sheep anti-rabbit I-l antibody (Serotec) was obtained, which
was based on the work by MacDougall et al. (1989), who detected I-l in
immunoblots using antibodies from both the phosphorylated and dephosphorylated
I-l protein as immunogens. Thus, the phosphorylated state of the protein used to
obtain the antibody had no effect on I-l detection. An anti-sheep FITC-labelled
secondary antibody (Sigma) was used to visualize the I-l antibody.
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4.2. Results
4.2.1 Expression of inhibitor-1 in the mouse whole-mount kidney
Analysis of 1-1 expression in mouse kidneys from a range of ages (El 2-5 through
to adult) showed that the protein was only detected in the cytoplasm of the
outermost layer of cells in all of the ages studied. Figures 4.1.a-c (E12-5, El 3-5
and El6 5 kidneys, respectively) showed that the I-1 protein was localized in the
surface, peripheral cellular layer. There was no 1-1 staining within the kidney.
The morphology of the I-1-positive cells suggested they were unilaminar,
squamous epithelia (Williams et al. 1995). The 1-1 antibody did not label within
the kidney tissue and this suggested that 1-1 was not localized to the stem cells of
the MM.
Ell uninduced MM and El T5 induced MM (including presence of the coclomic
cavity) showed 1-1 expression in the coelomic epithelium, which contains the
developing kidney (Fig. 4.1.d). Elowever, removal of the coelomic tissue and
incubation of only the rudimentary kidney with the 1-1 antibody showed no 1-1
expression (Fig. 4. l.e). This result confirmed that the 1-1 expression pattern was
not an 'edge effect': if this was the case, then the positive peripheral staining
would have been present after removal of the coelomic epithelium.
Kidneys incubated with serum, but no primary antibody, showed no 1-1 expression
in the tissue (Fig. 4.1 .f). The use of PBS instead of PBSTX during the incubation
steps did not alter the 1-1 staining pattern although the background was slightly
lower in those samples that had been processed in the presence of the detergent.
Kidneys fixed with 4% PFA plus glutaraldehyde were analysed since Lowenstein
et al. (1995) found that inclusion of this fixative gave stronger immunoreactivity,
presumably because of better preservation of antigenic sites and/or retention of
antigen. The presence of glutaraldehyde did not enhance the signal nor reveal
other cell types expressing 1-1 in the kidneys. Also, methanol-fixed kidneys did
not show 1-1 expression, suggesting that the antigen was lost or masked using this
fixative.
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Figure 4.1. Inhibitor-1 expression in the developing mouse kidney. The cells were
counter-stained with propidium iodide (red). The inhibitor-1 protein (F1TC) is
expressed by the peripheral layer of cells in: (a) E12-5; (b) E15-5; (c)E16-5; and (d)
El 1-5 kidneys, (e) The El 1-5 kidney dissected free of the coelomic epithelium does
not express inhibitor-1. (f) Kidneys incubated without the 1-1 antibody do not give a
positive signal. Bars: (a - d & e) 20 pm; and (f) 65 pm.
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4.2.2. Expression of inhibitor-1 in wax embedded kidney sections
To compare the 1-1 expression pattern of the whole-mount kidneys with sectioned
material, kidney sections were incubated with the 1-1 antibody. El 5-5, E16-5 and
newborn kidneys were fixed in 4% PFA, dehydrated through alcohol and xylene,
and then embedded in paraffin wax. Following this, 7-(.tm sections were placed
onto TESPA slides. The sections were incubated with the 1-1 antibody, as
described in Chapter 2 ("Materials and methods'), and visualized using the FITC-
labelled secondary antibody, although no propidium iodide was added as a
counter-stain. As a control, no 1-1 antibody was applied to the section. The results
showed that there was a positive signal around the kidney periphery (Figs 4.2.a—c),
similar to the whole-mount kidneys incubated with the 1-1 antibody (Figs 4.1.a-d
and section 4.2.1, above). However, all sections (including those incubated
without the 1-1 antibody) had high levels of non-specific background and the
occasional highly fluorescent cell (Figs 4.2.d-f). This observation was similar to
the results by Fryckstedt et al. (1993).
The whole-mount kidneys incubated with the 1-1 antibody gave very low
background in comparison to the kidney sections and the resolution of the tissue
was better than sectioned material. Therefore, whole-mount tissue was used for
future analyses.
4.2.3. Expression pattern of Pax-2 protein in the mouse whole-mount
kidney
The anti-Pax-2 antibody identifies the nuclei of condensing mesenchyme-to-
epithelial cells and the duct tubules of the kidney (Dressier & Douglass 1992). If
there is expression of 1-1 in the metanephric mesenchyme, then it would be
expected to co-express with Pax-2. E13*5—15-5 whole-mount kidneys were
incubated with the antibody using the protocol described in Chapter 2. The
condensing metanephric mesenchyme was labelled with the Pax-2 antibody (Figs
4.3.a-c). Omission of the Pax-2 antibody gave no nuclear staining (4.3.d).
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Figure 4.2. Inhibitor-1 expression in wax-embedded kidney sections. The inhibitor-1
protein was visualised with FITC but no counter-stain was used, (a & b) El 5-5 and
(c) El 6-5 kidneys show inhibitor-1 expression in the peripheral layer of cells and some
internally labelled cells (a & b, white arrows), (d) E15-5, (e) E16-5 and (f) newborn
sections incubated with no inhibitor-1 antibody show no peripheral labelling, but the
internal cells give a positive FITC signal. Bars: (1, 3 & 4) 100 pm; (2) 20 pm; and
(5 & 6) 50 pm.
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Figure 4.3. Pax-2 expression in whole-mount (a) E13-5, (b) E14-5 and (c)
El5-5 mouse embryonic kidneys, (d) The control El3-5 kidney was incubated
in the absence of the Pax-2 antibody. The condensing mesenchyme is positive
for Pax-2 (F1TC, indicated by the white arrow) but the peripheral layer of cells
that are positive for 1-1 (Fig. 4.2) are negative for Pax2 (red arrow). Bars:
(a - c) 20 pm; and (d) 100 pm.
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Double labelling of kidneys using the Pax-2 and 1-1 antibodies were not successful
because of the difference in incubation conditions required for the antibodies.
Bard et al. (1996) referred to stem cells as early condensates, and therefore, these
cells would be identified by the Pax-2 antibody. However, there was no co-
expression of Pax-2 and 1-1 in the E13-5—E15-5 kidneys analysed (Fig. 4.3.a)
suggesting that 1-1 is not a marker of induced metanephric mesenchyme, and
hence, 1-1 is not a stem cell marker in the developing kidney.
4.2.4. Expression of laminin in the mouse whole-mount kidney
The 1-1-positive cells determined in section 4.2.1 had unilaminar epithelium
morphology, according to classification by Williams et al. (1995). To test the
hypothesis that these I-1-positive cells had an epithelial phenotype, whole-mount
kidneys were incubated with an anti-laminin antibody. Laminins are a major
component of basement membranes (Chapter 1, section 1.5.3). In all of the
kidneys analysed (E13-5-E16-5), nephrogenic and duct tubules had basal laminae
and these provided internal controls for examining the peripheral cells. Figure
4.4.a shows weak and incomplete staining of the basal lamina in the underlying
single layer of cells encapsulating the El2-5 organ. However, expression levels
increased by El3-5 (Fig. 4.4.b) and continued to do so as the kidney developed
(Fig. 4.4.c showing an El6-5 kidney). Kidneys incubated without the laminin
antibody did not show any laminin staining (Fig. 4.4.d).
The laminin expression observations were compatible with the I-1-positive cells
having an epithelial phenotype, and overall, the results suggested that the 1-1
protein was expressed by the mesothelium, a cellular layer that covers the tissue of
the coelomic cavity and is derived from the coelomic epithelium. However, no
internal epithelia (i.e. endodermal cells) expressed 1-1, and thus, 1-1 was not a
general epithelial marker.
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Figure 4.4. Laminin expression in the developing mouse kidney. Laminin was
visualized with FITC and the tissue was counter-stained with propidium iodide.
The internal basal laminae expressed laminin but the surface basal lamina was
weak in (a) El2-5 and (b) E13-5 kidneys, (c) Laminin expression did increase as
the kidney aged (El6-5). (d) El4-5 kidney incubated with no laminin antibody
showed no laminin expression. Bars: (a & b) 20 pm; (c) 50 pm; and (d) 100 pm.
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4.2.5. Expression of pan cyokeratin in the mouse whole-mount
kidney
To confirm the laminin expression pattern, an anti-pan cyokeratin antibody was
used to analyse El3-5 kidneys. Methanol-fixed kidneys were incubated with the
antibody (Figs 4.5.a & b). The internal epithelial cells were strongly labelled by
the antibody, but the peripheral layer of epithelial cells expressed the protein more
weakly. This observation was similar to the laminin expression pattern. These
results confirmed that the I-1-positive peripheral cells were epithelial in
phenotype. Kidneys which had been fixed using 4% PFA were negative, and thus,
the cytokeratin protein was lost using this fixative. Kidneys incubated in the
absence of the primary antibody did not express the protein as a result of loss or
masking of the antigen.
4.2.6. Summary of kidney analysis
Analysis of the developing mouse kidney suggested that the 1-1 protein was
expressed only in the outermost peripheral layer of cells. These cells were not
metanephric mesenchyme, as confirmed by the Pax-2 protein expression pattern.
The laminin and pan cyokeratin results showed that the cells had an epithelial
phenotype, although these epithelial markers were weakly expressed in early
kidneys. Therefore, these results suggested that 1-1 expression was restricted to
the mesothelium of the kidney in the developing mouse embryo. The mesoderm-
derived mesothelium originates from the coelomic epithelium and lines the viscera
of the body cavity (parietal mesothelium; Kaufman & Bard 1999).
4.2.7. Expression of inhibitor-1 and laminin in other mouse viscera
The 1-1 expression pattern of the developing kidney suggested that the protein was
restricted to the mesothelium. To test this new hypothesis, 1-1 expression in other
tissues of the developing mouse embryo was analysed (Table 4.1). Confirmation
of the epithelial phenotype was obtained by incubation of mouse tissue with the
laminin antibody (Table 4.2).
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Figure 4.5. (a & b) Pan cytokeratin expression in methanoi-fixed whole-mount
El3-5 kidneys. Pan cytokeratin was visualized with FITC and the tissue counter-
stained with propidium iodide. The epithelial cells were positive for pan
cytokeratin: the peripheral layer of epithelial cells was more weakly labelled with
the antibody than the internal epithelia, similar to laminin expression in the
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Comparison of embryonic mouse lung tissue incubated with laminin and 1-1 (Figs
4.6.a & b) showed that the peripheral layer of cells were 1-1 positive and had an
underlying basal lamina; therefore, they had an epithelial phenotype. Also, the
basal lamina of lung and the other viscera strongly expressed laminin, unlike the
kidney. Incubation of a range of tissue from various tissues showed that 1-1
expression was limited to the single outer layer of surface epithelium of organs of
the coelomic cavity (i.e. lung, intestine, heart, liver and gonad; Table 4.1 and Figs
4.6.b-f).
In the adult mouse, 1-1 was also present in the surface epithelium of kidney, heart,
lung, liver and the skin. There was no non-specific staining present in any of the
tissues analysed (Table 4.1).
All basal laminae of the tissues analysed were labelled using the laminin antibody,
showing that laminin is a general epithelial marker. When compared to the 1-1
expression pattern, there was confirmation that 1-1 is not a general epithelial
marker; no internal epithelia were labelled and the 1-1 protein was restricted to the
peripheral epithelial layer, i.e. the mesothelium (Figs 4.1, 4.4 and 4.6.a & b).
4.2.8. Expression of inhibitor-1 during testis development
Analysis of embryonic gonads revealed I-l expression of the mesothelium (i.e. the
epithelial layer surrounding the gonads) at -E12-5 (Fig. 4.7.b). At this stage of
development, both male and female gonads are morphologically indistinguishable,
and hence, are termed indifferent. However, I-l was expressed by cells within a
small number of the testes at -E13-5 (Figs 4.7.C & d, showing presence of cells
expressing I-l within the testes). From El3-5 onwards, 1-1 was expressed only in
the mesothelial epithelium around the developing testes and not within the tissue
(Fig. 4.6.f). This was consistent with developmental analysis describing
mesothelial cell migration into the gonads in early testes formation (Buehr et al.
1993; Martineau et al. 1997; Capel et al. 1999; Kaufman & Bard 1999). These
results also confirmed that the particular expression pattern for I-l was not as a
result of lack of penetration of the antibody within the tissue, since the internal
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Figure 4.6. Laminin and inhibitor-1 expression in whole-mount mouse tissue,
(a) Laminin expression in El2-5 lung. Inhibitor-1 expression in (b) El 3-5 lung;
(c) E17-5 intestine; (d) E12-5 heart; (e) E12-5 liver; and (f) E17-5 ovary. Bars:
(a & b, d & e,) 20 pm; (c) 40 pm; and (f) 100 pm.
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a b
Figure 4.7. Inhibitor-1 expression in whole-mount mouse gonads. Inhibitor-1 was
visualized with FITC and the tissue was counter-stained with propidium iodide, (a)
Incubation of E12-5 gonad with no 1-1 antibody gave no FITC labelling, (b) The E12-5
gonad labelled with 1-1 showed positive 1-1 labelling, (c & d) The sex cords of~E13-5
testis were positive for 1-1 expression, an observation only found in some of the El 3-5
testes analysed. Bars: (a - c) 100 pm; and (d) 50 pm.
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mesothelial cells were labelled. E12-5 gonads incubated without 1-1 antibody did
not show any staining (Fig. 4.7.a). Laminin expression of testes and ovaries
confirmed the peripheral basal lamina underlying the I-1-positive layer of cells.
4.2.9. Expression of inhibitor-1 in other mouse tissue
There was 1-1 expression in the outer epithelium or cornea of the developing eye,
which is ectoderm-derived (Fig. 4.8.a shows the surface view of the lens, and
Table 4.1) and also in the epithelia of the surface ectoderm of skin (Figs 4.8.b & c,
and Table 4.1). Tissue incubated in the absence of 1-1 showed no positive staining
(Fig. 4.8.d). This tissue also had a unilaminar, squamous epithelial phenotype
(Williams et al. 1995).
4.2.10. Confirmation of the inhibitor-1 expression pattern in the
kidney
The anti-I-1 antibody from Serotec was deleted from their catalogue after
completion of the expression analysis in the mouse whole-mount tissues.
Fortunately, an alternative source of 1-1 antibody was obtained from Santa Cruz
Biotechnologies. This goat anti-I-1 antibody was used to label whole-mount
kidneys (following the same protocol for the Serotec antibody) and a similar,
though weaker, staining pattern was obtained. This confirmed that 1-1 was
expressed by the mesothelium in embryonic kidneys.
Cryostat sections of frozen mouse kidney were analysed using the Santa Cruz
antibody, but no adequate staining pattern was obtained. It is possible that the 1-1
antigen may be lost during the processing of the tissue. This showed the superior
tissue resolution obtained from the use of whole-mount tissue and confocal
analysis.
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Figure 4.8. Inhibitor-1 expression in whole-mount El6-5 mouse tissue. Inhibitor-
1 was visualized with FITC and the tissue was counter-stained with propidium
iodide, (a) 1-1 expression was present in the surface ectoderm layer of epithelial
cells in the eye (surface view) and (b & c) the skin, (d) Incubation of tissue
without the 1-1 antibody showed no positive staining. Bars: (a & c) 20 pm; and
(b & d) 100 pm.
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4.2.11. Expression of inhibitor-1 in human lung tissue
The possibility that 1-1 could be used as a marker for mesothelium in human tissue
and perhaps, as a marker for mesothelioma was investigated using whole-mount
tissue and confocal microscopy. A sample of normal whole-mount human lung
that had been formalin fixed (supplied by Dr Donald Salter, Department of
Pathology, University of Edinburgh) was incubated with the 1-1 antibody, but the
tissue had very high auto-fluorescence in all channels of the confocal microscope.
Analysis of human tissue that had not been incubated in antibody or blocker
confirmed that the tissue did auto-fluoresce. This may have been because of the
formalin fixative used or. perhaps, it is a feature of the adult lung. Analysis of the
unfixed, unprocessed tissue confirmed that the adult tissue had endogenous
autofluorescence. This meant that fluorescent confocal analysis was not possible
for the human lung tissue. Autofluorescence is a major problem in analysis of
material because of the flavoproteins and other cellular components interfering
with the fluorochrome in use (Aubin 1979; Benson et al. 1979). Andersson et al.
(1998) used mammalian cells and a confocal laser scanning microscope to show
that mitochondria, and probably lysosomes, are responsible for autofluorescence.
Wax embedding of fixed lung tissue followed by sectioning of the material was
carried out but 1-1 was not detected using an alkaline phosphatase-labelled second
antibody. Failure of the tissue to give a signal may reflect a lower level of 1-1
expression in human tissue, although this could be a future direction to further
investigate 1-1 and its expression in human tissue.
4.3. Discussion
The aim of this research chapter was to analyse 1-1 expression using confocal
microscopy and whole-mount tissue, and this resulted in a more detailed pattern of
1-1 expression in comparison to sectioned material.
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4.3.1. lnhibitor-1 is a marker for the mesothelium and surface
ectoderm
The I-l expression pattern in the kidney was compatible with the antibody
marking mesothelial cells, an epithelial derivative ofmesoderm-derived tissue that
characterizes the surface of the body cavities (parietal mesothelium) and their
constituent tissues (visceral mesothelium). Further analysis revealed I-l
expression in the peripheral epithelia from tissue of the coelom, confirming I-l
specificity to the mesothelium (McLaren et al., 2000, Appendix 2, p. 188). As
mentioned in Chapter 1, the lateral plate mesoderm of the developing mouse at
E8-5 divides to form the outer derivative (the somatopleure), which lies below the
ectoderm, and the inner compartment (the splanchnopleure), which lies next to the
endoderm (Williams et al. 1995; Kaufman & Bard 1999). Cells lining the
coelomic cavity proliferate during development and produce either mesenchymal
or epithelial cells: these mesenchymal cells differentiate to form the epithelial
lining i.e. the mesothelium (Kaufman & Bard 1999). Other structures formed from
these mesenchymal cells include smooth muscle and connective tissue coats of the
gut. Localized mesenchymal populations form parts of the liver, spleen and early
kidney. Regions of the coelomic epithelium produce the mesonephric epithelium,
cells which envelope the primordial germ cells, and the lining of the genital tracts
(Williams et al. 1995; Kaufman & Bard 1999). Since the results in this chapter
report I-l expression in the coelomic epithelium or mesothelium only (and not its
derivatives), this suggests that I-l may be down-regulated as the tissue
differentiates.
The Pax-2 antibody labelled the condensing mesenchyme in the developing kidney
and did not co-express with I-l: the anti-I-1 antibody labelled peripheral epithelial
cells. Therefore, I-l is not a stem cell marker in the developing kidney.
Confirmation of the mesothelial phenotype of the I-l-positive cells was obtained
by laminin and pan cyokeratin labelling of the kidney and other tissues. The pan
cyokeratin expression pattern in the kidney coincided with the I-l-positive cells,
and the laminin antibody detected the basal laminae secreted by these cells.
However, both antibodies showed weak expression for early kidneys and the
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laminin expression pattern did increase as the kidney matured. The reasons for
this weak peripheral expression pattern were not entirely clear since the internal
epithelia of the kidney strongly labelled with both antibodies. Therefore, the
epithelial layer of the kidney weakly expresses laminin and cytokeratin in the early
stages of kidney development unlike other organs from the coelomic cavity (e.g.
lung). This may reflect a difference in kidney development from other visceral
organs, since the kidney arises from the intermediate mesoderm whereas the heart,
for example, forms from coelomic epithelial cells (Kaufman & Bard 1999).
Although the origin of the kidney's mesothelial layer and capsule is unknown, it is
possible that this layer derives from the mesothelial cells lining the coelomic
cavity, or it differentiates from the peripheral cells of the metanephric
mesenchyme.
There were several reasons to support the hypothesis that 1-1 was specific to the
epithelium of surface ectoderm and the mesothelium. Incubation of tissue in the
presence of serum but in the absence of the 1-1 antibody gave no background
staining, showing that the expression pattern was not a result of the secondary
antibody. Removal of the coelomic epithelium from El 1 kidney rudiment showed
no 1-1 staining of the early kidney, and thus, the 1-1 staining pattern was not
caused by an 'edge effect'. There was internal 1-1 labelling in a small number of
testes at ~E13, and thus, lack of penetration of the antibody did not cause the
distinctive 1-1 staining pattern. Use of an anti-I-1 antibody from a different
supplier (Santa Cruz Biotechnology Inc.) showed an identical staining pattern to
the Serotec antibody. Furthermore, analysis of kidney sections after wax
embedding confirmed that 1-1 was present only in the peripheral cells, although
the resolution of the tissue in these sections was poor and there was non-specific
background staining.
Previous analyses of the 1-1 expression have mainly used immunoblotting
(MacDougall et al. 1989; Hemmings et al. 1992; Fryckstedt et al. 1993; Sakagami
et al. 1994; Lowenstein et al. 1995). The only published data for the 1-1 protein
expression in kidney was by Fryckstedt et al. (1993), who analysed newborn rat
kidney cryostat sections and showed 1-1 protein expression in some tubule cells of
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the inner cortex. However, these results are in conflict with the work in this
chapter and those by Svennilson et al. (1995). Wax-embedded mouse kidney
sections which had been incubated with secondary F1TC antibody only (i.e. no
primary antibody was applied; Figs 4.2.d-f) showed non-specific labelling of some
cells, similar to those shown in the study by Fryckstedt. The in situ hybridization
results of E15 rat kidney sections by Svennilson et al. (1995) do not correspond to
those obtained in this chapter but there was no mention of the use of a negative
control (i.e. sense oligonucleotide) used in the above study. Therefore, it may be
possible that the 1-1 mRNA is synthesized by the peripheral stem cells but
expressed by the mesothelial cells.
There was little cross-reaction with other proteins in the whole-mount specimens,
as confirmed by low background staining. Also, since the tissues used were
derived from a variety of mouse types, the 1-1 expression pattern was not strain
specific. However, neuronal and skeletal muscle expression were not investigated,
but previous research has shown I-1 that is expressed in these tissues (MacDougall
et al. 1989; Hemmings et al. 1992; Sakagami et al. 1994; Lowenstein et al 1995).
The conclusion from this study is that 1-1 is not a stem cell marker in the
developing kidney.
4.3.2. lnhibitor-1 expression during testis development
During early testes development, cells of the mesonephros migrate into the gonads
and form the testes cords (Buehr et al. 1993; for review of development, see
Kaufman & Bard 1999). This migration been shown to be under the control of the
Y chromosome gene Sry, which is expressed in mouse from El0 5 to El2-5
(Hacker et al. 1995; Martineau et al. 1997; Capel et al. 1999). The results
presented in this chapter using 1-1 and laminin antibodies suggested that these
migrated cells (or at least a portion of the migrated cells) are epithelial, and from
El 3-5 onwards, only the surface layer of cells of the testes continued to express I-
1. This implied that the 1-1 gene may be controlled downstream of Sry during
testes development, and 1-1 expression was lost as the phenotype of these cells
altered after migration. Migration of epithelial cells into the testes was also
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suggested by Wartenberg et al. (1991) after analysis of the developing rabbit
testes. Buehr et al. (1993) and Martineau et al. (1997) showed that several cell
populations migrate from the mesonephros into the developing testes. In the
developing ovary, there is limited invasion of mesonephric cells in the cortex of
the gonad.
4.3.3. Future work
The possibility that 1-1 could be used as a marker for mesothelioma in humans has
not been fully investigated in this project because of the problem of endogenous
autofluorescence of human lung tissue when analysed by confocal microscopy.
This is an aspect of the research that could be analysed further. It raises the
possibility that 1-1 could be used as a specific marker for mesothelioma, a fatal
malignant cancer of the mesothelium. The tumour is most commonly found in the
pleural cavity since the disease is predominantly linked to asbestos exposure.
Diffuse malignant mesothelioma is an aggressive tumour characterized by serosal
thickening. The tumours range from epithelial through to mesenchymal in tissue
type, and thus, are categorized as being epithelial, sarcomatous / fibrous or
biphasic (for review, see Attanoos & Gibbs 1997). As yet, there is not a marker
available that can effectively distinguish between mesothelioma and other tumours
of the pleura (e.g. adenocarcinoma). Currently, a panel of antibodies is required to
verify tumour type, including antibodies against glandular markers (e.g. CEA and
B72-3), all of which are negative for mesotheliomas (for review, see Whitaker
2000). Anti-cytokeratin CK 5/6 has been shown to be potentially useful to
differentiate the epithelioid tissue of mesothelioma (positive staining) and the
adenocarcinoma (negatively stained tissue; Clover et al. 1997). Oates & Edwards
(2000) found the antibodies calretinin and E1BME-1 to be the most successful
markers for mesothelioma distinction, although this view differs from other
researchers since delineation between tumour types is not absolute. Oates &
Edwards (2000) also showed that the gene product of transcription factor WT-1
was detected in 72% of mesotheliomas and 20% of adenocarcinomas, but the
protein is not detectable in autopsy material, which is a drawback. Whitaker
(2000) suggested antibodies against EMA, Calretinin and Cytokeratin 5/6, and an
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additional two antibodies (selected from the group CEA, B72-3, Ber-EP4 and
LeuMl) provide a suitable range ofmarkers for mesothelioma distinction.
Clearly, there is a need for a specific marker for mesothelioma identification since
the exclusion method currently used is fallible. The epithelial form of malignant
mesothelioma is the most common form of the tumour; thus, 1-1 may have the
potential to be a mesothelioma-specific marker for these forms of the tumour.
Elowever, given that the sex cords of the developing testis were only transiently
labelled (presumably differentiation occurred after the cord formation), 1-1
expression may be down-regulated after mesothelial tissue differentiation.
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Chapter 5
Analysis of the 5' flanking





A preliminary investigation of potential regulatory elements of the 1-1 gene was
undertaken. Varying lengths of 5' flanking genomic sequence were inserted into a
reporter gene construct, and introduced into a human embryonic kidney and a rat
mesothelial cell line. The results show that the rat mesothelial cell line 4/4 RM-4
had a lower transfection rate than the human embryonic kidney cell line HEK293.
No conclusions could be drawn from the transfection experiments since no cells
expressed the fluorescent protein. The only difference that may be relevant was
that the HEK293 cells gave a higher number of weakly fluorescent cells after
transfection with the 3-3-kb genomic construct. Although inconclusive, the
groundwork for future analysis has been carried out.
5.1.2. Aim of the chapter
The experiments described in this chapter were designed to determine whether
there were transcriptional regulatory elements in the 5' flanking sequence of the
mouse 1-1 gene. This would either reflect the presence of promoter and/or
enhancer elements necessary for protein expression. The initial work carried out
involved insertion of 5' flanking sequence into a vector that contained the (3-
galactosidase, with the aim of producing transgenic mice. Thus, the role of 1-1
during development of the whole embryo could then be determined.
5.1.3. Background and strategy for analysis of inhibitor-1 flanking
region
5.1.3.1 The pGT1-8IRES|3geo vector: Chapter 3 detailed the screening of a
mouse genomic library and the isolation of two types of clones which contained
homology to rat I-l mRNA. These clones were characterized and showed that the
type 2 clone contained the first coding exon for the deduced I-l protein and ~9 kb
of flanking 5' sequence that could potentially contain promoter sequences.
Therefore, it was planned that the reporter DNA GTl -8IRESPgeo (constructed by
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W. Skarnes, P. Mountford and P. Tate in 1992; Fig. Ale, Appendix 1, p. 170)
would be ligated to the flanking 5' DNA. This construct would then be introduced
into the mouse germ line, resulting in the production of transgenic mice and 1-1
expression during kidney development could be followed in vivo. This expression
pattern could then be compared to 1-1 distribution in vitro, as determined in
Chapter 4.
The pGTl-8IRES(3geo vector was selected for analysis since it contained the (3geo
gene and internal ribosome entry site (IRES) sequences. (3geo is a fusion of the
lacZ gene and the neo neomycin resistance gene. The lacZ gene allows (3-
galactosidase detection of the tagged 1-1 gene when it is introduced into the mouse
germ line. G418 sulphate is an aminoglycoside that disrupts protein synthesis, and
is used for the selection of prokaryotic and eukaryotic cells which contain the neo
gene (Calbiochem data sheet; Darmstadt, Germany). The presence of (3geo in a
construct allows both the reporting and selection of a gene when introduced into
embryonic stem cells and grown on selective medium. However, gene trapping
can be unpredictable but inclusion of the IRES sequences results in the reporter
gene being independently translated. IRES are DNA sequences which interact
with ribosomes and contribute to efficient RNA translation. This is an advantage
since older vectors which lack IRES result in the fusion protein only being
generated from the correct frame, and orientation of both the reporter and gene of
interest (Chowdhury et al. 1997) whereas any insertion into an active gene should
give functional reporter expression using IRES. Furthermore, IRES does not have
any detrimental effects on gene expression, it is not toxic to the ES cells
(Mountford & Smith 1995), it integrates in the genome of the ES cells in an
unbiased manner and it is not tissue specific (Chowdhury et al. 1997).
Figure 5.1 shows how the genomic clone type 2 (isolated from the library
screening in chapter 3) was modified to include Sail restriction sites for the
insertion of the GTT8IRES(3geo DNA and Xhol restriction sites for isolation of
the final construct from the vector backbone. Therefore, oligonucleotides were









































Figure 5.1. Insertion of unique restriction sites into clone type 2 DNA. (a) The type 2
DNA (black line) showing the position of the 1-1 protein-coding exons (coloured boxes,
not to scale) and the position of the CpG island (not to scale). The restriction sites for
insertion of oligonucleotides are indicated by an asterisk (*). The scale bar is indicated,
(b) The sequence of the restriction sites of Notl, Ec/XI, Sail and Xhol. The arrows
indicate the site of digestion, (c) The oligonucleotide sequences (red) were inserted at the
Notl and Ec/XI sites. The 5' and 3' nucleotides of the Notl restriction site are in brackets.
Thus, the unique restriction sites of Xhol and Sail were introduced into the clone
resulting in loss of the Notl site but the Ec/XI site remained intact.
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Digestion of the genomic DNA with Notl and EclXl followed by insertion of the
oligonucleotides would result in the presence of the Xhol and Sail unique sites
within the genomic DNA (Figs 5.2 & 5.3, and Fig. Ale, Appendix 1, p. 170).
Flowever, building of the pGTl-8IRES(3geo construct was not successful since the
reporter and genomic DNA did not ligate, even after extensive modifications to
both types of DNA and alteration of the experimental protocol.
5.1.3.2. The pEGFP-1 vector: Because of the failure to ligate the reporter
GTT8IRES(3geo and genomic DNA, a different approach for determining the
presence of promoter elements was required. As an alternative to
GTl-8IRES(3geo, an enhanced green fluorescent protein (EGFP) vector was used.
The vector pEGFP-1 (Clontech Laboratories Inc.; GenBank Accession number
U55761; Fig. Alf, Appendix 1, p. 171) is promoterless and expresses EGFP only
if a functional promoter is present in the inserted DNA. Therefore, insertion of the
mouse genomic DNA into this vector followed by transfection of mammalian cells
would indicate whether the genomic DNA contained any promoter elements. The
advantage of using this vector was that transfected cells could be directly
visualized using confocal microscopy, whereas (3-galactosidase would be detected
indirectly.
GFP has widely been used for direct visualization of proteins in living cells since
its isolation from the jellyfish, Aequorea victoria, and has been used in the
analysis of gene expression and cell lineage (Chalfie et al. 1994). There have been
various modifications to the wild-type molecule to maximize the emission of the
protein produced and to allow its use in mammalian cells grown at 37 °C. The
pEGFP-1 vector from Clontech encodes the GFPmutl variant that has a double





Figure 5.2. The plan for transfer of genomic type 2 DNA into a Sft/I-knockout vector.
Type 2 clone DNA (black line) from the original pBluescript vector (pale blue) was
transferred into a Sa/I-knockout pBluescriptllKS vector (darker blue). The first exon is
represented by the olive box (not to scale), (a) The modified type 2 clone showing the
position of the inserted Xhol and Sail oligonucleotides, (b) The genomic DNA after
digestion with Xhol (~11 kb). The Sail knockout pBluescriptllKS vector was digested
with Xhol. (c) The final pBluescriptllKS Sail knockout vector after insertion of the















Xho I Sa/I Sacl Sacl Sa/I X/?ol
Figure 5.3. The steps involved in building the final GT1-8IRESPgeo construct. The
construct was designed to contain the modified genomic DNA (black line; ~11 kb) and
the GT1-81RESPgeo DNA (green line; -~9kb). (a) The linearized pBluescriptllKS DNA
is represented by a blue line and the first exon is represented by an olive box (not to
scale). The red arrow shows the position of the unique SalI site into which the
GTl-81RESPgeo DNA would be inserted, (b) The linearized GTT8IRESPgeo DNA
showing the components of the vector and selected restriction sites, (c) The predicted
final construct expected after ligation of the insert into the genomic vector.
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The altered type 2 mouse genomic clone DNA outlined in 5.1.3.1, above (i.e. after
insertion of the oligonucleotides containing the Xhol and Sail unique restriction
sites), was digested then successfully inserted into the pEGFP-1 vector without
further modification. Two constructs containing 9 kb and 3-3 kb of genomic DNA
were produced (pEGFPLM9 and pEGFPLM3-3, respectively; Fig. 5.4). These
final constructs were then used to transfect cell lines.
5.1.3.3. Transfection of mammalian cells: Transfection is the introduction
of foreign DNA into cells to produce a protein and it has become a powerful tool
for analysis of gene regulation and function. Transiently transfected cells (or
transients) are cells which grow in the absence of a selective agent (e.g. G418
sulphate), but not all the cells will be transfected. Stable-transfected cells survive
in the presence of a selective chemical since each cell has been transfected and
must contain the resistance gene from the introduced DNA in order to survive.
The method chosen for analysis of the final EGFP genomic constructs was the
transfection of mammalian cell lines with the reagent FuGENE 6 reagent (Roche)
since the reagent required minimal optimization and is non-toxic to the cells. In
this research chapter, transients were analysed using the cell lines HEK293
(derived from human embryonic kidney) and 4/4 RM-4 (a rat mesothelial cell
line). HEK293 cells are highly transfectable and have been used extensively in
transfection studies, and thus, were the control cell line to show that the
experimental system was working optimally. The reason for using the 4/4 RM-4
cell line was that Chapter 4 showed that the 1-1 protein was expressed in the
mesothelium. Therefore, transfection of the mesothelial cells with the constructs













Figure 5.4. The EGFP constructs developed for analysis of the 5' flanking DNA of
the inhibitor-1 gene from type 2 clone. The .Sacll restriction site lies -300 bp before
the start of the first exon (olive box) and just within the 5' end of the CpG island
(indicated by the arrow). The exon and CpG island are not to scale. The (a) 9-kb and
(b) 3-3-kb lengths of flanking genomic DNA were isolated using enzymes Xhol and
Sacll, and Kpn\ and SacW, respectively. The restriction fragments were cloned into
the multiple cloning site (MCS) of the pEGFP-1 vector.
Sacll Apa\ XmaI Sma\
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The vector pEGFP-Nl (Clontech; GenBank Accession number U55762; Fig. Alg,
Appendix 1, p. 172) was used as a transfection marker to ensure that the
experimental design was working properly. This vector contains a strong
promoter (derived from the cytomegalovirus), and thus, allowed each transfected
cell to express EGFP. The vector also contains the same GFPmutl variant as
pEGFP-1 for enhanced fluorescence. For negative controls, untreated cells, the
addition of FuGENE 6 in the culture medium and transfection with the vector
pEGFP-1 were used. All the DNA used in the transfection studies were derived
from maxipreps, and therefore, were ultra-pure and contained low levels of
endotoxins which could potentially affect cell growth (FuGENE 6 handbook,
Roche).
5.2. Results
5.2.1. The GT1-8IRESPgeo construct
The initial work in this chapter involved the modification of the genomic type 2
clone isolated from the library screening in Chapter 3. This involved the
introduction of the unique restriction sites Xhol and Sail into the DNA at the
existing Notl and EclXI sites (Figs 5.1, 5.2 and A6, Appendix 1, p. 180). The Sail
site would allow ligation of the GT1 -8IRES(3geo DNA into the vector containing
the genomic DNA (Fig. 5.3). The unique Xhol site would then allow complete
isolation of the final construct from the pBluescript backbone before introduction
into the mouse germ cells.
Initially, the type 2 clone DNA was digested with Notl or EclXl, followed by
ligation of the Sall/Xhol oligonucleotides, resulting in the introduction of the Xhol
and Sail restriction sites flanking the genomic insert of type 2 clone. The Notl site
was lost after insertion of the oligonucleotides, although the EclXl site remained
intact, as confirmed by restriction digestion. The DNA had to be partially digested
with EclXl to give insertion at the 5' site (Fig. 5.1). Successful insertion of the
oligonucleotides was confirmed by restriction digest of the altered type 2 DNA
with Xhol and Sail since the unmodified DNA did not digest with these enzymes.
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This modified genomic DNA was then digested with Xhol and the resulting 9-kb
fragment was gel purified and GENECLEANed in preparation for the next stage.
After successful insertion of the oligonucleotides into the genomic DNA, it was
decided to alter pBluescriptIIKS-/+ to remove the Sail site. There were two
reasons for using this vector. First, it was readily available. Secondly, insertion of
the 9-kb Sail fragment of GT1-8IRES(3geo would have required partial Sail
digestion of the modified genomic DNA and this would have created unnecessary
extra steps. Therefore, the most logical plan was to knock out the Sail site from
the pBluescriptll vector using Pfu polymerase. This enzyme fills in 5' overhangs
in the presence of excess dNTPs, and after re-ligation of the pBluescriptll DNA,
this resulted in complete removal of the Sail restriction enzyme site in
pBluescriptll, as confirmed by restriction digestion. This modified pBluescriptll
was then digested with Xhol and ligated to the 9-kb Xhol genomic fragment (Fig.
5.2). The resulting plasmid DNA contained only one Sail site, into which the
reporter DNA could be inserted (Fig. 5.3).
Attempts to ligate the IRES(3geo DNA and the genomic DNA vector were
unsuccessful. As an alternative strategy, it was decided to insert the genomic
DNA into the partially digested pGTl-8IRESPgeo vector using Sail and insertion
of the Sail 9-kb fragment from the modified genomic DNA. Flowever, this
method also did not result in the final construct.
Following these efforts, various other modifications were attempted. Insertion of
oligonuleotides containing unique restriction sites into both the genomic and
pGTl-8IRES(3geo DNA was carried out. This allowed the introduction of unique
ends for ligation of the reporter and genomic DNA since the identical Sail ends
may have reduced the likelihood of successful ligation. However, no final
construct was obtained after this modification. Attempts to insert a unique Noll
site into the first protein coding exon were unsuccessful using an ExSite PCR-
based site-directed mutagenesis kit (Stratagene).
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Alternative sources of agarose for DNA extraction, different gel purification
methods, transformation of Stratagene Ultracompetent XL-10 Gold cells, use of
electro-competent cells and colony screening using the radio-labelled fragment of
IRES DNA were used to try to isolate the final construct. Again, these alterations
did not result in the ligation of the two DNA types. In each case, the final isolated
DNA was either the pBluescriptll/genomic DNA vector or the pGTT8IRES(3geo
vector, depending upon whether the inserted DNA was pGTl-8IRES(3geo or
genomic DNA, respectively. It was consistently at the final step where there was
failure to ligate the DNA. This avenue of work was exhausted then abandoned
since no successful construct was obtained.
5.2.2. The EGFP-1 construct
Due to time and financial constraints, an alternative reporter gene to the IRES(3geo
was used. pEGFP-1 is a promoterless GFP vector that has optimized fluorescence
and higher expression in mammalian cells than GFP. The multiple cloning site
(MCS) of this vector contained restriction sites which were compatible with the
sites found in the upstream genomic sequence of the type 2 clone.
The type 2 genomic clone that had been altered to include the unique sites Xhol
and Sail (as described in section 5.2.1; Figs 5.1 & 5.2) was used to build the
EGFP-1 construct. Restriction digestion of this modified type 2 clone with Xhol
and Shell resulted in -9 kb of upstream genomic DNA (Fig. 5.4). The 9-kb
genomic DNA was digested, gel purified, GENECLEANed then successfully
ligated into the Xhol and Shell sites of the EGFP-1 vector (Fig. 5.4). The inserted
genomic DNA did not include the first exon since presence of the ATG start codon
of the 1-1 sequence would have interfered with translation of the fusion protein.
The unique Shell site at the 3' end of the genomic DNA was -300 bp upstream
from the ATG start codon of the first exon, and the restriction site was within the
CpG island (Fig. A7, Appendix 1, p. 181). Ideally, the restriction site used would
have been closer to the start of the first exon but lack of restriction sites excluded
this possibility: this was confirmed by sequence analysis by the Webcutter
123
computer program, http ://www.medkem. gu. sel. The restriction enzyme Ncol
recognises the sequence CCATGG and would have been suited to include the
entire upstream 5' since it would have recognized the start ATG codon (Fig. A7,
Appendix 1, p. 181). Unfortunately, digestion of the type 2 clone DNA with this
enzyme showed the presence of many Ncol sites in the length of DNA. Also,
there was not a corresponding Ncol site in the EGFP vector MCS for cloning.
Ultimately, there were six identical EGFP clones isolated which had the 9-kb
genomic insert present from the 5' Xhol site to the 3' Sacll site, (pEGFPLM9).
These clones were digested and compared to the original type 2 clone DNA to
confirm that there had been no loss ofDNA during the ligation process.
A second construct (pEGFPLM3-3) was built using Kpnl and Sacll enzymes to
generate a smaller fragment from type 2 clone, and this clone shared the same 3'
Sacll site with the larger genomic clone (Fig. 5.4). However, the EGFP-1 control
used in the ligation reactions (i.e. vector only) that had been digested with Sacll
and Kpnl gave high numbers of background colony numbers, suggesting that the
Sacll enzyme had not efficiently digested the EGFP-1 DNA. According to the
New England Biolabs catalogue (Beverly, MA, USA), certain Sacll sites can be
resistant to cleavage, and therefore, it is possible that the EGFP-1 Sacll site may
be resistant to digestion. Therefore, Kspl enzyme, an isoschizomer of Sacll, was
used to digest the EGFP-1 vector. The 3-3-kb KpnMSacl fragment was isolated
after agarose gel electrophoresis then ligated into the EGFP-1 vector that had been
digested with Kpnl and Kspl (Figs 5.4 and A6, Appendix 1, p. 180).
Midipreps of the pEGFPLM9 and pEGFPLM3-3 constructs and the vectors
pEGFP-1 and pEGFP-Nl were prepared using the Promega Wizard® Plus
MaxiPrep DNA Purification System. The presence of the inserted DNA was
confirmed by restriction digestion and agarose gel electrophoresis.
5.2.3. Transfection using FuGENE 6
FuGENEim 6 transfection reagent (Roche) is non-toxic, lipid-based and can
function in the presence of serum. According to Roche, transfection efficiency is
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greater using FuGENE 6 than alternative transfection methods, such as
electroporation, and has the added advantage that no major experimental
optimization is required. The protocol in the Roche handbook was carried out as
described.
Malek & Khaledi (1998) showed that transient transfection of cells using an
altered GFP reached maximum expression after 48 h but decreased significantly
after 96 h. With this in mind, the initial transfection experiments carried out were
cultured for 48 h or 72 h. The positively transfected cells were identified by
confocal microscopy after mounting in Vectashield with propidium iodide.
Positively transfected cells were labelled green and all cells counter-stained with
propidium iodide. The pEGFP-Nl vector was used as a transfection marker since
every transfected cell would express EGFP as a result of the presence of the strong
CMV promoter. The pEGFP-1 vector was used as a negative control since there
would be no fluorescent expression because of the lack of a functional promoter.
The control cell line used was the highly transfectable HEK293 cell line derived
from human embryonic kidney cells (a kind gift from Dr Rory Duncan,
Department of Biomedical Sciences, University of Edinburgh). These cells were
used to show that the transfection conditions were optimal. This cell line has been
used extensively for transfection experiments.
The cell line 4/4 RM-4 was obtained from the European Collection of Cell
Cultures (ECACC; http://www,ecacc.org.) and is derived from rat mesothelium.
There was no mouse mesothelial cell line in the ECACC databank. The rat cell
line was used since 1-1 is expressed in the mesothelium, as described in Chapter 4.
No references to the mesothelial cell line were found in the Roche website
(http://biochem.roche.com) or the Medline database (accessed through
http://www.bids.comT suggesting that the 4/4 RM-4 cell line had not previously been
used for transfection experiments. For each transfection condition analysed, the
experiments were repeated two or three times to ensure reproducibility.
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5.2.4. lnhibitor-1 protein expression of the HEK293 and 4/4 RM-4 cell
lines
To confirm that the I-l protein was expressed in the mesothelial line, but not the
human embryonic kidney cell line, monolayers of the two lines were cultured,
fixed in PFA and processed according to the protocol outlined in Chapter 2. The
Serotec antibody was deleted from the catalogue shortly after completion of the
work carried out in Chapter 4 and the only alternative commercial source of an I-l
antibody was from Santa Cruz Biotechnology.
The results confirmed that the cells received from ECACC were mesothelial (and
also reflected the results obtained in Chapter 4). The HEK293 cells did not
express the protein, as shown in Fig. 5.5. These results confirmed the suitability of
the cell lines selected for the transfection studies.
5.2.5. The plating conditions of the cells for optimal transfection
The transfection protocol for the FuGENE 6 transfection reagent supplied by
Roche was followed to determine the best plating conditions for each cell line.
The cells were transfected either 6 h or 24 h after trypsinization, and were grown
for 48 h. EGFP-N1 DNA was used as a positive marker for transfection. A ratio
of 3:1 was used for FuGENE 6:DNA but a ratio of 6:1 was also included for the
cells transfected with EGFP-N1. After growth, the cells were fixed in PFA,
mounted and viewed using the confocal microscope. The plating condition that
gave the better transfection rate was used for the follow-up transfection
experiment, where the cells were grown for 72 h after transfection (Table 1).
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Figure 5.5. Inhibitor-1 protein expression of the cell lines (a & b) HEK293 and
(c & d) 4/4 RM-4. The control cells (a & c) were not incubated with the inhibitor-1
antibody. The cells were detected with FITC secondary antibody and counter-
stained with propidium iodide (red). The results show that the (b) HEK293 cells do
not express inhibitor-1 but (d) 4/4 RM-4 cells do. This confirms the suitability of
these two cell lines for use in the transfection experiments. Bars: (a - d) 100 pm.
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Table 5.1. Transfection of HEK293 and 4/4 RM-4 cells 6 h or 24 h after trypsinization (indicated
by '6 h' or '24 h'). The cells were grown for 48 h or 72 h, fixed in PFA and then analysed by
confocal microscopy. The ratio of FuGENE 6:DNA (pL:pg) is shown in brackets. The number of
cells was averaged from six random 500 pm2 areas across the slide.
Treatment 4/4 R1Y1-4 4/4 RM-4 4/4 RIM-4 HEK293 HEK293 HEK293
(6 h) (24 h) (24 h) (6 h) (24 h) (24 h)
grown grown grown grown grown grown
48 h 48 h 72 h 48 h 48 h 72 h
No treatment 0 0 0 0 0 0
FuGENE 6 (3:1) 0 0 0 0 0 0
EGFP-1 (3:1) 0 0 0 0 0 0
EGFP-N 1 (3:1) 2-2 2-6 4-5 590 60-8 73-3
EGFP-N 1 (6:1) 2-8 4-0 6-2 78-4 79-5 93-5
Table 5.1 shows that the plating condition that gave the best number of positive
cells for each cell line was transfection 24 h after trypsinization, followed by
growth for 72 h. This suggested that there was a difference in fluorescent protein
expression in cells cultured longer than 48 h, reflecting the results of Malek &
Khaledi (1998).
Fig. 5.6 shows images of the negative controls for both cell lines i.e. cells with no
treatment, FuGENE 6 only, and cells transfected with EGFP-1 vector only. There
was endogenous fluorescence present in the control cells for both HEK293 and 4/4
RM-4, as shown in Fig. 5.6. These cells provided the basal level to which the
highly positive EGFP-N1-transfected cells were compared.
The FIEK293 cells transfected with EGFP-N 1 gave a high number of positive cells
(i.e. cells expressing EGFP) as shown in Table 5.1. Transfection 24 h after
trypsinization gave better transfection rates than transfection 6 h after
trypsinization. Furthermore, the ratio of 6:1 for FuGENE 6: EGFP-N1 gave higher
transfection rate than the 3:1 ratio (Fig. 5.7). The high number of positively
transfected cells confirmed that the HEK293 cells are ideally suited for
transfection studies.
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Figure 5.6. The controls used in the transfection experiments for cell lines
(a - c) HEK293 and (d — f) 4/4 RM-4. The cells were either: (a & d) untreated;
(b & e) grown in the presence of FuGENE 6 or (c & f) transfected with EGFP-1
DNA. The cells were fixed then counter-stained with propidium iodide (red).
The white arrows indicate non-specific fluorescent cells. Bars: (a - f) 100 pm.
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Table 5.1 shows that the 4/4 RM-4 cells gave far lower numbers of positively
transfected cells with EGFP-N1 in comparison to the HEK293 cell line. However,
the results also reflect an increase in EGFP-expressing cells when the cells were
transfected 24 h after trypsinization using a ratio of 6:1 for FuGENE 6:DNA,
similar to the HEK293 results (Fig. 5.7).
5.2.6. The ratio of FuGENE 6:DNA for optimal transfection
The next experiment was designed to vary the ratio of FuGENE 6:pEGFP-Nl
DNA to give the optimal number of positively transfected cells. Both cell lines
were transfected 24 h after plating and were grown for 72 h, since these were the
optimal conditions established in section 5.2.5, above. Table 5.2 shows the effect
of the different ratios on positive cell number for HEK293 and 4/4 RM-4 cells,
respectively.
Table 5.2. Transfection of HEK293 and 4/4 RM-4 cells using variable ratios of FuGENE
6:pEGFP-Nl DNA (pg pL~'). The cells were transfected 24 h after trypsinization, grown for 72 h
and fixed before mounting. The ratio of FuGENE 6:DNA (pL:pg) is shown in brackets. The order
of transfection rates for F1EK293 is arranged from the highest number of transfected cells (1) to the
lowest number of transfected cells (5) and was estimated by eye using the x 20 magnification lens.
The number of 4/4 RM-4 cells transfected per ratio is indicated and was averaged from six random
500-pm2 areas across the slide.
Ratio of Order of transfection rate Average number of EGFP-
FuGENE6:DNA (highest 1; lowest 5) for positive 4/4 RIM-4 cells
(fig pL-1) EGFP-positive HEK293 cells
No treatment 0 0
FuGENE 6 (3:1) 0 0
EGFP-N1 (3:0-5) 5 5-7
EGFP-N1 (3:1) 3 6-8
EGFP-N1 (3:2) 4 61
EGFP-N1 (6:1) 1 18 6
EGFP-N1 (6:2) 2 6-6
EGFP-N1 (6:3) 2 3-2
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Figure 5.7. Transfection of cell lines (a & b) HEK293 and (c & d) 4/4 RM-4
using EGFP-N1. The positive cells are labelled green (FITC) and the cells were
counter-stained with propidium iodide (red). The cells were transfected 24 h after
trypsinization, grown for 72 h, fixed then analysed by confocal microscopy. The
FuGENE 6:DNA ratios (pg: pL) of (a & c) 3:1 and (b & d) 6:1 were used. Bars:
(a - d) 100 pm.
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The number of transfected HEK293 cells was very high for all the different ratios
of FuGENE 6:pEGFP-Nl DNA and it was difficult to give accurate cell numbers.
However, it was possible to compare the different DNA ratios and determine by
eye the most effective transfection conditions. Thus, an arbitrary scale with the
highest rate of transfection given the values from the highest rate (1) to the lowest
rate (6), although even the lowest ranked ratio of FuGENE 6:DNA gave high
numbers of positively transfected cells. The results confirmed the preliminary
results from section 5.2.5 in that the ratio of 6:1 of FuGENE 6:DNA gave the
optimal number of transfected cells for cell line HEK293.
The results for the 4/4 RM-4 cell line showed that the cell line was not as easily
transfected as the F1EK293 cell line using the transfection marker EGFP-N1.
However, the FuGENE 6:pEGFP-Nl DNA ratio of 6:1 gave a significantly higher
number of positively transfected cells than other ratios analysed, as shown in
Table 5.3, and Figs 5.7 & 5.8. This difference was less pronounced for the
HEK293 cells, since each ratio gave high transfection rates.
The experiments in this and the previous section identified the optimal conditions
for transfection of the two cell lines. For both the HEK293 and 4/4 RM-4 cells,
the highest number of transfected cells were obtained using a FuGENE 6:DNA
ratio of 6:1, transfection 24 h after trypsinization followed by growth for 72 h
before mounting.
5.2.7. The effect of fixative on fluorescent protein expression
The effect of the PFA fixative on fluorescent protein expression was analysed
since it was possible that this could lead to loss of signal. Untreated cells, cells
exposed to FuGENE 6, and cells transfected with EGFP-1 and EGFP-N1 DNA,
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Figure 5.8. The average number of positively transfected 4/4 RM-4 cells
using various ratios of FuGENE 6:EGFP-N1 DNA (uL:ug). The error bars
indicate standard deviation.
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Figures 5.9 and 5.10 show that the fixative had no obvious effect on the number of
transfected cells for either HEK293 or 4/4 RM-4 cells, respectively (Figs 5.6 &
5.7). The fixed cells from both cell lines had a dampened signal rather than loss of
fluorescence (Figs 5.6, 5.9 & 5.10).
Some of the unfixed cells had a rounded appearance, but there was no loss of
signal associated with this. Since the cells were analysed within 2 days of
mounting, there was no significant loss of morphology for the unfixed material.
5.2.8. Transfection of cell lines using pEGFPLM9 and pEGFPLM3-3
The genomic constructs pEGFPLM9 and pEGFPLM3-3 were used to transfect the
HEK293 and 4/4 RM-4 cell lines using the optimized conditions outlined in
sections 5.2.5-7. Both fixed and unfixed cells were analysed since section 5.2.7
showed that the use of PFA appeared to dampen the fluorescent signal, although it
did not eliminate fluorescence (Figs 5.9 & 5.10).
Figure 5.11 shows that transfection of both cell lines with the pEGFPLM9 and
pEGFPLM3-3 constructs did not result in any positive cells. The positive control
EGFP-N1 did give highly positive cells in both cell lines, confirming that the cells
lines were transfectable and that the DNA preparation did not cause adverse effect
on cell growth. The unfixed negative controls all showed endogenous non-specific
fluorescent expression, as shown in Figs 5.9 & 5.10.
The 3-3-kb construct appeared to give a higher number of these weakly positive
HEK293 cells, but this was not apparent in the 4/4 RM-4 cell line. This
observation may reflect the presence of a weak 1-1 promoter. This was the only
observable difference between the control transfected cells and those transfected
with genomic DNA.
Although the results from the transfection of the cell lines with the genomic
constructs were disappointing, the direction for future work is indicated even
though lack of time prevented further analysis.
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Figure 5.9. The controls used in the transfection experiments for cell line HEK293.
The cells were either: (a) untreated; (b) grown in the presence of FuGENE 6; or
transfected with (c) EGFP-1 or (d) EGFP-N1. The cells were not fixed before being
counter-stained with propidium iodide (red). Bars: (a - d) 100 pm.
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Figure 5.10. The controls used in the transfection experiments for cell line 4/4
RM-4. The cells were either: (a) untreated; (b) grown in the presence of
FuGENE 6; or transfected with (c) EGFP-1 or (d) EGFP-N1. The cells were not
fixed before being counter-stained with propidium iodide (red). Bars:
(a - d) 100 pm.
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Figure 5.11. Transfection of the cell lines HEK293 and 4/4 RM-4 using the
genomic constructs pEGFPLM3-3 and pEGFPLM9. (a & b) HEK293 cells and
(c & d) 4/4 RM-4 cells were transfected using the constructs (a & c) pEGFPLM3-3
and (b & d) pEGFPLM9. The cells were not fixed before being counter-stained
with propidium iodide (red). Bars: (a-d) 100 pm.
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5.3. Discussion
The aim of this research chapter was to characterize the 5' flanking region of the
mouse 1-1 gene. The building of the construct containing the GTl-8IRESpgeo
sequence was not successful, but two lengths of genomic DNA were successfully
inserted into a promoterless EGFP vector, resulting in the constructs pEGFPLM9
and pEGFPLM3-3. The initial plan to use the construct to produce transgenic
mice was altered because of a lack of time and money, and therefore, transiently
transfected cells were analysed. Although inconclusive, the work carried out in
this chapter does indicate directions of future work.
5.3.1. Construction of reporter plasmids
The reason for the unsuccessful ligation of the pGTT8IRESPgeo and genomic
DNA is unknown. The genomic DNA was successfully inserted into the pEGFP-1
vector, showing that the genomic DNA was clonable. However, the particular
conformation of the pGTl-8IRESPgeo and the genomic DNA may have been
unsuitable for successful ligation, or the final size of the construct (>20 kb) was at
the upper limit for successful competent cell transformation and growth, and
plasmid replication. The size of the predicted final construct may be the most
plausible reason. Fortunately, two lengths of the 5' genomic DNA were
successfully ligated into the pEGFP-1 vector. These 9-kb and 3-3-kb lengths of
genomic DNA were of reasonable size for initial characterization of the upstream
sequence of the 1-1 gene.
5.3.2. Transfection of cell lines
The cell line 4/4 RM-4 used in this study was confirmed to be mesothelial by its
expression of 1-1 using the antibody from Santa Cruz Biotechnology. The
HEK293 cell line did not express the protein (Fig. 5.5).
In the transfection experiments, there were non-specific fluorescent cells present in
the control cells for both HEK293 and 4/4 RM-4 (Fig. 5.6). There was no
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difference in the levels of these weakly fluorescent cells in the untreated control
group, cells grown in the presence of FuGENE 6 or those transfected with EGFP-
1. These control cells provided the basal level to which the highly positive EGFP-
N1-transfected cells were compared (Fig. 5.7).
The initial transfection experiments were important to determine the optimal
transfection conditions for each cell line. Both the HEK293 and 4/4 RM-4 cells
shared optimal conditions: the cells were transfected 24 h after trypsinization using
a ratio of 6:1 for the FuGENE 6:DNA, and the cells were grown for 72 h before
mounting. PFA fixation of the cells gave a dampened, though not reduced,
fluorescent signal. If the 1-1 promoter was weak, then any loss in signal may be
significant, and thus, both fixed and unfixed cells were analysed when transfected
with the genomic constructs. The only minor drawback in not fixing the cells was
the development of a rounded shape, but the cells were viewed within 2 days of
mounting to prevent major loss of morphology. Each experiment was repeated at
least twice to confirm the results presented in this chapter.
In theory, the results from the genomic construct transfection experiments would
indicate one of the following:
(1) if both the constructs showed EGFP expression in transfected cells, then the
promoter elements will be present in the 3-3-kb length ofDNA;
(2) if only the 3-3-kb construct gave GFP expressing cells, then the promoter
regions will lie within this region, but there will be negative regulatory
sequences upstream (contained within the 9-kb region);
(3) if only the 9-kb construct gave positively transfected cells then the promoter
regions must lie upstream from the 3-3-kb DNA sequence; or
(4) if neither construct results in GFP expression then one of the following may be
involved:
(a) the regulatory sequences may lie within, or upstream or downstream
from the protein-coding exons;
(b) there may be negative regulatory elements within the 3-3-kb length of
DNA;
(c) the 1-1 promoter is weak;
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(d) the 285 bp of 5' upstream sequence between the Sacll site and the first
exon contains regulatory elements; or
(e) there is tissue specificity of 1-1 expression.
Since the positive and negative controls worked well in the transfection
experiments using the two cell lines, the lack of positively transfected cells was
not a result of the low transfection rates of the cell lines used. The lack of positive
cells after transfection with the genomic constructs suggests the reason for this is
one of the reasons given in 4 (a-e), above. It would be impossible to determine
the precise reason without further experimentation.
The results presented in this chapter suggest that the HEK293 cells transfected
with the 3-3-kb construct may have a higher number of the weakly transfected
cells. This may not be significant, but does, perhaps, indicate that there may be
weak expression in the HEK293 cells using this construct.
The 4/4 RM-4 cells gave lower transfection rates than the HEK293 cells using the
EGFP-N1 DNA, reflecting the highly transfectable nature of the HEK293 line, but
also suggesting that line 4/4 RM-4 is poorly transfectable. There is no published
record for this mesothelial cell line being used in transfection experiments
(confirmed by a search of the Roche website and Medline database), perhaps
because of low transfectability. Also, the low rates were not a result of the
endotoxin levels or purity of the DNA used since the HEK293 cell line gave high
transfection rates using the same DNA maxipreps. The basal number of non¬
specific fluorescent cells was consistent for the controls and genomic constructs,
and the 3-3-kb construct did not give rise to any positively transfected 4/4 RM-4
cells. However, this may reflect the poor transfectability of the mesothelial cell
line rather than absence of promoter sequences.
The use of the rat mesothelial line could be the reason for the lack of positively
transfected cells since mouse genomic DNA was used in the transfection
experiments, but there was no mouse mesothelial cell line available from ECACC.
The predicted mouse and rat 1-1 mRNA and protein sequences are over 95%
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homologous (as shown in Chapter 3) although this does not necessarily imply that
the regulatory sequences will be strongly homologous.
5.3.3. Sequence analysis
The GRAIL/polII program forms part of the NIX analysis at MRC HGMP-RC
(http://menu.hgmp.mrc.ac.uk/menu-bin/Nix/Nix.pl) and was used to examine the T8-kb
sequence upstream from the first exon. The analysis showed the sequence from
nucleotide positions 331 to 365 (Fig. A7, Appendix 1, p. 181) shows the presence
of TATA and cap sequences. This analysis gave a figure of 0-779 ('good'
according to the analysis) on a scale from 0 (indicating no promoter sequences) to
1 (indicating the likelihood of the presence of promoter sequences). The program
recognizes only PolII promoters with TATA-like elements and detects
approximately 60% ofPolII promoter regions with TATA-like elements.
An alternative algorithm within the NIX program, TSSW, predicts potential
transcription start sites using a linear discriminant function (LDF) that combines
functional motifs and oligonucleotide composition. LDF values above 4 represent
candidate transcription sites. The program detected a 'good' potential functional
motif, GA, at nucleotide position 1772 (Fig. A7, Appendix 1, p. 181) with a LDF
value of 10-52 that lies within the CpG island and 26 base pairs before the start of
the first protein-coding exon. Unfortunately, this particular stretch of DNA was
omitted from the EGFP genomic constructs because of a lack of restriction sites
present in the genomic DNA. A 'marginal' functional motif was detected at
nucleotide position 2335 (Fig. A7, Appendix 1, p. 181) and had a LDF value of
8-81, but this stretch ofDNA was not present in either of the genomic constructs.
The results from the NIX computer analysis suggested the presence of potential
regulatory elements in the sequenced 1-8-kb length of genomic DNA. However, it
was not possible to determine if these features are important for 1-1 gene




The purpose of this research chapter was to identify the promoter elements of the
1-1 gene. The initial work plan had to be altered as a result of unforeseen
circumstances since the building of the construct containing GTT8IRESPgeo was
unsuccessful. The alternative strategy involving the pEGFP-1 vector did result in
the production of two constructs. Transiently transfected HEK293 or 4/4 RM-4
cells showed that there were no obviously transfected cells using either the long or
the short genomic constructs. Although the results presented in this chapter are
not conclusive, neither are they negative since the positive controls determined the
transferability of the cell lines used and do give direction for future research.
5.3.5. Future work
Ideally, the EGFP-1 genomic constructs would have been a result of non-
directional cloning since this would have the advantage of insertion of the genomic
DNA into the vector in both directions. Lack of unique restriction sites within the
type 2 clone (Fig. A6, Appendix 1, p. 180) and time constraints did not allow for
further experimentation into this. Thus, future work could involve this line of
research.
The 285-bp nucleotides from the Sacll restriction site to the start of the first
protein coding exon was lost because of restriction site limitation, as confirmed by
sequence analysis by the Webcutter computer program. Therefore, it is possible
that this region of DNA contains the start site necessary for transcription, as
suggested by NIX sequence analysis. Unfortunately, introduction of a unique
restriction site into the first exon using ExSite PCR-based site-directed
mutagenesis was not successful. Insertion of a unique restriction site nearer to the
ATG start codon would have confirmed whether this 285-bp stretch of DNA from
the SacW site to the first exon contains (or is part of) the 1-1 promoter sequence.
Future work could involve the building of a smaller construct (-1-5 kb) to
determine whether there are any negative regulatory elements present in the 3-3-kb
length of genomic DNA, but it should include the missing 285-bp sequence. This
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would allow the creation of transgenic mice using the EGFP constructs.
Furthermore, use of a longer length of mouse genomic DNA (e.g. a YAC clone)






In order to characterize the mouse 1-1 gene, the aim of the work undertaken in this
project was to:
• isolate genomic clones from a mouse library, from which the genomic structure
of the 1-1 gene could be determined (Chapter 3);
• analyse the protein expression pattern in the developing mouse embryo using
whole-mount tissue and confocal microscopy (Chapter 4);
• characterize the flanking 5' genomic sequence to determine the presence of
regulatory elements (Chapter 5).
The rabbit, rat and human protein sequences had previously been determined
either by sequence analysis (rabbit) or by prediction from mRNA sequences (rat
and human). The mouse sequence had not been determined and, therefore,
Chapter 3 described the screening of a mouse genomic library to isolate clones that
contained sequence homology to the known rat 1-1 mRNA sequences. Analysis of
these clones determined the genomic structure of the 1-1 gene, including the
predicted mouse 1-1 mRNA and protein sequences which are over 95%
homologous to the rat sequences, and share certain sequence motifs that are
required for 1-1 binding to PP-1. Chapter 4 showed that the 1-1 protein was not
expressed in the metanephric mesenchyme and, thus, 1-1 is not a kidney stem cell
marker: the 1-1 protein is a novel marker for the mesothelium and is also expressed
in the surface layer of cells of the ectoderm. Chapter 5 reported the analysis of the
upstream genomic DNA for potential promoter sequences; the results were
inconclusive, but reasons are considered for this. Since each research chapter
discussed the results that it contained, this final discussion chapter briefly recaps
the findings of each chapter and considers future work based on the work carried
out.
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6.2. The protein-coding region of the inhibitor-1 gene
Chapter 3 determined that the protein-coding region of the mouse I-1 gene spans a
7 kb region of genomic DNA, with the protein encoded by seven exons. The
predicted protein sequence is strongly homologous to the predicted sequence from
rat muscle cDNA (Elbrecht et al. 1990), the sequenced proteins derived from
rabbit skeletal muscle (Aitken et al. 1982) and liver (MacDougall et al. 1989), and
the deduced human sequence from cDNA clones isolated from a brain library
(Endo et al. 1996). Indeed, the mouse and rat predicted mRNA and protein
sequences share over 95% homology.
There are two elements in the human 1-1 protein structure which are required for
efficient PP-1 inhibition: a KIQF motif at the amino end of the sequence and a
threonine at amino acid position 35 (Endo et al. 1996). Both features are present
in the mouse sequence. There is also a serine at amino acid 67 in the mouse
sequence that may be a site of phosphorylation, as suggested by Huang & Paudel
(2000) using recombinant human 1-1. The apparent molecular mass of mouse 1-1
determined by SDS-PAGE is 30-5 kDa (Hemmings et al. 1992) and this is
consistent with the 30 kDa protein detected for rat 1-1 (MacDougall et al. 1989;
Hemmings et al. 1992; Fryckstedt et al. 1993; Lowenstein et al. 1995) but the
~5% variation in amino acid sequence between mouse and rat mRNA identified in
this project would account for the 0-5 kDa difference in protein weight.
6.3. Inhibitor-1 protein expression in the developing mouse
embryo
The 1-1 protein expression pattern of the mouse embryo was determined in
Chapter 4 using whole-mount tissue, a commercially available antibody and
confocal microscopy. This is the first time that 1-1 expression was determined in
this way. The only published data showing 1-1 protein detection is by Fryckstedt
et al. (1993), who analysed cryostat sections of rat newborn kidney. However,
that study showed that only the occasional proximal convoluted tubule cell was
labelled, and the expression pattern was not consistent with the results in this
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project, nor with those of Svennilson et al. (1995) who used in situ hybridization
to show mRNA expression in the stem cells. The results ofmy detailed project did
not show protein expression in these cells, thus, 1-1 is not a stem cell marker of the
developing metanephric kidney.
The results of this project showed that 1-1 was only found in the mesothelium and
the surface ectoderm but not in other epithelial cells. Both tissue types have
unilaminar epithelial morphology (Williams et al. 1995) but neither smooth
muscle nor brain tissue was analysed since expression in these tissues has already
been documented by MacDougall et al. (1989), Hemmings et al. (1992), Sakagami
et al. (1994) and Lowenstein et al. (1995). Confirmation of the I-l-positive cells
having an epithelial phenotype was shown using epithelial-specific antibodies
(anti-laminin and anti-pan cytokeratin). Other tissues of the coelomic cavity,
which are bounded by mesothelium, were analysed, showing similar 1-1 staining to
that found in kidney. This observation suggests a unique expression pattern for 1-1
in the embryo and indicates that 1-1 could be used as a marker for the
mesothelium. Interestingly, the only internal labelling exhibited by 1-1 was in the
occasional developing testis (~E13) during formation of the primary sex cords, but
the 1-1 signal was down-regulated after formation of the cords. This suggests that
1-1 is downstream from the gene sry that controls the migration of mesonephric
cells into the developing testis to form the sex cords.
The presence of 1-1 in the mesothelial and ectodermal cells will inhibit the activity
of PP-1 (1-1 is thought to have no other role in the cell) and so lead to an increase
in intra-cellular phosphorylation reactions, although it is not clear if these cells
require this inhibition for control of the cell cycle, protein synthesis or some other
cellular pathway. The results given in chapter 4 showed that 1-1 expression is
unaltered as the coelomic epithelium differentiates to mesothelium (determined
during kidney development from Ell onwards) though there was loss of the 1-1
protein after migration of mesonephric tissue to form the testis sex cords. Since I-
1 is expressed in coelomic epithelium and ectoderm from early development
through to the adult, these tissues must require 1-1 expression for normal function.
Moreover, exogenous inhibition of PP-1 (and PP-2A) in cultured El3 rat kidneys
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by Svennilson et al. (1995) resulted in inhibition of growth and disrupted nephron
formation, suggesting that endogenous 1-1 and PP-1 levels must be balanced for
maintenance of normal growth and development.
Identifying any unique role for 1-1 is further complicated by there being other
known inhibitors of PP-1. DARPP-32 (dopamine- and cAMP-regulated
phosphoprotein) and inhibitor-2 have both shared and separate motifs required for
binding PP-1 (Huang et al., 1999). DARPP-32 is expressed in developing and
mature rat kidneys (Fryckstedt et al. 1993). However, it is not possible to
comment on the phosphorylation state of 1-1 because the Serotec antibody used in
this study can detect both forms of the protein (MacDougall et al. 1989). The
precise function of 1-1 in the developing embryo will be determined by gene
targeting experiments.
Allen (et al. 2000) analysed wild-type mice and found 1-1 expression in the dentate
gyrus and hippocampus. The 1-1 knock-out mouse (Allen et al. 2000) exhibited no
major physical defects due to loss of the gene's activity, but there was disruption
in long-term potentiation at perforant path-dentate granule cell synapses. Loss of
1-1 in the knock-out mice did not effect the insulin levels on glycogen synthase
since wild-type mice had identical levels, suggesting that 1-1 is not involved in the
signal transduction pathway for glycogen synthesis (Scrimgeour et al. 1999). This
observation suggests that loss of 1-1 expression may be compensated for by the
presence of another protein phosphatase type-1 inhibitor. However, Scrimgeour
found no expression of DARPP-32 in the muscles of the I-l~~ mice; thus, there
was no increase in levels of this protein after loss of 1-1 expression. Also, muscles
from mice that lacked both the 1-1 and DARPP-32 genes had similar glycogen
synthase levels to wild-type mice.
Although MacDougall et al. (1989) did not detect 1-1 expression in mouse liver by
immunoblotting, this was probably due to the lower proportion of mesothelial cells
in this tissue in comparison to e.g. kidney and gonad: Fig. 4.6.e clearly shows the
presence of 1-1 in mouse liver.
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Incubation of tissue from the El 1 coelomic cavity suggested that the mesothelium
lining of the kidney derives from coelomic epithelium (which surrounds the
intermediate mesoderm at ~E11-5 when the kidney is still small and envelops the
kidney when it enlarges). However, why this should result in a weakly labelled
epithelial cell layer was not clear.
6.4. The 5' flanking sequence of the inhibitor-1 gene
The plan ofwork for chapter 5 (analysis of 5' flanking DNA sequences) had to be
altered since the GTT8IRES(3geo DNA was not successfully ligated to the
genomic DNA for reasons unknown, although the final construct size (>20 kb)
remains the most likely cause. A different approach was required and this
involved the insertion of two lengths of genomic DNA into a promoterless EGFP
vector, followed by transient transfection of two cell lines.
The transfection studies using either of the genomic constructs did not result in
positive transiently transfected cells in the rat mesothelial cell line 4/4 RM-4 or in
the highly transfectable cell line HEK293. The only potentially significant finding
was that there was a slight increase in weakly positive cells in the HEK293 cell
line after transfection with the 3-3-kb construct. This may not be relevant since it
is possible that the genomic construct may cause apoptosis and this could have
resulted in this observation. However, the experiments did show that the
alternative approach undertaken to analyse promoter sequence analysis was
reasonable i.e. use of the promoterless EGFP vector followed by transient
transfection of cultured cells. The experiments showed that neither the
experimental procedure nor the cell lines used were responsible for the negative
results, since the transfection marker EGFP-N1 resulted in positive cells for both
cell lines. However, the design of the EGFP constructs was limited by lack of
suitable restriction sites in the genomic DNA sequence and attempts to insert a
unique site using oligonucleotides and PCR-mediated ExSite mutagenesis were
unsuccessful.
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The reason for lack of positively transfected cells after transfection with the
genomic constructs may have been due to the absence of promoter sequences or
the presence of negative regulatory elements in the genomic DNA. The missing
285 bp length of genomic DNA (from the start codon of the first protein-coding
exon to the 5' Sacll site) may be vital for promoter regulation due to the presence
of a transcription start site, as suggested after analysis by the computer program
NIX. It is difficult to confirm the functional role of this site without further
experimentation. However, the results did show that the experimental procedure
was not deficient since positively transfected cells were obtained using a positive
transfection marker (EGFP-N1) and the two cell lines. Nonetheless, the
experiments described in Chapter 5 do lay the groundwork for future work.
6.5. Conclusion
The aim of the project has been successful in characterizing the mouse 1-1 gene:
the structure of the gene, and the mRNA and protein sequences have been
predicted from genomic clones; the protein expression pattern has been determined
by confocal microscopy and whole-mount tissue and has shown a unique
expression pattern for 1-1 in the developing mouse embryo; and although
incomplete, the initial groundwork has been carried out to determine the 1-1 gene
regulatory elements.
6.6 Future work
There are two areas identified from the work carried out in this research project
that can be considered for future work. Firstly, the presence of the 1-1 protein in
the mesothelium suggests the potential for the protein to be a marker for
mesothelioma tissue. However, since there was loss of 1-1 expression after
migration of the mesonephric cells into the developing testis to form the sex cords,
then differentiation of the mesothelium may result in loss of 1-1 expression.
Future work would confirm this, although use of fluorescent confocal microscopy
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may not be the ideal tool since the human tissue has high levels of endogenous
fluorescence.
The second area that would benefit from future work is the characterization of the
1-1 gene regulatory elements. Although the 1-1 protein-coding region of the gene
has been fully characterized in this project, the regulatory elements have not been
identified. Lack of time and unforeseen problems meant that one of the initial
aims of the project (i.e. to produce transgenic mice) was not successful. Inhibitor-
1 knockout mice have already been produced by Allen et al. (2000) but the mice
did not exhibit developmental defects since the mice survived after birth, but this
does not invalidate the possibility of producing transgenic mice to show the in vivo
expression pattern of the 1-1 protein. Analysis of the transients after transfection
with the genomic constructs, pEGFPLM9 and pEGFPLM3-3, showed lack of
EGFP expression in either of the two cell lines. This may have been a result of
absent (or incomplete) promoter elements, loss of the transcription site or the
presence of negative regulatory elements. Future work could include the use of a
YAC clone, for example, that contains a longer length of flanking 5' sequence
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Figure Al. The maps of vectors used in the research project: (a) pGEM"-T Easy
(Promega); (b) the XPS vector of the mouse genomic library (MoBiTec), showing the
position of the loxP and restriction sites; (c) pBluescriptSK+/- (Stratagene); (d)
pBluescriptIIKS+/- (Stratagene); (e) pGTl-8IRESPgeo (built by W. Skarnes, P.
Mountford and P. Tate in 1992); (f) pEGFP-1 (Clontech); and (g) pEGFP-Nl
(Clontech).
(a) The vector pGEM®-T Easy from Promega was used to clone the 336-bp PCR product
from 1912-d05. The restriction sites in the multiple cloning site (MCS) are shown.
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A.PS SI-SII-N
Xba 1 (S-N-R-X-H)-B-K -Xba 1
rB-(H-X-R-N-S) pBiuescripl










(b) The structure of the APS vector and the resulting insert DNA, pBluescript and loxP
sites after automatic subcloning in Cre recombinase-expressing cells. In the final
plasmid, the sites Hindlll (H), Xhol (X), EcoRl (R), Notl (N) and Sail (S) are lost,




Sacl Sacll Eagl Spe\ Sma\ EcoR\ Hind\\\ Cla\ HincU Xho\ Eco0109\Kpn\
BstX Not\Xba\ BamH\Pst\ EcoRV Bsp^06^Acc\ DraU
Sa/I Apa\
(c) pBluescriptSK (+/-) from Stratagene (above) is a 2958-bp phagemid derived from
pUC19. The MCS shows the restriction sites present.
168
Nae I 131
Kpn\ Eco0109l HincU Bsp1061 EcoRV Pst\ Sma\ Spe\ Not\ BstX\ Sacl
DraW Xho\ Acc/ C/al Hind\ 11 EcoRI SamHI Xfaal Eagl Sacll
Apa\ Sa/I
(d) pBluescriptllKS from Stratagene (above) is a 2961-bp phagemid derived from
pUC19. The MCS shows the restriction sites present.
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(e) The vector pGTl-8IRESPgeo (above) is 9-37 kb and the main restriction sites are







Eco47lll BglII Xho\ Sacl Hind\\\ Pst\ Sal I Kpn\ Sacll Xmal AgeI
Ec/136ll EcoRI Acc\ /4sp718l Apa\ Sma\ BamHI
Bsp^20\
(f) pEGFP-1 (above; Clontech; GenBank Accession number U55761) is 4 2 kb in size
and encodes a red-shifted variant of wild-type GFP to give brighter fluorescence and




Nhe\ BglII Xho\ Sacl HindIII Pst\ Sal I KpnI Sacll Xmal Age I
Eco47lll Ec/13611 EcoRI Acc\ 4sp718l Apa\ Smal BamHI
Bsp 1201
(g) pEGFP-Nl (above; Clontech; GenBank Accession number U55762) is 4-7 kb in size
and encodes for the same red-shifted variant of wild-type GFP as pEGFP-1. The MCS
shows the restriction sites present.
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Figure A2. Sequence analysis of 1912-d05. The mouse clone 1912-d05 was
commercially sequenced (KC) and compared to the I.M.A.G.E. sequence (IM).
Differences are indicated by highlighted pink nucleotides: (N) unknown nucleotide







































Figure A3. Sequence analysis of 3141-o09. The clone was commercially sequenced
(KC) and compared to the I.M.A.G.E. sequence (IM). The first 500 nucleotides are
shown, but sequence homology differs after nucleotide 410. Differences are indicated
































Figure A4. Comparison of the different sequences of clone 1912-d05.
Sequences from King's College, London (KC), the partial sequence supplied by
I.M.A.G.E. (IM), the MWG-Biotech (MW), and the DNASHEF sequence (SH)
were compared. Differences are indicated by highlighted pink nucleotides: (N)
is an unknown nucleotide (yellow); and (-) a gap for best alignment. There is

































































Not\Hind\\\SacWi clEc RIPsflSco IPst\BamH\Sma\st\t\Xba\XbaBam I SaclEcoRIBssHIPsflvulBamHIIPvulKpn\SmPst\Kpn BamHIIKpn\a HIPvuWSmalPvuW P̂vull Xba)
1kb










SaclSamHIl INotl Hind\\\ind\\\Pst\Kpn Btn\EcoRIBssHISacl
SaclI EclXI t
FigureA6.Therestrictionmapoftyp2clon(12kb,drawnscal ).po itionhexocol u db x)andt es l areindicated.Thgre nrowsi icatetE lXI(5')nNoll3rest ictiosi shw rlecti tXholS ll oligonucleotides.
Figure A7. Nine kilobases of sequenced genomic DNA. The genomic sequence of the
region containing the 1-1 protein-coding exons (|, I 3, |U and 1) from the ATG start
codon (nt position 1800) to the TGA stop codon (nt position 8709). The CpG island is
underlined. The pBluescript vector sequences have been removed to allow the
continuous sequence to be represented. N denotes a nucleotide of unknown type
because of failure of sequencing. The SacII site (CCGCGG) is at nt position 1511
(italics). A total of 9065 nucleotides were sequenced from subcloned fragments from
the two clone types isolated from the library. Nucleotide 1 does not refer to the
transcription start site since the promoter regions associated with the 1-1 gene are not
known, but does refer to the 5' flanking region ofDNA that was sequenced.
1 AGGGGTCGGG ACTGTCCCTT CAGGTCATCC AGGCCTGGCC AAGAGGATAG
51 AGAATGTCCC TCTCTAGAAG CACTATGCCC CTAAGTGTAT GTGTGGGAGG
101 GAGAAGCAAA GAGAAGGAAA ATAATGGCCC AGCCCTAAGA CACCGTCTGC
151 CCTGTCTCCC ATATTATTGA TTCATCACCT CTCCGTGCAC ATTGCACTGG
201 GATGTGGGTA AACAGACATT GGGATCCAGG GACACTGAAC ATTTTCCCTA
251 CTATCCAAAC AGAGCAAAAA GGCTGGGAGA AGCATTCCCA GAGTCCCATT
301 ACTTCAACAG CAAATGGAGG AGCAACTGGC TATAGAACCT TCAGGGCTGC
351 TGAGTGGCTG CAACCTGGCC TTGCCCTGGA GAAAGCTGAG CCTGTCTGCT
401 GTGTAAAAGG ATCCCTAGGG GAGGAAGGGG GTGAGGGTGG GGCTATTTTT
451 GGAGGGAAGA GGGGAAGGGG CCATGGAAAA CACACCAGAG AACTCCAGAC
501 TGAGGTTTAA AGCTGCCCCC TAGAGTGGGG GATGACCAAG GCCCCATTCC
551 CCTGGAGCCA AGCTTAAACC TAGATAGACC CTGCCCTCTG TTCAGTTTAA
601 GACTACAAAG AAACTGATCT CCCCGTACTT CCATACCCCC CCTTCAGCAC
651 TATAGGCCTT CTCCTTCTCT ATCTCAGTTC CACTGTGCCT CCTGAATACA
701 TTAGGAACCC TTCCACCTCT CCAGCACCCA CCTCTCTCTG TCTAGTGACC
751 CTAACCCTAG TACAGAGCAC TTCAGTTCCT ATGAATATCC TGTCGCCTTC
801 ACTGGTTAGT ACCGAGTGGC ATGTTGATCC CATACCAACC CAGTAAGTTC
851 TTCTAGTAGT CTAACTTCCA TGCCAATAGT CACGACAGAG CAGGGCAGAG
901 CATTTTCATT GTCCTGCCAA CAGTGAAAGT GGACACCAGC CATCTGTAAA
951 CAGGCCACCC CGGTGGGGTG TCCTCCACTC CCCATCCCCA TCCCTGTAAT
1001 CCCCTTAAAG GCCTTTCACC TACTTTGCAG CTCACAATGT AGCAAGCAGA
1051 AAGTGAAATC TATTTCACAA GCAGGATTGG CTTTCACCTC CATGGCTTCT
1101 TCTTTACCCT AAATGGCCCC TCTCCCCAAG CCCTTGGTCC ACTCACACTC
1151 CAAAGAGTCT TACTCTGCCG ACTCTCTGAG AGCTTCCCCT CTTCTCTCTC
1201 TTGTCCAGGA GTGTTCCCTG AACAGTAGCC AAAGCTCGCA CCTGCCCTCA
1251 AAGTTTTCAC ATCCACTCTA GTAATTGGCC TCAAGGGGAA GTTCCCTCCC
1301 AGTCTAACTT TAATCCCTCC TGCTGTGTAC CTAAATCTCC TTTCAATCTT
1351 TTCTCTTTGT GAAATCTCCT TTAGATCATA AACATAATCT ACCTCTGGAG
1401 CTGTGTCCTT TCTTTTTTCC AGACCATGAA ACCTGCACCA GCTTGAAGAA


















































TGGATGCCGG CCGCGGGTGG TCTAGGAAGC GACCAACCGG GGTCTGGATC
CTTAGCTTGA GGGGCGGCAA CCTGCACAGC CGCCAGCACA GCCACGACGG
GGTTAAGGCT CGGGACTGGG GGAGGACGGG GCCGGAGGAC GGTGACGAGC
CAATCCGCAA CAACACAGTC CCCAAGCGGA GCGGGCGCGC CGAGCCAGGA
GCTGCAAGCC GAGCGCCGGG CTGGGGCCAG GGCCGGAGCG CAACAGAGAG
GGAGCGCGCC CGCCCCAGCC CGAGGTCCGC CGCTGCCTGA CCGGGAGCCl
TGGAGCCCGA CAACAGCCCA CGGAAGATCC AGTTTACGGT CCCGCTGCTG
GAGCCTCACC TGGACCCGGA GGCGGCGGAG CAGGTACAGG CAGGGCGGGG





















































































































































































































































tccaacctca gagccctgct gacctttggt catgggctcc ttgggttccc
aatacaggta ctgcatcaag tcactgatac cccttncaca gtctcagtca
cttccactac tctccagtgg caaccccacc ccaccaaaac agaangaaag
ttagggatca aagggatggt cccacttcca catacacgan catnttgtac
cagaagcagc cagagacaat tccattcaat tttcacacca cacacncaca
cncagangtt ngctttttgg gancttgaat gcactaaaac ntatgcncta
gtttcctgan caaaantcat ttntcattna tctgttttnt ttggaaaanc
cctttngtta aaanncttct acattcnntt taggnnctag gtatcttgtc
acctccagcc accactgcca atgctgatga tgacaagaga caaatatgna
cagatctaaa tctgatccgt tgcgtcctca ctggaccctg cttccccagg
actgctagct ttatctaccc acagccctga gagaacagca ggagctccaa
aacggcnntt aaacccatgt gatgcctctc tcttccaaac cttccccaga
aaaggaaaaa ctacacatcc taagagtcta taggattcag caacaatcag
cttaatagat agcaggacag gaagaaaagc cagcagcagg aggggggcat
tcagttggaa ctcatgccac cggtctgctt tatatgatca tttcccctgg
ggctggccag gattctacct cctcaagtcc tgttcaccat taggaccact
tcccctattc ctggccaatt aaaaagccat tgtgtccaag gctagtgaaa
ccttagagta ttgagggacc gtggtggcca ggggaatggt gcactcagcc
cttccttcat ggtggatgaa cctgagggag gccttctgaa gacaggtatg
agcccacaaa gggttaatgt ctgcttcagg ggtggactgg agtctgaggg
aaagccctct gatctctcat gttatttctg accattgatc caggatggac
agaaatcaat gcacagagtg gacagagttt ccgaaaggag agctggggag
gacaaggaga ggatgaagag acagtacaag gaagggactg tgtagtttct
tgtgtcccca agagcagctc acccctgaag aagggaatgg gccaatggaa
ctccagagta accagtaact tttgggggga tgtgcagaat cggactgggg
gggggtattc ctagcgaact tgacctctta ttcttcctcc cctaacccag
HHHB ipgggggg gggSBBSS ggggggi ■■■HIhhhh |gtaacccct tgtaagaggg gatgggtgct agagagatag
ggcagacctc agtagtagag atttccccgt gctgactcag caagatttat
tttgctttta caaacatgga aatctgctag gcggggaggg ggacaccctg
attccctaag cccccaggca tcaggatggt caatttagtg caggttgctg
tgacaacacc cttgtagttt tagtgcaggt tgctgtgaca acagccttgt
agttttctcc agcaactaag atgtctgcta tttccactcc aaatgcagta
gtgacagctg tgagggggag agattgtctc catcatctag catcaggtcc
ccagagggtg aggttagaaa cagctcaggg agcagctaga attctggtca
ccagactccc caccagggtc tgaggacaca aggtcttaga gaatgtcaga
ggagcttggt aagtgtaaaa aagtgaccag gctagtctga aatcgggcca
aagtctccag ctctccccac cccaactttc ataaatggtg cacatctatg
gaccctgacc agaatgagtt tgctattctc tctcagggag ccctgctcct
gtgaaggctc agctctggtc tgggggtaaa agaatgacta gaagggaaaa
gagacctgga tgctgcagag gaggaaacaa aaacaaaaac aaaaacgccg
aagggccaca catttgcctt cacagtcttc agagcctgag gccaggatgc
aggcttaggc tggtcaaagg gtccactctg ttttgacaaa gccaagccac
agtcaagggg gatctgctgt gtaccttctt cttaagaact cggtctttga
ngaaactttt gggtttcctg tcttatcact ggttttccct attnccccag
aaatagatga agaccggatc cccaactcac ttctcaaggt gagctggccc
ctaccattca gcccaggcct caaaagccaa accctcatcc tccagatctg










































































































































































































































8701 AAGAWBBB fCAGAAGTTG GTATCCGGGG ATCACCACTG CAGTGTGGAA
8751 ATTCATGGAC ACTGGATGTT TCTTAATCTC TTGTTTTTAA AAAGTGATAA
8801 ATTTAGGTGT TAGGTCCTTG GAGCTTTTCT TCTTTCCAGC CCGGGGATCC
8851 CTTCCTCCTT CAGCTCTTGT CTGCACCCCA CTGCCCCCAC CCTCAGGACC
8901 GATTAAGGAA GGAAATAGCA AACTGACAAA AGCCTAGCCT CCACTAGCAA
8951 AATAGAAAAA TAGACGTCTG GAAGTAGGAG GTCGCCTCAA GGTTTTCCTT
9001 TGNNCTGTGG AAAGCTCTGC CCACAGAGCA GGTTAGCCTA CTTGGGAGAC
9051 TGCTGCTCTA AAGCG
185
Figure A8. Comparison of the 2kb HindlW restriction fragment from clone type 1 (Tl)
and clone type 2 (T2) isolated from the library screening. Since the two sequences are
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tstract
Protein phosphatase inhibitor-1 (inhibitor-1 or 1-1) is involved in signal transduction and is an endogenous inhibitor of protein phospha-
e-1. The mouse 1-1 protein sequence has been deduced from cDNA and is strongly homologous to the published rat sequence. A mouse
nomic library was screened, and the I-1 gene was characterized and localized by fluorescent in situ hybridization (FISH) to chromosome
;F. Protein expression in a range of embryonic and adult tissue was analysed using confocal microscopy. Inhibitor-1 is expressed by: the
elomic epithelium; the epithelial bounding layer of cells of the kidney, lung, liver, heart, intestine and gonad; and the surface ectoderm,
e blast cells of the kidney do not express 1-1. We conclude that I-1 is a marker for mesothelium. © 2000 Elsevier Science Ireland Ltd. All
hts reserved.
ywords: Protein phosphatase inhibitor-1; Inhibitor-1; I-1; Chromosome; mRNA; Gene; Mesothelium; Ectoderm; Laminin-1
Results
I. Genetic analysis
A keyword search of the dbEST database yielded a full-
tgth mouse cDNA clone homologous to rat protein phos-
atase inhibitor-1 (inhibitor-1 or I-1; dbEST clone 926702;
nnon et al., 1996). Sequencing this clone allowed us to
duce the 171-amino-acid sequence of the protein, which
ows 95.3% homology to the rat sequence (Fig. 1). Using
>T sequences as a probe, two types of genomic clones
;re isolated from a library screening: the type 1 clone
4 kb) spans the entire 1-1 coding sequence; and the type
Hone (12 kb) includes the first exon and ~9 kb of the 5'
nking sequence (Fig. 2). Subclones from type 1 DNA
;re sequenced and analysed to identify exon location,
lalysis of ~400 bp of the 5' sequence (including the
st exon) using the NIX computer program (http://
vw.hgmp.mrc.ac.uk/) revealed a CpG score of 0.74. The
rorithm is based on work by Gardiner-Garden and From-
;r (1987) using a scale between 0 and 1.0, with values
jser to 1.0 indicating the presence of a CpG island. Fluor-
:ent in situ hybridization (FISH) showed that the 1-1 gene
Corresponding author. Tel.: +44-131-650-3106; fax: +44-131-650-
15.
E-mail address: lornam@holyrood.ed.ac.uk (L. McLaren).
(Fig. 3a) is located at the end of chromosome 15, band F
(Fig. 3b).
1.2. Protein expression
Svennilson et al. (1995) suggested that 1-1 is a specific
marker for kidney mesenchymal stem cells. Therefore, the
1-1 expression pattern in mouse kidneys was investigated
(Table 1). From El2.5 onwards, the protein is restricted to
the cytoplasm of the peripheral layer of cells (Fig. 4a,b) that
has a unilaminar squamous epithelial morphology (Williams
et al., 1995). However, in Ell and 11.5 kidneys, LI is
expressed by the coelomic epithelium surrounding the inter¬
mediate mesoderm within which is the early kidney rudiment
(Fig. 4c).
The Pax-2 antibody labels nuclei ofcondensed metanephric
mesenchyme at the kidney periphery (Dressier and Douglass,
1992). E13.5—15.5 kidneys were analysed for Pax-2 expres¬
sion (Fig. 4d), but since the antibody did not label the outer¬
most layerof cells, there is no co-expression with I-1. Thus, 1-1
does not label metanephric mesenchyme cells.
The epithelial morphology of the I-1-positive cells was
confirmed with anti-laminin and anti-pan cytokeratin anti¬
bodies using El2.5-16.5 kidneys. The laminin antibody
labelled the basal lamina of the peripheral I-1-positive
cells and developing nephrogenic tubules (Fig. 4e,f).
Other organs from the coelomic cavity (e.g. lung and
25-4773/00/$ - see front matter © 2000 Elsevier Science Ireland Ltd. All rights reserved.
: S0925-4773(00)00388-9



























Fig. 1. Comparison of mouse inhibitor-1 amino acid sequence with the
predicted sequence from rat skeletal muscle cDNA (Elbrecht et al.,
1990), the deduced human sequence from cDNA clones isolated from a
brain library (Endo et al., 1996) and the sequenced protein derived from
rabbit skeletal muscle (Aitken et al., 1982). The alignments were obtained
by Clustal analysis (http://www.hgmp.mrc.ac.uk/). Asterisks indicate resi¬
dues which are identical in all four species. The 25 nucleotide differences
between the mouse and rat mRNA sequences result in eight amino acid
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Fig. 2. Two clone types were isolated from the A 129 mouse genomic libn
and span the inhibitor-1 (I-1) gene with a 2-kb overlap. The CpG island a
selected restriction sites are marked. The 1-1 gene is contained in ~7 kb
genomic DNA and the deduced protein sequence is encoded by se\
exons.
tives of ectoderm) was not visible in whole-mount embry
(E9.5-11.5), nor in embryonic mesenchymal derivativ
(e.g. bone and tendon), vascular endothelium or epitheli
tissue such as lung bronchii (data not shown).
heart from El2.5 to adult) express a peripheral laminin-
positive basal lamina (Fig. 5a) that underlies the I-1-positive
cells (Table 1 and Fig. 5b—f).
The developing gonads express 1-1 in the coelomic
epithelial layer from El2.5 (Fig. 6a,b). In the testis, 1-1 is
also expressed by the sex cords, but is down-regulated after
their formation: at —E13.5, three out of 12 testes were posi¬
tive for 1-1 expression in the internal sex cords (Fig. 6c-e),
but after El3.5, there was no further internal 1-1 expression.
Inhibitor-1 is also expressed in the outermost layer of
cells of the ectoderm and the periderm of the cornea, an
ectoderm-derived layer (Fig. 7 and Table 1). However, 1-1
expression in brain and neural tube (the other major deriva-
2. Conclusion
The localization and immunostaining observatio
suggest that 1-1 is expressed by the mesothelium, a unil
minar squamous epithelial cell layer derived from the coel-
mic epithelium that covers the tissue of the coelomic cavii
3. Experimental procedures
3.1. Genetic analysis
The dbEST database was screened to obtain mou











Fig. 3. Chromosomal localization of the inhibitor-1 (1-1) gene, (a) The genomic clone type 1 was labelled with biotin. and the signal visualized using success
layers of avidin FITC, biotinylated anti-avidin and avidin FITC. The chromosomes were counterstained with 1 g 1 1 4',6-diamidino-2-phenylindole (DAI
and hybridization signals were visualized with a Zeiss Axioplan epifluorescence microscope. The white arrows show the 1-1 gene on a normal mo1
metaphase spread and the 1-1 signal is apparent in an adjacent interphase cell, (b) Giemsa banding of the metaphase spread showing the localization of
1-1 gene on chromosome 15 band F (indicated by red arrows).
L. McLaren et al /Mechanisms ofDevelopment 96 (2000) 237-241 239
able I
nalysis of mouse tissue for inhibitor-1 (1-1) expression
issue Embryonic age of mouse tissue (days)"
9.5" 10.5" 11.5b 12.5 13.5 14.5 15.5 16.5 17.5 18.5 Adult
idney ND ND + + + + + + + + +
ung ND ND ND + + + + + + + +
iver ND ND ND + + + + + + + +
eart ND ND ND + + + + + + + +
itestine ND ND ND + ND ND + + ND + +
onad ND ND ND + + + + + + + +
kin + + + + + + + + + + +
ye + + + ND ND ND ND + ND ND ND
a + , positive staining for I-l; ND, not determined.
b Whole-mount embryo used.
26702 was sequenced and a 5' 336-bp PCR product was
mplified. A A 129 PS mouse genomic library (NBL Gene
ciences Ltd) was screened using the 336-bp PCR product
nd full-length clone 926702. DNA from the type 1 clone
'as subcloned, sequenced and analysed using the NIX
computer program (http://www.hgmp.mrc.ac.uk/). The
genomic DNA clone type 1 was labelled by nick translation
with Bio-16-dUTP (Roche) and hybridized to normal mouse
metaphase chromosomes, as described by Fantes et al.
(1992).
g. 4. Confocal analysis of a range of kidney ages using antibodies to inhibitor-1 (I-l), Pax-2 and laminin (FITC, green; propidium iodide, red). Inhibitor-1
;pression is shown in: (a) El 2.5 kidney (bar = 20 p.m); the I-1 signal is indicated by the white arrow and is restricted to the periphery of the developing organ;
0 E16.5 kidney (bar = 20 pm); and (c) El 1.5 kidney (bar = 20 pm); I-l expression is present in the epithelium of the coelomic cavity (white arrow, A), but
rt in the rudimentary kidney (white arrow, B). (d) Pax-2 expression in the E13.5 kidney (bar = 20 pm). The nuclei of the peripheral condensed mesenchyme
:11s and collecting tubes are positive (indicated by the white arrow). The red arrow shows the peripheral layer of cells that does not express Pax-2. Laminin
:pression in: (e) El2.5 kidney (bar = 20 pm); there is weak laminin expression in the basal lamina of the peripheral cells of the tissue (white arrow, A) in
tmparison to that around the ureteric bud (white arrow, B); and (f) E13.5 kidney (bar = 20 pm); peripheral laminin staining increases as the kidney matures.
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Fig. 5. Laminin and inhibitor-1 expression in tissue of the coelomic cavity
(FITC, green; propidium iodide, red), (a) Laminin expression in El2.5 lung
(bar = 20 pm). There is laminin expression in the basal laminae of the
peripheral layer of cells and within the lung (indicated by white arrows),
(b-f) Inhibitor-1 expression in embryonic mouse tissue: (b) El3.5 lung
(bar = 20 |xm); (c) E17.5 intestine (bar = 50 pin): (d) E12.5 heart
(bar = 20 pm); (e) El2.5 liver (bar = 20 pm); and (f) El7.5 ovary
(bar = 100 pm).
3.2. Protein expression
Noon on the day of mating is referred to as E0.5. Mouse
Fig. 7. Inhibitor-1 expression at El6.5 (FITC, green; propidium iodide. re(
showing (a) the surface view of periderm of the eye (bar = 20 pan) an
(b,c) the surface ectoderm of hindlimb digits (b, bar = 100 pm; c, bar = 2
pm). Inhibitor-1 expression is restricted to the surface epithelial cells.
embryonic and ndiili I issues wore, fixed in 4% para forma
dehyde. The 1-1 antibody (Serotec) was diluted in PBS/If
Triton X-100 (Sigma) and whole-mount specimens wet
incubated overnight. The 1-1 antibody was detected b
anti-sheep FITC antibody (Sigma), and the tissue wr
RNase-treated, counterstained with propidium iodide an
analysed by confocal microscopy (Leitz TSCNT). Tissu
incubated in PBS instead of PBSTX gave an identic;
expression pattern. For negative controls, tissues wei
processed as described above, but no primary antibod-
was added. Anti-Pax-2 antibody (a gift from Dr Greg Dres:
ler) and anti-laminin antibody (Sigma) were detected b
anti-rabbit-FITC secondary antibody (Sigma).
Fig. 6. Inhibitor-1 (I-1) expression in the developing gonads (FITC, green; propidium iodide, red). (a,b) Inhibitor-1 expression in El2.5 in different gonads
restricted to the surface epithelium (a, bar = 100 pm; b, bar = 20 pm). (c-e) Inhibitor-1 expression in the sex cords of ~E13.5 testis (c, bar = 100 pm;
bar = 50 pm; e, bar = 20 pm). Three out of 12 testes analysed had I-l-positive sex cords at this age, but older gonads showed no internal expression of tl
protein, suggesting down-regulation of 1-1 after mesothelial cell migration.
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